Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 116
Encontrada(s) 2 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

The axonal repellent Slit2 inhibits pericyte migration: Potential implications in angiogenesis

  • Guijarro-Muñoz, Irene
  • Cuesta Martínez, Ángel
  • Alvarez-Cienfuegos, Ana
  • Geng, Juanguao
  • Alvarez-Vallina, Luís
  • Sanz, Laura
The Slit family of secreted proteins acts through the Roundabout (Robo) receptors to repel axonal migration during central nervous system development. Emerging evidence shows that Slit/Robo interactions also play a role in angiogenesis. The effect of Robo signaling on endothelial cells has been shown to be context-dependent. However, the role of Slit/Robo in pericytes has been largely unexplored. The aim of this study was to determine the effect of Slit2 on primary human pericytes and to address the underlying mechanisms, including the receptors potentially implicated. We demonstrate that both Robo1 and Robo4 are expressed by human pericytes. In the presence of their ligand Slit2, spontaneous and PDGF-induced migration of pericytes was impaired. This antimigratory activity of Slit-2 correlated with the inhibition of actin-based protrusive structures. Interestingly, human pericyte interaction with immobilized Slit2 was inhibited in the presence of anti-Robo1 and anti-Robo4 blocking antibodies, suggesting the implication of both receptors. These results add new insights into the role of Slit proteins during the angiogenic process that relies on the directional migration not only of endothelial cells but also of pericytes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy

  • Chavarria, Laia|||0000-0002-7455-9929
  • Alonso, Juli
  • García Martínez, Rita|||0000-0003-2159-2757
  • Simón Talero, Macarena|||0000-0002-1409-3936
  • Ventura-Cots, Meritxell|||0000-0001-9513-2855
  • Ramírez, Clara
  • Torrens, Maria|||0000-0003-3479-0066
  • Vargas Blasco, Víctor|||0000-0002-7190-6948
  • Rovira, Alex|||0000-0002-2132-6750
  • Córdoba Cardona, Juan
Brain magnetic resonance (MR) study has shown metabolic abnormalities and changes in water distribution of the brain tissue that may relate to the pathogenesis of hepatic encephalopathy (HE). We designed a study to investigate the disturbances in brain water and metabolites during episodic HE using a 3-T MR scanner. Cirrhotic patients with different grades of HE underwent MR during hospitalization (n=18). The MR was repeated at 6 weeks' follow-up (n=14). The results were compared with those of a group of healthy volunteers (n=8). During episodic HE, brain diffusion-weighted imaging showed a high apparent diffusion coefficient (ADC) (12% to 14%) that decreased during follow-up (-1% to-4%). These disturbances were accompanied by high glutamine (581%), low choline (-31%), and low myo-inositol (-86%) peaks on MR spectroscopy. In overt HE, patients showed high glutamine that decreased during follow-up (-22%). In addition, these patients exhibited a rise in plasma S100 beta and enlargement of brain white-matter lesions. In conclusion, several disturbances detected by MR support the presence of impaired brain water homeostasis during episodic HE. Although astrocytes have a major role in this condition, brain edema during episodic HE may be extracellular and does not appear to be directly responsible for the development of neurologic manifestations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations

  • Garcia-Garcia, G.
  • Aparisi, M.J.
  • Jaijo, T.
  • Rodrigo, R.
  • Leon, A.M.
  • Avila-Fernandez, A.
  • Blanco-Kelly, Fiona|||0000-0003-0052-5651
  • Bernal, Sara|||0000-0003-4427-0574
  • Navarro, R.
  • Diaz-Llopis, M.
  • Baiget Bastús, Montserrat
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Millan, J.M.
  • Aller, E.
Background: Usher Syndrome type II (USH2) is an autosomal recessive disorder, characterized by moderate to severe hearing impairment and retinitis pigmentosa (RP). Among the three genes implicated, mutations in the USH2A gene account for 74-90% of the USH2 cases. Methods. To identify the genetic cause of the disease and determine the frequency of USH2A mutations in a cohort of 88 unrelated USH Spanish patients, we carried out a mutation screening of the 72 coding exons of this gene by direct sequencing. Moreover, we performed functional minigene studies for those changes that were predicted to affect splicing. Results: As a result, a total of 144 DNA sequence variants were identified. Based upon previous studies, allele frequencies, segregation analysis, bioinformatics' predictions and in vitro experiments, 37 variants (23 of them novel) were classified as pathogenic mutations. Conclusions: This report provide a wide spectrum of USH2A mutations and clinical features, including atypical Usher syndrome phenotypes resembling Usher syndrome type I. Considering only the patients clearly diagnosed with Usher syndrome type II, and results obtained in this and previous studies, we can state that mutations in USH2A are responsible for 76.1% of USH2 disease in patients of Spanish origin. © 2011 Garcia-Garcia et al; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Economic Evaluation of Traditional Treatments for Localized Prostate Cancer, A 10-Year Cohort Study

  • Zamora, Víctor|||0000-0003-2061-0052
  • Bosch, Guillermo
  • Becerra, Virginia|||0000-0002-8811-3899
  • Garin, Olatz|||0000-0001-6193-0779
  • Ávila, Mónica|||0000-0001-9583-5104
  • Gutiérrez Miguélez, Cristina|||0000-0002-6944-772X
  • Suárez, José Francisco|||0000-0001-6427-4391
  • Goñi, Alai|||0000-0002-6365-9617
  • Macías Hernández, Víctor|||0000-0003-2904-5715
  • Mariño, Alfonso|||0000-0002-6720-3916
  • Hervás Morón, Asunción|||0000-0002-7439-1820
  • Herruzo, I.
  • Cabrera, Patricia|||0000-0001-6050-7354
  • Ponce de León Roca, Javier|||0000-0003-0250-2533
  • Sancho-Pardo, Gemma|||0000-0003-2266-6172
  • Pont, À.
  • Rubio-Valera, M.
  • Alonso, Jordi|||0000-0001-8627-9636
  • Cots Reguant, Francesc|||0000-0003-0238-8902
  • Guedea, Ferran|||0000-0001-8798-8696
  • Castells-Esteve, Manel|||0000-0003-2370-2008
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
Objectives: To perform a cost-effectiveness analysis based on primary data from a cohort of patients with localized prostate cancer followed throughout 10 years, comparing radical prostatectomy, brachytherapy, and external beam radiotherapy (EBRT) and applying disease-specific utilities, from a national health system's perspective. Materials and Methods: Patients diagnosed with localized prostate cancer were consecutively recruited in 2003-2005 from 10 Spanish hospitals (n = 674) (ClinicalTrials.gov number: NCT01492751). The expanded prostate cancer index composite (EPIC) and short-form 36 (SF-36) questionnaires were administered through telephone interviews before treatment and annually during follow-up. The outcome measures to evaluate the incremental cost-effectiveness ratio between treatments (ICER) were quality-adjusted life-years (QALYs), calculated by the patient-oriented prostate utility scale (PORPUS) utility index, obtained with a mapping from the EPIC and the SF-36, and survival data. Ten-year medical activities were used to derive costs. Both unweighted and propensity score-weighted analyses were performed. Results: The weighted mean of 10-year QALYs was the highest for radical prostatectomy (8.53), followed by brachytherapy (8.49) and external radiotherapy (8.20), but the difference was only statistically significant with the latter. Costs were significantly higher for brachytherapy (€21,348) than radical prostatectomy (€12,281) and EBRT (€7,560). Compared to EBRT, the weighted ICER for radical prostatectomy was €14,169/QALY gained and €48,417/QALY for brachytherapy. Conclusion: Our findings support that radical prostatectomy was the most cost-effective alternative, but the differences in effectiveness among the three treatments were small. The incremental cost of radical prostatectomy and brachytherapy compared to EBRT, however, does not justify restricting these alternatives. Trial Registration: ClinicalTrials.gov identifier: NCT01492751.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Coenzyme Q10-Responsive Ataxia: 2-Year-Treatment Follow-up

  • Pineda, Merce
  • Montero, Raquel
  • Aracil, Asunción
  • O'Callaghan, Mar M.
  • Mas, Ana
  • Espinós-Armero, Carmen Ángeles
  • Martínez-Rubio, Dolores
  • Palau, Francesc
  • Navas, Placido
  • Briones, Paz
  • Artuch, Rafael
[EN] We assessed the clinical outcome after coenzyme Q(10) (CoQ(10)) therapy in 14 patients presenting ataxia classified into two groups according to CoQ(10) values in muscle (deficient or not). We performed an open-label prospective study: patients were evaluated clinically (international cooperative ataxia rating scale [ICARS] scale, MRI, and videotape registration) at baseline and every 6 months during a period of 2 years after CoQ(10) treatment (30 mg/kg/day). Patients with CoQ(10) deficiency showed a statistically significant reduction of ICARS scores (Wilcoxon test: P = 0.018) after 2 years of CoQ(10) treatment when compared with baseline conditions. In patients without CoQ(10) deficiency, no statistically significant differences were observed in total ICARS scores after therapy, although I patient from this group showed a remarkable clinical amelioration. Biochemical diagnosis of CoQ(10) deficiency was a useful tool for the selection of patients who are good candidates for treatment as all of them responded to therapy. However, the remarkable clinical response in I case without CoQ(10) deficiency highlights the importance of treatment trials for identification of patients with CoQ(10)-responsive ataxia., This work was supported by grants from the Fondo de Investigacion Sanitaria (FIS PI080663 and PI080307). The CIBERER is an initiative of the Instituto de Salud Carlos III (ISCIII MICIN, Spain). We are grateful to patients and their families for their kind collaboration and to Professor Di Mauro for the critical revision of the article. We acknowledge Dr. M. Lluch for fibroblast cultures and the expert technical assistance of Sonia Moliner. R. Artuch is supported by the program Intensificacion de la Actividad Investigadora (ISCIII). The research activity of M. Pineda, A. Aracil, A. Mas, P. Navas, and P. Briones was funded by Fondo de Investigacion Sanitaria and CSIC. R. Montero, M.M. O'Callaghan, D. Martinez, and F. Palau were funded by the CIBERER. C. Espinos has a "Miguel Servet" contract (FIS).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway

  • Lupo,Vincenzo
  • Martínez-Rubio, Dolores
  • Sevilla, Teresa
  • Vílchez, Juan José
  • Palau, Francesc
  • Espinós-Armero, Carmen Ángeles
  • Galindo, Máximo Ibo|||0000-0001-8448-9760
[EN] Mutations in SH3TC2 (KIAA1985) cause Charcot-Marie-Tooth disease (CMT) type 4C, a demyelinating inherited neuropathy characterized by early-onset and scoliosis. Here we demonstrate that the SH3TC2 protein is present in several components of the endocytic pathway including early endosomes, late endosomes and clathrin-coated vesicles close to the trans-Golgi network and in the plasma membrane. Myristoylation of SH3TC2 in glycine 2 is necessary but not sufficient for the proper location of the protein in the cell membranes. In addition to myristoylation, correct anchoring also needs the presence of SH3 and TPR domains. Mutations that cause a stop codon and produce premature truncations that remove most of the TPR domains are expressed as the wild-type protein. In contrast, missense mutations in or around the region of the first-TPR domain are absent from early endosomes, reduced in plasma membrane and late endosomes and are variably present in clathrin-coated vesicles. Our findings suggest that the endocytic and membrane trafficking pathway is involved in the pathogenesis of CMT4C disease. We postulate that missense mutations of SH3TC2 could impair communication between the Schwann cell and the axon causing an abnormal myelin formation., This work was supported by the Fondo de Investigacion Sanitaria [grant numbers PI08/90857, PI08/0889, CP08/00053] and the Spanish Ministry Science and Innovation [grant number SAF2006-01047]. V. L. is a recipient of JAE predoctoral fellowship from the Spanish Scientific Research Council (CSIC). M. I. G. has a `Ramon y Cajal' contract funded by the Ministry of Science and Innovation. C. E. has a `Miguel Servet' contract funded by the Fondo de Investigacion Sanitaria. Both CIBERER and CIBERNED are initiatives from the Instituto de Salud Carlos III. We are grateful to patients and their families for their kind collaboration. We thank B. Alarcón for his technical assistance and also anonymous reviewers for their invaluable insight and suggestions
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease

  • Sivera, Rafael
  • Espinós-Armero, Carmen Ángeles
  • Vílchez, Juan J.
  • Mas, Fernando
  • Martínez-Rubio, Dolores
  • Chumillas, María José
  • Mayordomo, Fernando
  • Muelas, Nuria
  • Bataller, Luis
  • Palau, Francesc
  • Sevilla, Teresa
[EN] Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K). Most of these mutations present a recessive inheritance, but few autosomal dominant GDAP1 mutations have also been reported. We performed a GDAP1 gene screening in a clinically well-characterized series of 81 index cases with axonal CMT neuropathy, identifying 17 patients belonging to 4 unrelated families in whom the heterozygous p.R120W was found to be the only disease-causing mutation. The main objective was to fully characterize the neuropathy caused by this mutation. The clinical picture included a mild-moderate phenotype with onset around adolescence, but great variability. Consistently, ankle dorsiflexion and plantar flexion were impaired to a similar degree. Nerve conduction studies revealed an axonal neuropathy. Muscle magnetic resonance imaging studies demonstrated selective involvement of intrinsic foot muscles in all patients and a uniform pattern of fatty infiltration in the calf, with distal and superficial posterior predominance. Pathological abnormalities included depletion of myelinated fibers, regenerative clusters and features of axonal degeneration with mitochondrial aggregates. Our findings highlight the relevance of dominantly transmitted p.R120W GDAP1 gene mutations which can cause an axonal CMT with a wide clinical profile., We are grateful to the propositi and their relatives for their kind collaboration. We also want to thank I. Llopis and M. Escutia for their help with sample management. This work was supported by the Instituto de Salud Carlos III [PI08/90857, PI08/0889, CP08/00053 and PS09/00095], the Fundacion para la Investigacion del Hospital Universitari La Fe [CM06/00154], the Spanish Ministry Science and Innovation [grant number SAF2006-01047], and the Generalitat Valenciana [grant no. Prometeo/2009/05]. Dr. C. Espinos has a "Miguel Servet'' contract funded by the Fondo de Investigacion Sanitaria. Both Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) and Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) are initiatives from the Instituto de Salud Carlos III.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series

  • Sivera, Rafael
  • Sevilla, T.
  • Vílchez, Juan Jesús
  • Martínez-Rubio, Dolores
  • Chumillas, María José
  • Vázquez, Juan Francisco
  • Muelas, Nuria
  • Bataller, Luis
  • Millán, José María
  • Palau, Francesc
  • Espinós-Armero, Carmen Ángeles
[EN] Objectives: To determine the genetic distribution and the phenotypic correlation of an extensive series of patients with Charcot-Marie-Tooth disease in a geographically well-defined Mediterranean area. Methods: A thorough genetic screening, including most of the known genes involved in this disease, was performed and analyzed in this longitudinal descriptive study. Clinical data were analyzed and compared among the genetic subgroups. Results: Molecular diagnosis was accomplished in 365 of 438 patients (83.3%), with a higher success rate in demyelinating forms of the disease. The CMT1A duplication (PMP22 gene) was the most frequent genetic diagnosis (50.4%), followed by mutations in the GJB1 gene (15.3%), and in the GDAP1 gene (11.5%). Mutations in 13 other genes were identified, but were much less frequent. Sixteen novel mutations were detected and characterized phenotypically. Conclusions: The relatively high frequency of GDAP1 mutations, coupled with the scarceness of MFN2 mutations (1.1%) and the high proportion of recessive inheritance (11.6%) in this series exemplify the particularity of the genetic distribution of Charcot-Marie-Tooth disease in this region., This collaborative joint project is awarded by IRDiRC and funded by the Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion within the framework of the National R+D+I Plan (grants IR11/TREAT-CMT, PI08/90857, PI08/0889, CP08/00053, PI12/00453, and PI12/0946), cofunded with FEDER funds, and the Generalitat Valenciana (grant Prometeo/2009/051). The Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) and the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) are initiatives from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Genetic epidemiology of the Charcot-Marie-Tooth in the Spanish Gypsy population: the Hereditary Motor and Sensory Neuropathy type Russe in depth

  • Sevilla, T.
  • Martínez-Rubio, D.
  • Márquez, C.
  • Paradas, C.
  • Colomer, J.
  • Jaijo, T.
  • Millán, JM
  • Palau, F.
  • Espinós-Armero, Carmen Ángeles
[EN] Four private mutations responsible for three forms demyelinating of Charcot-Marie-Tooth (CMT) or hereditary motor and sensory neuropathy (HMSN) have been associated with the Gypsy population: the NDRG1 p.R148X in CMT type 4D (CMT4D/HMSN-Lom); p.C737_P738delinsX and p.R1109X mutations in the SH3TC2 gene (CMT4C); and a G>C change in a novel alternative untranslated exon in the HK1 gene causative of CMT4G (CMT4G/HMSN-Russe). Here we address the findings of a genetic study of 29 Gypsy Spanish families with autosomal recessive demyelinating CMT. The most frequent form is CMT4C (57.14%), followed by HMSN-Russe (25%) and HMSN-Lom (17.86%). The relevant frequency of HMSN-Russe has allowed us to investigate in depth the genetics and the associated clinical symptoms of this CMT form. HMSN-Russe probands share the same haplotype confirming that the HK1 g.9712G>C is a founder mutation, which arrived in Spain around the end of the 18th century. The clinical picture of HMSN-Russe is a progressive CMT disorder leading to severe weakness of the lower limbs and prominent distal sensory loss. Motor nerve conduction velocity was in the demyelinating or intermediate range., We thank all patients and their relatives for their kind collaboration. We also thank Drs G. Glover, R. Vilches, F. Galan, and C. Diaz for referring patients for genetic analysis. We also acknowledge F Barraclough for English corrections. This work was supported by the Instituto de Salud Carlos III (ISCIII) (grants number PI08/90857, PI08/0889, CP08/00053 and PS09/00095) co-funded with FEDER funds and by the ISCIII-IRDiRC Programme (TREAT-CMT grant). C. E. has a 'Miguel Servet' contract funded by the ISCIII. Both Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) and Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) are initiative from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Impact of monopolar radiofrequency coagulation on intraoperative blood loss during liver resection: a prospective randomised controlled trial

  • Quesada-Diez, Rita
  • Poves, Ignasi
  • Vilaplana, Carles
  • Andaluz, Anna
  • Moll, Xavier
  • Dorcaratto, Dimitri
  • Grande, Luís
  • Burdío Pinilla, Fernando
  • Berjano, Enrique|||0000-0002-3247-2665
Purpose: To evaluate the impact of using monopolar thermal coagulation based on radiofrequency (RF) currents on intraoperative blood loss during liver resection. Materials and methods: A prospective randomized controlled trial was planned. Patients undergoing hepatectomy were randomized into two groups. In the Control group (n=10), hemostasis was obtained with a combination of stitches, vessel-sealing bipolar RF systems, sutures or clips. In the monopolar radiofrequency coagulation (MRFC) group (n=18), hemostasis was mainly obtained using an internally cooled monopolar RF electrode. Results: No differences in demographic or clinical characteristics were found between groups. Mean blood loss during liver resection in the Control group was more than twice that of the MRFC group (556±471 ml vs. 225±313 ml, p=0.02). The adjusted mean bleeding/transection area was also significantly higher in the Control group (7.0±3.3 ml/cm2 vs. 2.8±4.0 ml/cm2 , p=0.006). No significant differences were observed in the rate of complications between the groups. Conclusions: The findings suggest that the monopolar electrocoagulation created with an internally-cooled RF electrode considerably reduces intraoperative blood loss during liver resection., This work was supported by a medical research grant from the Spanish Government (FIS PI080934) and by Spanish "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad" under Grant TEC2014-52383-C3-R (TEC2014-52383-C3-1-R and TEC2014-52383-C3-3-R).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Transección hepática sin suturas mediante un nuevo instrumento asistido por radiofrecuencia. Modelado teórico, estudio experimental y ensayo clínico, Sutureless hepatic transection using a new radiofrequency assisted device. Theoretical model, experimental study and clinic trial

  • Martinez-Serrano, MA
  • Grande, Luis
  • Burdío, Fernando
  • Poves, Ignasi
  • Quesada, Rita
  • Berjano, Enrique|||0000-0002-3247-2665
[ES] El instrumento ideal para realizar la transección hepática debería aunar en una sola herramienta hemostasia segura y rápida. Presentamos nuestra investigación multidisciplinar encaminada al desarrollo de un dispositivo de transección hepática asistido por radiofrecuencia (RF); la investigación incluye: modelado teórico por computador, estudio experimental y ensayo clínico de este dispositivo. El modelado teórico se realizó por computador basado en el Método de Elementos Finitos (MEF) con objeto de estudiar la distribución de energía eléctrica y temperatura en el tejido y valorar el efecto de las características del instrumento. El estudio experimental basado en un modelo in vivo porcino sugiere que el nuevo instrumento permitiría aumentar la velocidad de transección del parénquima hepático con una menor hemorragia por área de transección al compararlo con otras técnicas ampliamente extendidas en la cirugía hepática. Estos datos permitieron afrontar la realización de la primera fase de un ensayo clínico, cuyos resultados preliminares sugieren que el nuevo instrumento es seguro y eficaz., [EN] The ideal instrument for performing hepatic transection should combine safe and rapid haemostasis in a single tool. We present a new multidisciplinary investigation designed to develop a hepatic transection device assisted by radiofrequency (RF); the investigation included: a computerised theoretical model, and experimental study and a clinical trial of this device. The theoretic modelling was performed by computer, based on the Finite Elements Method (FEM), with the objective of studying the distribution of electrical energy and temperature in the tissue, and to assess the effect of the characteristics of the instrument. The experimental study, based on an in vivo porcine model, suggested that the new instrument would allow the transection velocity of the hepatic parenchyma to be increased with lower bleeding per transection area compared with other techniques extensively used in liver surgery. These data should enable the first phase of clinical trial to be conducted, with preliminary results that suggest that the new device is safe and effective., Los autores agradecen al Ministerio de Ciencia e Innovación el apoyo financiero otorgado mediante el Programa de Proyectos de I + D + i (Proyecto n.8 TEC2008-01369/TEC), y el Programa de Promoción de la Investigación Biomédica y en Ciencias de la Salud (Proyecto n.8 PI080934).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Approach to the epidemiology of venomous bites in Spain

  • Saz-Parkinson, Zuleika
  • Pino Luengo, Miguel del
  • López-Cuadrado, Teresa
  • Andújar, Dionisio
  • Carmona-Alférez, Rocío
  • Martín Flores, Ricardo
  • Amate, José María
This review presents a geographic distribution of the three autochthonous venomous snake species, which are the only viperids present in Spain, among the Iberian fauna: Vipera aspid; Vipera seoianei and Vipera latasti. This is followed by a detailed descriptive analysis of hospital care provided to patients admitted into hospital due to venomous bites, in the period from 1997 to 2009, using the data from the Spanish hospital discharge registry database. This analysis reveals that in Spain, during this period, 1649 cases were recorded, which means that hospital care was required for more than one hundred cases per year, of which nearly 1% of the cases resulted in death. Cases were recorded in all the Autonomous communities, but more than half (54, 14%) were concentrated in the following four regions: Cataluña, Castilla and León, Galicia and Andalucía. It is notable that this concentration of cases is not associated only with the population demographics of the community, but is also the result of the concurrence of very diverse factors of exposure including: habitat of venomous fauna, volume of rural population, farming activities, and practice of outdoor leisure activities. We also carried out a gross economic calculation for the use of hospital resources by each snakebite case requiring hospital care in Spain, which provided us with an approximate figure of 2000€ per case., We would like to thank Dra. María Ángeles Gogorcena Aoiz, from the Institute of Health Information of the Ministry of Health, Social Services and Equality, for her help in accessing the data from the hospital discharge registry database. We would also like to thank Mr. Mario García París, Mr. Jesús Dorda and Ms. Soledad Alonso, from the National Museum of Natural Sciences of Madrid who have provided us the images of the three autochthonous viper species that appear in the article. This work is a partial result of the research agreement signed between the Instituto de Salud Carlos III and Instituto Bioclon S.L. de C.V. partially funded by “Fondo de Cooperación Internacional en Ciencia y Tecnología entre México y la Unión Europea” (FONCICYT) (application number 93608). It is part of a research project (ref. PI08/90612) of the Spanish National R&D plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

  • Rodríguez, Victoria
  • Alameda, Luis
  • Quattrone, Diego
  • Tripoli, Giada
  • Gayer-Anderson, Charlotte
  • Spinazzola, Edoardo
  • Trotta, Giulia
  • Jongsma, Hannah E
  • Stilo, Simona
  • La Cascia, Caterina
  • Ferraro, Laura
  • La Barbera, Daniele
  • Lasalvia, Antonio
  • Tosato, Sarah
  • Tarricone, Ilaria
  • Bonora, Elena
  • Jamain, Stéphane
  • Selten, Jean-Paul
  • Velthorst, Eva
  • de Haan, Lieuwe
  • Llorca, Pierre-Michel
  • Arrojo, Manuel
  • Bobes, Julio
  • Bernardo, Miguel
  • Arango, Celso
  • Kirkbride, James
  • Jones, Peter B
  • Rutten, Bart P
  • Richards, Alexander
  • Sham, Pak C
  • O'Donovan, Michael
  • Van Os, Jim
  • Morgan, Craig
  • Di Forti, Marta
  • Murray, Robin M
  • Vassos, Evangelos
Schizophrenia (SZ), bipolar disorder (BD) and depression (D) run in families. This susceptibility is partly due to hundreds or thousands of common genetic variants, each conferring a fractional risk. The cumulative effects of the associated variants can be summarised as a polygenic risk score (PRS). Using data from the EUropean Network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI) first episode case-control study, we aimed to test whether PRSs for three major psychiatric disorders (SZ, BD, D) and for intelligent quotient (IQ) as a neurodevelopmental proxy, can discriminate affective psychosis (AP) from schizophrenia-spectrum disorder (SSD)., This work was supported by funding from the European Community's Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). VR was funded by a PhD scholarship supported by Lord Leverhulme's Charitable Trust and the Velvet Foundation. EV is funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. CA was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), Fundación Familia Alonso and Fundación Alicia Koplowitz. MB was supported by the Ministry od Economy and Competitivity (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM, by the CERCA Programme/Generalitat de Catalunya and Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya, en la convocatoria corresponent a l'any 2017 de concessió de subvencions del PERIS 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345; and grateful for the support of the Institut de Neurociències, Universitat de Barcelona., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Determinants of between-hospital variations in outcomes for patients admitted with COPD exacerbations: findings from a nationwide clinical audit (AUDIPOC) in Spain

  • Pozo-Rodríguez, Francisco
  • Castro-Acosta, A.
  • Álvarez, C. J.
  • López-Campos, J. L.
  • Forte, A.
  • López-Quilez, A.
  • Agustí, Alvar
  • Abraira, V.
[Background] Previous studies have demonstrated significant variability in the processes of care and outcomes of chronic obstructive pulmonary disease (COPD) exacerbations. The AUDIPOC is a Spanish nationwide clinical audit that identified large between-hospital variations in care and clinical outcomes. Here, we test the hypothesis that these variations can be attributed to either patient characteristics, hospital characteristics and/or the so-called hospital-clustering effect, which indicates that patients with similar characteristics may experience different processes of care and outcomes depending on the hospital to which they are admitted., [Methods] A clinical audit of 5178 COPD patients consecutively admitted to 129 Spanish public hospitals was performed, with a 90-day follow-up. Multilevel regression analysis was conducted to model the probability of patients experiencing adverse outcomes. For each outcome, an empty model (with no independent variables) was fitted to assess the clustering effect, followed by a model adjusted for the patient- and hospital-level covariables. The hospital-clustering effect was estimated using the intracluster correlation coefficient (ICC); the cluster heterogeneity was estimated with the median odds ratio (MOR), and the coefficients of predictors were estimated with the odds ratio (OR)., [Results] In the empty models, the ICC (MOR) for inpatient mortality and the follow-up mortality and readmission were 0.10 (1.80), 0.08 (1.65) and 0.01 (1.24), respectively. In the adjusted models, the variables that most represented the patients’ clinical conditions and interventions were identified as outcome predictors and further reduced the hospital variations. By contrast, the resource factors were primarily unrelated with outcomes., [Conclusions] This study demonstrates a noteworthy reduction in the observed crude between-hospital variation in outcomes after accounting for the hospital-cluster effect and the variables representing patient's clinical conditions. This emphasises the predictor importance of the patients’ clinical conditions and interventions, and understates the impacts of hospital resources and organisational factors., Supported by the Spanish Ministry of Health, Instituto de Salud Carlos III, FIS project numbers: PI07/90129, PI07/90309, PI07/90486, PI07/90503, PI07/90516, PI07/90721, PI08/90129, PI08/90578, PI08/90251, PI08/90529, PI08/90129, PI07/90403, PI08/90447, PI08/90457, PI08/90486 and PI08/90550, the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) and the Spanish Society of Respiratory and Thoracic Surgey (SEPAR)., Peer reviewed
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Publication Artículo científico (JournalArticle)

Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models

  • Cuadrado-Castano, Sara
  • Ayllón Barasoain, Juan
  • Mansour, Mena
  • Iglesia-Vicente, Janis de la
  • Jordan, Stefan
  • Tripathi, Shashank
  • García Sastre, Adolfo
  • Villar, Enrique
Newcastle disease virus (NDV) is considered a promising agent for cancer therapy due to its oncolytic properties. These include preferential replication in transformed cells, induction of innate and adaptive immune responses within tumors, and cytopathic effects in infected tumor cells due to the activation of apoptosis. To enhance the latter and thus possibly enhance the overall oncolytic activity of NDV, we generated a recombinant NDV encoding the human TNF receptor Fas (rNDV-B1/Fas). rNDV-B1/Fas replicates to similar titers as its wild-type (rNDV-B1) counterpart; however, overexpression of Fas in infected cells leads to higher levels of cytotoxicity correlated with faster and increased apoptosis responses, in which both the intrinsic and extrinsic pathways are activated earlier. Furthermore, in vivo studies in syngeneic murine melanoma models show an enhancement of the oncolytic properties of rNDV-B1/Fas, with major improvements in survival and tumor remission. Altogether, our data suggest that upregulation of the proapoptotic function of NDV is a viable approach to enhance its antitumor properties and adds to the currently known, rationally based strategies to design optimized therapeutic viral vectors for the treatment of cancer., R01AI088770 from NIAID to A. García-Sastre and PI08/1813 from the Spanish Fondo de Investigaciones Sanitarias (co-financed by FEDER funds from the EU) to E.Villar. S.Cuadrado-Castano was a predoctoral fellowship holder from the Spanish JCYL (co-financed by European Social Funds (EDU/330/2008; 2008–2012). M. Mansour was supported by NCI 5 T32 CA 78207-13 training grant.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Physical activity and bone health in schoolchildren: The mediating role of fitness and body fat

  • Torres-Costoso, A.
  • Gracia-Marco, L.
  • Sánchez-López, M.
  • Notario-Pacheco, B.
  • Arias-Palencia, N.
  • Martínez-Vizcaíno, V.
Background: The relationship between physical activity (PA) and bone health is well known, although the role of percent body fat (%BF) and fitness as confounders or mediators in this relationship remains uncertain. Objective: To examine whether the association between PA and bone mineral content (BMC) is mediated by %BF and cardiorespiratory fitness (CRF). Methods: In this cross sectional study, BMC, total %BF (by DXA), vigorous PA (VPA), CRF, age and height were measured in 132 schoolchildren (62 boys, aged 8-11 years). ANCOVA was used to test differences in BMC by %BF, CRF and VPA, controlling for different sets of confounders. Simple mediation analyses and serial multiple mediation analyses were fitted to examine whether the relationship between PA and BMC is mediated by %BF and fitness. Results: Children with high %BF had higher total body BMC than their peers after controlling for all sets of confounders. Children with good CRF or VPA had significantly less total body BMC after controlling for age and sex but in children with good CRF this inverse relation disappeared after adjusting by %BF. %BF and CRF both act as a full mediator in the association between VPA and BMC, after inclusion of the potential confounders in the models. Conclusion: Fitness and %BF seem to have a mediator role on the relationship between physical activity and bone mass.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A pharmacovigilance study in first episode of psychosis: Psychopharmacological interventions and safety profiles in the peps project

  • Bioque, M.
  • Llerena, A.
  • Cabrera, B.
  • Mezquida, G.
  • Lobo, A.
  • González-Pinto, A.
  • Díaz-Caneja, C.M.
  • Corripio, I.
  • Aguilar, E.J.
  • Bulbena, A.
  • Castro-Fornieles, J.
  • Vieta, E.
  • Lafuente, A.
  • Mas, S.
  • Parellada, M.
  • Saiz-Ruiz, J.
  • Cuesta, M.J.
  • Bernardo, M.
  • Gassó, P.
  • Amoretti, S.
  • García Bernardo, E.
  • Tapia-Casellas, C.
  • Alonso-Solís, A.
  • Grasa, E.
  • Hernández, M.
  • González, I.
  • Ruiz, P.
  • Modrego, F.
  • Escartí, M.J.
  • Mané, A.
  • Torrent, C.
  • Baeza, I.
  • Contreras, F.
  • Albacete, A.
  • Bobes, J.
  • García-Portilla, Ma P.
  • Zabala Rabadán, A.
  • Segarra Echevarría, R.
  • Rodriguez-Jimenez, R.
  • Morales-Muñoz, I.
  • Butjosa, A.
  • Landin-Romero, R.
  • Sarró, S.
  • Ibáñez, Á.
  • Sánchez-Torres, A.Ma
  • Balanzá-Martínez, V.
Background: The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice. Methods: Sixteen participating centers from the PEPs project recruited 335 first episode of psychosis patients, aged 7 to 35 years. This article describes and discusses the psychopharmacological interventions and safety profiles at baseline and during a 60-day pharmacovigilance period. Results: The majority of first episode of psychosis patients received a second-generation antipsychotic (96.3%), orally (95%), and in adjusted doses according to the product specifications (87.2%). A total of 24% were receiving an antipsychotic polytherapy pattern at baseline, frequently associated with lower or higher doses of antipsychotics than the recommended ones. Eight patients were taking clozapine, all in monotherapy. Males received higher doses of antipsychotic (P=.043). A total of 5.2% of the patients were being treated with long-acting injectable antipsychotics; 12.2% of the patients received anticholinergic drugs, 12.2% antidepressants, and 13.7% mood stabilizers, while almost 40% received benzodiazepines; and 35.52% reported at least one adverse drug reaction during the pharmacovigilance period, more frequently associated with higher antipsychotic doses and antipsychotic polytherapy (85.2% vs 45.5%, P<.001). Conclusions: These data indicate that the overall pharmacologic prescription for treating a first episode of psychosis in Spain follows the clinical practice guideline recommendations, and, together with security issues, support future research of determinate pharmacological strategies for the treatment of early phases of psychosis, such as the role of clozapine, long-acting injectable antipsychotics, antipsychotic combination, and the use of benzodiazepines.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study

  • Quintero, E.
  • Carrillo, M.
  • Leoz, M.L
  • Cubiella, J.
  • Gargallo, C.
  • Lanas, A.
  • Bujanda, L.
  • Gimeno-García, A.Z.
  • Hernández-Guerra, M.
  • Nicolás-Pérez, D.
  • Alonso-Abreu, I.
  • Morillas, J.D.
  • Balaguer, F.
  • Muriel, A.
Background: First-degree relatives (FDR) of patients with colorectal cancer have a higher risk of developing colorectal cancer than the general population. For this reason, screening guidelines recommend colonoscopy every 5 or 10 y, starting at the age of 40, depending on whether colorectal cancer in the index-case is diagnosed at <60 or =60 y, respectively. However, studies on the risk of neoplastic lesions are inconclusive. The aim of this study was to determine the risk of advanced neoplasia (three or more non-advanced adenomas, advanced adenoma, or invasive cancer) in FDR of patients with colorectal cancer compared to average-risk individuals (i.e., asymptomatic adults 50 to 69 y of age with no family history of colorectal cancer). Methods and Findings: This cross-sectional analysis includes data from 8, 498 individuals undergoing their first lifetime screening colonoscopy between 2006 and 2012 at six Spanish tertiary hospitals. Of these individuals, 3, 015 were defined as asymptomatic FDR of patients with colorectal cancer (“familial-risk group”) and 3, 038 as asymptomatic with average-risk for colorectal cancer (“average-risk group”). The familial-risk group was stratified as one FDR, with one family member diagnosed with colorectal cancer at =60 y (n = 1, 884) or at <60 y (n = 831), and as two FDR, with two family members diagnosed with colorectal cancer at any age (n = 300). Multiple logistic regression analysis was used for between-group comparisons after adjusting for potential confounders (age, gender, and center). Compared with the average-risk group, advanced neoplasia was significantly more prevalent in individuals having two FDR with colorectal cancer (odds ratio OR] 1.90; 95% confidence interval CI] 1.36–2.66, p < 0.001), but not in those having one FDR with colorectal cancer diagnosed at =60 y (OR 1.03; 95% CI 0.83–1.27, p = 0.77) and <60 y (OR 1.19; 95% CI 0.90–1.58, p = 0.20). After the age of 50 y, men developed advanced neoplasia over two times more frequently than women and advanced neoplasia appeared at least ten y earlier. Fewer colonoscopies by 2-fold were required to detect one advanced neoplasia in men than in women. Major limitations of this study were first that although average-risk individuals were consecutively included in a randomized control trial, this was not the case for all individuals in the familial-risk cohort; and second, the difference in age between the average-risk and familial-risk cohorts. Conclusions: Individuals having two FDR with colorectal cancer showed an increased risk of advanced neoplasia compared to those with average-risk for colorectal cancer. Men had over 2-fold higher risk of advanced neoplasia than women, independent of family history. These data suggest that screening colonoscopy guidelines should be revised in the familial-risk population.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Trends in socioeconomic inequalities in mortality in small areas of 33 Spanish cities

  • Marí-Dell''Olmo, M.
  • Gotsens, M.
  • Palència, L.
  • Rodríguez-Sanz, M.
  • Martinez-Beneito, M.
  • Ballesta, M.
  • Calvo, M.
  • Cirera, L.
  • Daponte, A.
  • Domínguez-Berjón, F.
  • Gandarillas, A.
  • Goñi, N.I.
  • Martos, C.
  • Moreno-Iribas, C.
  • Nolasco, A.
  • Salmerón, D.
  • Taracido, M.
  • Borrell, C.
Background: In Spain, several ecological studies have analyzed trends in socioeconomic inequalities in mortality from all causes in urban areas over time. However, the results of these studies are quite heterogeneous finding, in general, that inequalities decreased, or remained stable. Therefore, the objectives of this study are: (1) to identify trends in geographical inequalities in all-cause mortality in the census tracts of 33 Spanish cities between the two periods 1996–1998 and 2005–2007; (2) to analyse trends in the relationship between these geographical inequalities and socioeconomic deprivation; and (3) to obtain an overall measure which summarises the relationship found in each one of the cities and to analyse its variation over time.Methods: Ecological study of trends with 2 cross-sectional cuts, corresponding to two periods of analysis: 1996–1998 and 2005–2007. Units of analysis were census tracts of the 33 Spanish cities. A deprivation index calculated for each census tracts in all cities was included as a covariate. A Bayesian hierarchical model was used to estimate smoothed Standardized Mortality Ratios (sSMR) by each census tract and period. The geographical distribution of these sSMR was represented using maps of septiles. In addition, two different Bayesian hierarchical models were used to measure the association between all-cause mortality and the deprivation index in each city and period, and by sex: (1) including the association as a fixed effect for each city; (2) including the association as random effects. In both models the data spatial structure can be controlled within each city. The association in each city was measured using relative risks (RR) and their 95 % credible intervals (95 % CI).Results: For most cities and in both sexes, mortality rates decline over time. For women, the mortality and deprivation patterns are similar in the first period, while in the second they are different for most cities. For men, RRs remain stable over time in 29 cities, in 3 diminish and in 1 increase. For women, in 30 cities, a non-significant change over time in RR is observed. However, in 4 cities RR diminishes. In overall terms, inequalities decrease (with a probability of 0.9) in both men (RR¿=¿1.13, 95 % CI¿=¿1.12–1.15 in the 1st period; RR¿=¿1.11, 95 % CI¿=¿1.09–1.13 in the 2nd period) and women (RR¿=¿1.07, 95 % CI¿=¿1.05–1.08 in the 1st period; RR¿=¿1.04, 95 % CI¿=¿1.02–1.06 in the 2nd period).Conclusions: In the future, it is important to conduct further trend studies, allowing to monitoring trends in socioeconomic inequalities in mortality and to identify (among other things) temporal factors that may influence these inequalities.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Tracheal self-expandable metallic stents: A comparative study of three different stents in a rabbit model

  • Serrano, Carolina
  • Lostalé, Fernando
  • Rodríguez-Panadero, Francisco
  • de Blas, Ignacio
  • Laborda, Alicia
  • de Gregorio, Miguel Angel
Introduction: The objective of this study was to assess tracheal reactivity after the deployment of different self-expandable metal stents (SEMS). Material and methods: Forty female New Zealand rabbits were divided into four groups. Three groups received three different SEMS: steel (ST), nitinol (NiTi), or nitinol drug-eluting stent (DES); the fourth group was the control group (no stent). Stents were deployed percutaneously under fluoroscopic guidance. Animals were assessed by multislice, computed tomography (CT) scans, and tracheas were collected for anatomical pathology (AP) study. Data from CT and AP were statistically analyzed and correlated. Results: The DES group had the longest stenosis (20.51±14.08 mm vs 5.84±12.43 and 6.57±6.54 mm in NiTi and ST, respectively, day 30; P<.05), and higher granuloma formation on CT (50% of cases). The NiTi group showed the lowest grade of stenosis (2.86±6.91% vs 11.28±13.98 and 15.54±25.95% in DES and ST, respectively; P<.05). The AP study revealed that the ST group developed intense proliferative reactivity compared to the other groups. In the DES group, a destructive response was observed in 70% of the animals, while the NiTi was the least reactive stent. CT was more effective in detecting wall thickening (positive correlation of 68.9%; P<.001) than granuloma (not significant). Conclusions: The ST group developed granulomas and significant stenosis. NiTi was the least reactive stent, while DES caused significant lesions that may be related to drug dosage. This type of DES stent is therefore not recommended for the treatment of tracheobronchial stenosis. Introducción: El objetivo de este estudio es evaluar la reactividad traqueal tras la implantación de distintos stents metálicos autoexpandibles (SMAE). Material y métodos: Se utilizaron 40 conejos hembra de raza neozelandesa, que se dividieron en 4 grupos. En 3 grupos se implantaron SMAE: de acero (SA), de nitinol (NiTi) o stents liberadores de nitinol (SLF). El cuarto grupo fue el grupo de control (sin stent). Los stents se implantaron por vía percutánea bajo control fluoroscópico. Los animales se evaluaron mediante tomografía axial computarizada (TAC) multicorte y las tráqueas se extirparon para su estudio anatomopatológico (EAP). Los datos de la TAC y el EAP se analizaron estadísticamente y se correlacionaron Resultados: El grupo que recibió SLF presentaba la mayor longitud de estenosis (20,51±14,08 mm frente a 5,84±12,43 y 6,57±6,54 mm en los grupos NiTi y SA, día 30; p < 0,05) y el mayor índice de formación de granulomas evidenciados mediante TAC (50% de los casos). El grupo al que se implantaron stents NiTi mostró el menor grado de estenosis (2,86±6,91% frente a 11,28±13,98 y 15,54±25,95% en los grupos SLF y SA; p < 0,05). En el estudio AP, el grupo SA presentó reactividad proliferativa intensa en comparación con los otros 2 grupos. En el grupo SLF se observó una respuesta destructiva en el 70% de animales, mientras que el stent NiTi fue el que menos reacción provocó. La TAC resultó ser superior para detectar el engrosamiento (correlación positiva de un 68,9%; p < 0,001) que para la observación de granulomas (n.s.). Conclusiones: El grupo SA desarrolló granulomas y estenosis significativas. El stent NiTi fue el que menos reacción indujo, mientras que el SLN provocó lesiones importantes que podrían estar relacionadas con la dosis de fármaco. Por consiguiente, este tipo de SLF no se recomienda para el tratamiento de la estenosis traqueobronquial.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Opposite cannabis-cognition associations in psychotic patients depending on family history

  • González-Pinto, A.
  • González-Ortega, I.
  • Alberich, S.
  • De Azúa, S.R.
  • Bernardo, M.
  • Bioque, M.
  • Cabrera, B.
  • Corripio, I.
  • Arango, C.
  • Lobo, A.
  • Sánchez-Torres, A.M.
  • Cuesta, M.J.
  • Ugarte, A.
  • Fernández, M.
  • Mezquida, G.
  • Meseguer, A.
  • Vieta, E.
  • Torrent, C.
  • Contreras, F.
  • Albacete, A.
  • Alonso-Solís, A.
  • Rabella, M.
  • Moreno-Izco, L.
  • Usall, J.
  • Butjosa, A.
  • Ibáñez, Á.
  • Bobes, J.
  • Al-Halabí, S.
  • Zapata-Usábel, M.T.
  • Laporta-Herrero, I.
  • Balanzá-Martínez, V.
  • Bergé, D.
  • Mané, A.
  • Rodriguez-Jimenez, R.
  • Morales-Muñoz, I.
  • Gutierrez, M.
  • Zabala, A.
  • Sarró, S.
  • Landin-Romero, R.
  • Serna, De La
  • Baeza, I.
  • Parellada, M.
  • Espliego, A.
  • Juan, J.S.
  • Aguilar, E.
The objective of this study is to investigate cognitive performance in a first-episode psychosis sample, when stratifying the interaction by cannabis use and familial or non-familial psychosis. Hierarchical-regression models were used to analyse this association in a sample of 268 first-episode psychosis patients and 237 controls. We found that cannabis use was associated with worse working memory, regardless of family history. However, cannabis use was clearly associated with worse cognitive performance in patients with no family history of psychosis, in cognitive domains including verbal memory, executive function and global cognitive index, whereas cannabis users with a family history of psychosis performed better in these domains. The main finding of the study is that there is an interaction between cannabis use and a family history of psychosis in the areas of verbal memory, executive function and global cognition: that is, cannabis use is associated with a better performance in patients with a family history of psychosis and a worse performance in those with no family history of psychosis. In order to confirm this hypothesis, future research should explore the actual expression of the endocannabinoid system in patients with and without a family history of psychosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effect of oral anticoagulants on the outcome of faecal immunochemical test

  • Bujanda, L.
  • Sarasqueta, C.
  • Lanas, Á.
  • Quintero, E.
  • Cubiella, J.
  • Hernandez, V.
  • Morillas, J.D.
  • Perez-Fernández, T.
  • Salas, D.
  • Andreu, M.
  • Carballo, F.
  • Bessa, X.
  • Portillo, I.
  • Jover, R.
  • Balaguer, F.
  • Cosme, A.
  • Castells, A.
Background: We aimed to evaluate whether oral anticoagulants (OACs) alter faecal immunochemical test (FIT) performance in average-risk colorectal cancer (CRC) screening. Methods: Individuals aged 50–69 years were invited to receive one FIT sample (cutoff 75¿ng¿ml–1) between November 2008 and June 2011. Results: Faecal immunochemical test was positive in 9.3% (21 out of 224) of users of OAC and 6.2% (365 out of 5821) of non-users (P-trend=0.07). The positive predictive value (PPV) for advanced neoplasia (AN) in non-users was 50.4% vs 47.6% in users (odds ratio, 0.70; 95% CI, 0.3–1.8; P=0.5). The PPV for AN in OAC more antiplatelets (aspirin or clopidogrel) was 75% (odds ratio, 2; 95% CI, 0.4–10.8; P=0.4). Conclusions: Oral anticoagulant did not significantly modify the PPV for AN in this population-based colorectal screening program. The detection rate of advanced adenoma was higher in the combination OAC more antiplatelets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Changes in frequency-doubling perimetry in patients with type i diabetes prior to retinopathy

  • Pinilla, I.
  • Ferreras, A.
  • Idoipe, M.
  • Sanchez-Cano, A.
  • Perez-Garcia, D.
  • Herrera, L.X.
  • Pinilla, M.J.
  • Abecia, E.
Purpose. To evaluate the ability of frequency-doubling technology (FDT) perimetry in detecting visual field defects in young adults with type I diabetes prior to retinopathy or with minor retinovascular changes. Methods. This comparative cross-sectional study included 30 healthy subjects and 73 age-matched patients with type I diabetes mellitus. All subjects underwent a full ocular examination including an FDT with the threshold C-20-5 strategy. Only one eye per subject was randomly included in the statistical analysis. FDT results and time to perform the test were compared between the groups. Results. The mean age was 27.1 years in the control group and 26.6 years in the diabetic group ( ). The mean period from the onset of diabetes was years, while minimal retinovascular changes were observed in 18 eyes. Mean deviation of FDT did not differ between the groups. Although global indices of FDT were within normal limits, pattern standard deviation of FDT was higher in the diabetic group ( ). The area under the receiver operating characteristic curve was 0.647 for pattern standard deviation of FDT (standard error = 0.052; ). Conclusion. FDT can detect retinal dysfunctions in diabetic patients prior to the onset of significant vascular complications.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Applying spatio-temporal models to assess variations across health care areas and regions: Lessons from the decentralized Spanish National Health System

  • Librero, J.
  • Ibañez, B.
  • Martínez-Lizaga, N.
  • Peiró, S.
  • Bernal-Delgado, E.
Objective To illustrate the ability of hierarchical Bayesian spatio-temporal models in capturing different geo-temporal structures in order to explain hospital risk variations using three different conditions: Percutaneous Coronary Intervention (PCI), Colectomy in Colorectal Cancer (CCC) and Chronic Obstructive Pulmonary Disease (COPD). Research design This is an observational population-based spatio-temporal study, from 2002 to 2013, with a two-level geographical structure, Autonomous Communities (AC) and Health Care Areas (HA). Setting The Spanish National Health System, a quasi-federal structure with 17 regional governments (AC) with full responsibility in planning and financing, and 203 HA providing hospital and primary care to a defined population. Methods A poisson-log normal mixed model in the Bayesian framework was fitted using the INLA efficient estimation procedure. Measures The spatio-temporal hospitalization relative risks, the evolution of their variation, and the relative contribution (fraction of variation) of each of the model components (AC, HA, year and interaction AC-year). Results Following PCI-CCC-CODP order, the three conditions show differences in the initial hospitalization rates (from 4 to 21 per 10, 000 person-years) and in their trends (upward, inverted V shape, downward). Most of the risk variation is captured by phenomena occurring at the HA level (fraction variance: 51.6, 54.7 and 56.9%). At AC level, the risk of PCI hospitalization follow a heterogeneous ascending dynamic (interaction AC-year: 17.7%), whereas in COPD the AC role is more homogenous and important (37%). Conclusions In a system where the decisions loci are differentiated, the spatio-temporal modeling allows to assess the dynamic relative role of different levels of decision and their influence on health outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, S.
  • Lorenzo Bermejo, J.
  • Chang Claude, J.
  • Hoffmeister, M.
  • Fernández Rozadilla, C.
  • Carracedo, A.
  • Castells, A.
  • Castellví Bel, S.
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Antoni, C.
  • Virgínia, P.
  • Sergi, C.B.
  • Balaguer, F.
  • Victoria, G.
  • Teresa, O.
  • María Dolores, G.
  • Maria, P.
  • Anna, S.
  • Leticia, M.
  • Miriam, C.
  • Josep, M.P.
  • Lanas, A.
  • Alcedo, J.
  • Ortego, F.J.
  • Joaquin, C.
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Montserrat, A.
  • Anna, A.
  • Xavier, B.
  • Mar, I.
  • Agustín, S.
  • Felipe, B.
  • Gemma, N.
  • Beatriz, B.
  • De Josep, M.
  • Cristina, Á.
  • Marc, P.
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, d.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Cristina, A.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Jaime, C.
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Jaime, S.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Antoni, T.
  • Juan, C.
  • Vicent, H.
  • Xavier, L.
  • Rosa, M.X.
  • Marta, P.
  • Mercè, R.
  • Anna, R.
  • Elisenda, P.
  • José, M.H.
  • Miquel, A.G.
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, E.
  • Montserrat, F.
  • Maria, E.
  • Josep, M.R.
  • Carmen, P.
  • Juan, B.
  • Joan, V.
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • Dolors, G.
  • Eva, R.
  • Teresa, R.
  • Maria, P.
  • Ma, M.C.
  • Marta, M.
  • Lourdes, P.
  • Daniel, M.
  • Ángel, C.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno, V.
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, H.
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Influence of a commercial antithrombotic filter on the caval blood flow during neutra and valsalva maneuver

  • Nicolas, M.
  • Lucea, B.
  • Laborda García, Alicia
  • Peña, E.
  • Gregorio, M.A. de
  • Martinez, M.A.
  • Malve, M.
Anticoagulants are the treatment of choice for pulmonary embolism. When these fail or are contraindicated, vena cava filters are effective devices for preventing clots from the legs from migrating to the lung. Many uncertainties exist when a filter is inserted, especially during physiological activity such as normal breathing and the Valsalva maneuver. These activities are often connected with filter migration and vena cava damage due to the various related vein geometrical configurations. In this work, we analyzed the response of the vena cava during normal breathing and Valsalva maneuver, for a healthy vena cava and after insertion of a commercial Günther-Tulip® filter. Validated computational fluid dynamics (CFD) and patient specific data are used for analyzing blood flow inside the vena cava during these maneuvers. While during normal breathing, the vena cava flow can be considered almost stationary with a very low pressure gradient, during Valsalva the extravascular pressure compresses the vena cava resulting in a drastic reduction of the vein section, a global flow decrease through the cava but increasing the velocity magnitude. This change in the section is altered by the presence of the filter which forces the section of the vena cava before the renal veins to keep open. The effect of the presence of the filter is investigated during these maneuvers showing changes in wall shear stress and velocity patterns.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

  • González-Ortega, I.
  • González-Pinto, A.
  • Alberich, S.
  • Echeburuá, E.
  • Bernardo, M.
  • Cabrera, B.
  • Amoretti, S.
  • Lobo, A.
  • Arango, C.
  • Corripio, I.
  • Vieta, E.
  • De La Serna, E.
  • Rodriguez-Jimenez, R.
  • Segarra, R.
  • López-Ilundain, J.M.
  • Sánchez-Torres, A.M.
  • Cuesta, M.J.
  • Zorrilla, I.
  • López, P.
  • Bioque, M.
  • Mezquida, G.
  • Barcones, F.
  • De-La-Cámara, C.
  • Parellada, M.
  • Espliego, A.
  • Alonso-Solís, A.
  • Grasa, E.M.
  • Varo, C.
  • Montejo, L.
  • Castro-Fornieles, J.
  • Baeza, I.
  • Dompablo, M.
  • Torio, I.
  • Zabala, A.
  • Eguiluz, J.I.
  • Moreno-Izco, L.
  • Sanjuan, J.
  • Guirado, R.
  • Cáceres, I.
  • Garnier, P.
  • Contreras, F.
  • Bobes, J.
  • Al-Halabí, S.
  • Usall, J.
  • Butjosa, A.
  • Sarró, S.
  • Landin-Romero, R.
  • Ibáñez, A.
  • Selva, G.
Background. Social cognition has been associated with functional outcome in patients with first episode psychosis (FEP). Social cognition has also been associated with neurocognition and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cognition, and functional outcome are related, the direction of their associations is not clear. Therefore, the main aim of this study was to analyze the influence of social cognition as a mediator between cognitive reserve and cognitive domains on functioning in FEP both at baseline and at 2 years. Methods. The sample of the study was composed of 282 FEP patients followed up for 2 years. To analyze whether social cognition mediates the influence of cognitive reserve and cognitive domains on functioning, a path analysis was performed. The statistical significance of any mediation effects was evaluated by bootstrap analysis. Results. At baseline, as neither cognitive reserve nor the cognitive domains studied were related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2 years of follow-up, social cognition acted as a mediator between cognitive reserve and functioning. Likewise, social cognition was a mediator between verbal memory and functional outcome. The results of the bootstrap analysis confirmed these significant mediations (95% bootstrapped CI (-10.215 to -0.337) and (-4.731 to -0.605) respectively). Conclusions. Cognitive reserve and neurocognition are related to functioning, and social cognition mediates in this relationship.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

  • Amoretti, S.
  • Verdolini, N.
  • Mezquida, G.
  • Rabelo-da-Ponte, F.D.
  • Cuesta, M.J.
  • Pina-Camacho, L.
  • Gomez-Ramiro, M.
  • De-la-Cámara, C.
  • González-Pinto, A.
  • Díaz-Caneja, C.M.
  • Corripio, I.
  • Vieta, E.
  • de la Serna, E.
  • Mané, A.
  • Solé, B.
  • Carvalho, A.F.
  • Serra, M.
  • Bernardo, M.
The extreme variability in symptom presentation reveals that individuals diagnosed with a first-episode psychosis (FEP) may encompass different sub-populations with potentially different illness courses and, hence, different treatment needs. Previous studies have shown that sociodemographic and family environment factors are associated with more unfavorable symptom trajectories. The aim of this study was to examine the dimensional structure of symptoms and to identify individuals’ trajectories at early stage of illness and potential risk factors associated with poor outcomes at follow-up in non-affective FEP. One hundred and forty-four non-affective FEP patients were assessed at baseline and at 2-year follow-up. A Principal component analysis has been conducted to identify dimensions, then an unsupervised machine learning technique (fuzzy clustering) was performed to identify clinical subgroups of patients. Six symptom factors were extracted (positive, negative, depressive, anxiety, disorganization and somatic/cognitive). Three distinct clinical clusters were determined at baseline: mild; negative and moderate; and positive and severe symptoms, and five at follow-up: minimal; mild; moderate; negative and depressive; and severe symptoms. Receiving a low-dose antipsychotic, having a more severe depressive symptomatology and a positive family history for psychiatric disorders were risk factors for poor recovery, whilst having a high cognitive reserve and better premorbid adjustment may confer a better prognosis. The current study provided a better understanding of the heterogeneous profile of FEP. Early identification of patients who could likely present poor outcomes may be an initial step for the development of targeted interventions to improve illness trajectories and preserve psychosocial functioning.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

  • Rodriguez, Natalia
  • Gasso, Patricia
  • Martinez-Pinteno, Albert
  • Segura, Alex-Gonzalez
  • Mezquida, Gisela
  • Moreno-Izco, Lucia
  • Gonzalez-Penas, Javier
  • Zorrilla, Inaki
  • Martin, Marta
  • Rodriguez-Jimenez, Roberto
  • Corripio, Iluminada
  • Sarro, Salvador
  • Ibanez, Angela
  • Butjosa, Anna
  • Contreras, Fernando
  • Bioque, Miquel
  • Cuesta, Manuel-Jesus
  • Parellada, Mara
  • Gonzalez-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miquel
  • Mas, Sergi
  • Silvia Amoretti, S.
  • Moren, Constanza
  • Stella, Carol
  • Gurriaran, Xaquin
  • Alonso-Solis, Anna
  • Grasa, Eva
  • Fernandez, Jessica
  • Gonzalez-Ortega, Itxaso
  • Casanovas, Francesc
  • Bulbuena, Antoni
  • Nunez-Doyle, Agatha
  • Jimenez-Rodriguez, Olga
  • Pomarol-Clotet, Edith
  • Feria-Raposo, Isabel
  • Usall, Judith
  • Munoz-Samons, Daniel
  • Ilundain, Jose L.
  • Maria Sanchez-Torres, Ana
  • Saiz-Ruiz, Jeronimo
  • Lopez-Torres, Isabel
  • Nacher, Juan
  • De la Camara Izquierdo, Concepcion
  • Gutierrez, Miguel
  • Alejandra Saiz, Pilar
A better understanding of schizophrenia subtypes is necessary to stratify the patients according to clinical attributes. To explore the genomic architecture of schizophrenia symptomatology, we analyzed blood co-expression modules and their association with clinical data from patients in remission after a first episode of schizophrenia. In total, 91 participants of the 2EPS project were included. Gene expression was assessed using the Clariom S Human Array. Weighted-gene co-expression network analysis (WGCNA) was applied to identify modules of co-expressed genes and to test its correlation with global functioning, clinical symptomatology, and premorbid adjustment. Among the 25 modules identified, six modules were significantly correlated with clinical data. These modules could be clustered in two groups according to their correlation with clinical data. Hub genes in each group showing overlap with risk genes for schizophrenia were enriched in biological processes related to metabolic processes, regulation of gene expression, cellular localization and protein transport, immune processes, and neurotrophin pathways. Our results indicate that modules with significant associations with clinical data showed overlap with gene sets previously identified in differential gene-expression analysis in brain, indicating that peripheral tissues could reveal pathogenic mechanisms. Hub genes involved in these modules revealed multiple signaling pathways previously related to schizophrenia, which may represent the complex interplay in the pathological mechanisms behind the disease. These genes could represent potential targets for the development of peripheral biomarkers underlying illness traits in clinical remission stages after a first episode of schizophrenia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Epigenetic clocks in relapse after a first episode of schizophrenia

  • Segura, Àlex-González
  • Prohens, Llucia
  • Mezquida, Gisela
  • Amoretti, Silvia
  • Bioque, Miquel
  • Ribeiro, María
  • Gurriarán-Bas, Xaquin
  • Rementería, Lide
  • Berge, Daniel
  • Rodriguez-Jimenez, Roberto
  • Roldán, Alexandra
  • Pomarol-Clotet, Edith
  • Ibáñez, Angela
  • Usall, Judith
  • García-Portilla, Maria Paz
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miquel
  • Mas, Sergi
  • González-Díaz, Jairo M.
  • Arbelo, Néstor
  • González-Peñas, Javier
  • Pina-Camacho, Laura
  • Diestre, Alba
  • Selma, Judit
  • Zorrilla, Iñaki
  • López, Purificación
  • Trabsa, Amira
  • Monserrat, Clara
  • Sanchez-Pastor, Luis
  • Nuñez-Doyle, Aggie
  • Fatjó-Vilas, Mar
  • Sarró, Salvador
  • Butjosa, Anna
  • Pardo, Marta
  • López-Ilundain, Jose M.
  • Sánchez Torres, Ana M.
  • Saiz-Ruiz, Jerónimo
  • Ochoa-Mangado, Enriqueta
  • RIevero, Olga
  • De la Cámara, Concepción
  • Segarra Echevarría, Rafael
  • González-Blanco, Leticia
The main objective of the present study was to investigate the association between several epigenetic clocks, covering different aspects of aging, with schizophrenia relapse evaluated over a 3-year follow-up period in a cohort of ninety-one first-episode schizophrenia patients. Genome-wide DNA methylation was profiled and four epigenetic clocks, including epigenetic clocks of chronological age, mortality and telomere length were calculated. Patients that relapsed during the follow-up showed epigenetic acceleration of the telomere length clock (p = 0.030). Shorter telomere length was associated with cognitive performance (working memory, r = 0.31 p = 0.015; verbal fluency, r = 0.28 p = 0.028), but no direct effect of cognitive function or symptom severity on relapse was detected. The results of the present study suggest that epigenetic age acceleration could be involved in the clinical course of schizophrenia and could be a useful marker of relapse when measured in remission stages.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

  • Solanes, Aleix
  • Mezquida, Gisela
  • Janssen, Joost
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • Arango, Celso
  • Vieta, Eduard
  • Castro-Fornieles, Josefina
  • Bergé, Daniel
  • Albacete, Auria
  • Giné, Eloi
  • Parellada, Mara
  • Bernardo, Miguel
  • Bioque, Miquel
  • Morén, Constanza
  • Pina-Camacho, Laura
  • Díaz-Caneja, Covadonga M.
  • Zorrilla, Iñaki
  • Corres, Edurne Garcia
  • De-La-Camara, Concepción
  • Barcones, Fe
  • Escarti, María José
  • Aguilar, Eduardo Jesus
  • Legido, Teresa
  • Martin, Marta
  • Verdolini, Norma
  • Martinez-Aran, Anabel
  • Baeza, Immaculada
  • de la Serna, Elena
  • Contreras, Fernando
  • Bobes, Julio
  • García-Portilla, María Paz
  • Sanchez-Pastor, Luis
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Salgado-Pineda, Pilar
  • Salvador, Raymond
  • Pomarol-Clotet, Edith
  • Radua, Joaquim
Detecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18–24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The effect of early life events on glucose levels in first-episode psychosis

  • Garcia-Rizo, Clemente
  • Cabrera, Bibiana
  • Bioque, Miquel
  • Mezquida, Gisela
  • Lobo, Antonio
  • Gonzalez-Pinto, Ana
  • Diaz-Caneja, Covadonga M.
  • Corripio, Iluminada
  • Vieta, Eduard
  • Baeza, Inmaculada
  • Garcia-Portilla, Maria Paz
  • Gutierrez-Fraile, Miguel
  • Rodriguez-Jimenez, Roberto
  • Garriga, Marina
  • Fernandez-Egea, Emilio
  • Bernardo, Miguel
  • PEPs Group
First episode of psychosis (FEP) patients display a wide variety of metabolic disturbances at onset, which might underlie these patients’ increased morbidity and early mortality. Glycemic abnormalities have been previously related to pharmacological agents; however, recent research highlights the impact of early life events. Birth weight (BW), an indirect marker of the fetal environment, has been related to glucose abnormalities in the general population over time. We aim to evaluate if BW correlates with glucose values in a sample of FEP patients treated with different antipsychotics. Two hundred and thirty-six patients were included and evaluated for clinical and metabolic variables at baseline and at 2, 6, 12, and 24 months of follow-up. Pearson correlations and linear mixed model analysis were conducted to analyze the data. Antipsychotic treatment was grouped due to its metabolic risk profile. In our sample of FEP patients, BW was negatively correlated with glucose values at 24 months of follow-up [r=-0.167, p=0.037]. BW showed a trend towards significance in the association with glucose values over the 24-month period (F=3.22; p=0.073) despite other confounders such as age, time, sex, body mass index, antipsychotic type, and chlorpromazine dosage. This finding suggests that BW is involved in the evolution of glucose values over time in a cohort of patients with an FEP, independently of the type of pharmacological agent used in treatment. Our results highlight the importance of early life events in the later metabolic outcome of patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cortical thinning over two years after first-episode psychosis depends on age of onset

  • Pina-Camacho, Laura
  • Martinez, Kenia
  • Diaz-Caneja, Covadonga M.
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Moreno, Carmen
  • Amoretti, Silvia
  • González-Pinto, Ana
  • Arango, Celso
  • Vieta, Eduard
  • Castro-Fornieles, Josefina
  • Lobo, Antonio
  • Fraguas, David
  • Bernardo, Miguel
  • Janssen, Joost
  • Parellada, Mara
  • Madero, Santiago
  • Gómez-Ramiro, Marta
  • Rodriguez-Toscano, Elisa
  • Santonja, Javier
  • Zorrilla, Iñaki
  • González-Ortega, Itxaso
  • Fayed, Nicolás
  • Santabárbara, Javier
  • Berge, Daniel
  • Toll, Alba
  • Nacher, Juan
  • García Martí, Gracián
  • Sague-Vilavella, Maria
  • Sanchez-Moreno, Jose
  • de la Serna, Elena
  • Baeza, Immaculada
  • Saiz-Masvidal, Cristina
  • Contreras, Fernando
  • González-Blanco, Leticia
  • Bobes-Bascarán, Teresa
  • Dompablo, Mónica
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • Sarró, Salvador
First-episode psychosis (FEP) patients show structural brain abnormalities at the first episode. Whether the cortical changes that follow a FEP are progressive and whether age at onset modulates these changes remains unclear. This is a multicenter MRI study in a deeply phenotyped sample of 74 FEP patients with a wide age range at onset (15–35 years) and 64 neurotypical healthy controls (HC). All participants underwent two MRI scans with a 2-year follow-up interval. We computed the longitudinal percentage of change (PC) for cortical thickness (CT), surface area (CSA) and volume (CV) for frontal, temporal, parietal and occipital lobes. We used general linear models to assess group differences in PC as a function of age at FEP. We conducted post-hoc analyses for metrics where PC differed as a function of age at onset. We found a significant age-by-diagnosis interaction effect for PC of temporal lobe CT (d = 0.54; p = 002). In a post-hoc-analysis, adolescent-onset (≤19 y) FEP showed more severe longitudinal cortical thinning in the temporal lobe than adolescent HC. We did not find this difference in adult-onset FEP compared to adult HC. Our study suggests that, in individuals with psychosis, CT changes that follow the FEP are dependent on the age at first episode, with those with an earlier onset showing more pronounced cortical thinning in the temporal lobe.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

  • Valli, Isabel
  • Gonzalez Segura, Alex
  • Verdolini, Norma
  • Garcia-Rizo, Clemente
  • Berge, Daniel
  • Baeza, Inmaculada
  • Cuesta, Manuel J.
  • Gonzalez-Pinto, Ana
  • Lobo, Antonio
  • Martinez-Aran, Anabel
  • Mezquida, Gisela
  • Pina-Camacho, Laura
  • Roldan Bejarano, Alexandra
  • Mas, Sergi
  • McGuire, Philip
  • Bernardo, Miquel
  • Vieta, Eduard
Background: Obstetric complications (OCs) are key contributors to psychosis risk. However, it is unclear whether they increase psychosis vulnerability independently of genetic risk, in interaction with it, or are a manifestation of psychosis proneness. We examined the role of distinct types of OCs in terms of psychosis risk and tested whether they interact differently with genetic vulnerability, whilst accounting for other known environmental risk factors. Study Design: 405 participants (219 first episode psychosis patients and 186 healthy volunteers) underwent a comprehensive assessment of OCs, measured using the Lewis-Murray scale and divided into complications of pregnancy, abnormalities of foetal growth and development, and complications of delivery. Participants were compared in terms of history of OCs, polygenic risk score for schizophrenia (PRS-SZ) and interactions between these. Results: Both complications of pregnancy and abnormalities of foetal growth were significantly associated with case–control status (p = 0.02 and 0.03, respectively), whereas complications of delivery were not. PRS-SZ showed a significant association with psychosis (p = 0.04), but there were no significant interactions between genetic risk for schizophrenia and OCs, either when these were considered globally or separated based on their timeframe. Conclusions: We observed no significant interaction between genetic and obstetric vulnerability, yet distinct types of OCs may have a different impact on psychosis risk, based on their nature and timeframe. Examining their differential role might clarify their relative contributions to this risk.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults

  • De la Serna, E.
  • Puig, O.
  • Mezquida, G.
  • Moreno-Izco, L.
  • Merchan-Naranjo, J.
  • Amoretti, S.
  • Ruiz Lázaro, P.
  • Gonzalez-Pinto, A.
  • Molina-Garcia, M.
  • Corripio, I.
  • Vieta, E.
  • Baeza, I.
  • Berge, D.
  • Penades, R.
  • Sanchez-Torres, A.
  • Cuesta, M.J.
  • Bernardo, M.
  • Castro-Fornieles, J.
Psychotic disorders typically manifest from late adolescence to early adulthood, and an earlier onset might be associated with greater symptom severity and a worse long-term prognosis. This study aimed to compare the cognitive characteristics of patients with first-episode psychosis (FEP) by their age at onset. We included 298 patients diagnosed with FEP and classified them as having an early onset (EOS), youth onset (YOS), or adult onset (AOS) based on age limits of <= 18 years (N = 61), 19-24 years (N = 121), and >= 25 years (N = 116), respectively. Socio-demographic and clinical variables included age at baseline, gender, socio-economic status, antipsychotic medication, DSM-IV diagnoses assessed by clinical semi-structured interview, psychotic symptom severity, and age at onset. Neuropsychological assessment included six cognitive domains: premorbid intelligence, working memory, processing speed, verbal memory, sustained attention, and executive functioning. The EOS group had lower scores than the YOS or AOS groups in global cognition, executive functioning, and sustained attention. Although the scores in the YOS group were intermediate to those in the EOS and AOS groups for most cognitive factors, no statistically significant differences were detected between the YOS and AOS groups. Age at onset results in specific patterns of cognitive interference. Of note, impairment appears to be greater with EOS samples than with either YOS or AOS samples. A longitudinal study with a larger sample size is needed to confirm our findings.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort

  • Segura, A. G
  • Mané, A.
  • Prohens, Ll.
  • Rodríguez, N.
  • Mezquida, G.
  • Cuesta, M. J
  • Vieta, E.
  • Amoretti, S.
  • Lobo, A.
  • González-Pinto, A.
  • Díaz-Caneja, C. M.
  • Roldán Bejarano, A.
  • Jiménez, E.
  • Baeza, I.
  • Legido, T.
  • Saiz-Ruiz, J.
  • Bernardo, M.
  • Mas, S.
  • PEPs Group
Cannabis use is highly prevalent in first-episode psychosis (FEP) and plays a critical role in its onset and prognosis, but the genetic underpinnings promoting both conditions are poorly understood. Current treatment strategies for cannabis cessation in FEP are clearly inefficacious. Here, we aimed to characterize the association between cannabis-related polygenic risk scores (PRS) on cannabis use and clinical course after a FEP. A cohort of 249 FEP individuals were evaluated during 12 months. Symptom severity was measured with the Positive and Negative Severity Scale and cannabis use with the EuropASI scale. Individual PRS for lifetime cannabis initiation (PRSCI) and cannabis use disorder (PRSCUD) were constructed. Current cannabis use was associated with increased positive symptoms. Cannabis initiation at younger ages conditioned the 12-month symptom progression. FEP patients with higher cannabis PRSCUD reported increased baseline cannabis use. PRSCI was associated with the course of negative and general symptomatology over follow-up. Cannabis use and symptom progression after a FEP were modulated by cannabis PRS, suggesting that lifetime initiation and use disorders may have partially independent genetic factors. These exploratory results may be the first step to identify those FEP patients more vulnerable to cannabis use and worse outcomes to ultimately develop tailored treatments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Obstetric complications and clinical presentation in first episode of psychosis

  • Verdolini, N.
  • Mezquida, G.
  • Valli, I.
  • García-Rizo, C.
  • Cuesta, M.
  • Vieta, E.
  • Bioque, M.
  • Lobo, A.
  • González-Pinto, A.
  • Pina-Camacho, L.
  • Corripio, I.
  • Garriga, M.
  • Baeza, I.
  • Martínez-Sadurní, L.
  • Bitanihirwe, B.
  • Cannon, M.
  • Bernardo, M.
  • De la Cámara, C.
  • Ruiz-Lázaro, P. M.
  • PEPs Group
Objective: Psychotic disorders exhibit a complex aetiology that combines genetic and environmental factors. Among the latter, obstetric complications (OCs) have been widely studied as risk factors, but it is not yet well understood how OCs relate to the heterogeneous presentations of psychotic disorders. We assessed the clinical phenotypes of individuals with a first episode of psychosis (FEP) in relation to the presence of OCs. Methods: Two-hundred seventy-seven patients with an FEP were assessed for OCs using the Lewis–Murray scale, with data stratified into three subscales depending on the timing and the characteristics of the obstetric event, namely: complications of pregnancy, abnormal foetal growth and development and difficulties in delivery. We also considered other two groups: any complications during the pregnancy period and all OCs taken altogether. Patients were clinically evaluated with the Positive and Negative Syndrome Scale for schizophrenia. Results: Total OCs and difficulties in delivery were related to more severe psychopathology, and this remained significant after co-varying for age, sex, traumatic experiences, antipsychotic dosage and cannabis use. Conclusions: Our results highlight the relevance of OCs for the clinical presentation of psychosis. Describing the timing of the OCs is essential in understanding the heterogeneity of the clinical presentation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode

  • Segura, Alex G.
  • Mezquida, Gisela
  • Martínez-Pinteño, Albert
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Moreno-Izco, Lucía
  • Amoretti, Silvia
  • Bioque, Miquel
  • Lobo, Antonio
  • González-Pinto, Ana
  • García-Alcon, Alicia
  • Roldán-Bejarano, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Toll, Alba
  • Cuesta, Manuel J.
  • Mas, Sergi
  • Bernardo, Miquel
Background Clinical intervention in early stages of psychotic disorders is crucial for the prevention of severe symptomatology trajectories and poor outcomes. Genetic variability is studied as a promising modulator of prognosis, thus novel approaches considering the polygenic nature of these complex phenotypes are required to unravel the mechanisms underlying the early progression of the disorder. Methods The sample comprised of 233 first-episode psychosis (FEP) subjects with clinical and cognitive data assessed periodically for a 2-year period and 150 matched controls. Polygenic risk scores (PRSs) for schizophrenia, bipolar disorder, depression, education attainment and cognitive performance were used to assess the genetic risk of FEP and to characterize their association with premorbid, baseline and progression of clinical and cognitive status. Results Schizophrenia, bipolar disorder and cognitive performance PRSs were associated with an increased risk of FEP [false discovery rate (FDR) ⩽ 0.027]. In FEP patients, increased cognitive PRSs were found for FEP patients with more cognitive reserve (FDR ⩽ 0.037). PRSs reflecting a genetic liability for improved cognition were associated with a better course of symptoms, functionality and working memory (FDR ⩽ 0.039). Moreover, the PRS of depression was associated with a worse trajectory of the executive function and the general cognitive status (FDR ⩽ 0.001). Conclusions Our study provides novel evidence of the polygenic bases of psychosis and its clinical manifestation in its first stage. The consistent effect of cognitive PRSs on the early clinical progression suggests that the mechanisms underlying the psychotic episode and its severity could be partially independent.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The polygenic basis of relapse after a first episode of schizophrenia

  • González Segura, Àlex
  • Prohens, Llucia
  • Gassó, Patricia
  • Rodríguez, Natalia
  • Garcia-Rizo, Clemente
  • Moreno-Izco, Lucía
  • Andreu-Bernabeu, Álvaro
  • Zorrilla, Iñaki
  • Mane, Anna
  • Rodríguez-Jiménez, Roberto
  • Roldán, Alexandra
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Sáiz, Pilar A
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Ester
  • Bernardo, Miquel
  • Mas, Sergi
  • Mezquida, Gisela
  • Arbelo, Néstor
  • De Matteis, Mario
  • Galvañ, Joaquín
  • Duque Guerra, Alejandra
  • Arias i Queralt, Laia
  • Perez-Bacigalupe, Maria
  • Gonzalez-Ortega, Itxaso
  • Toll, Alba
  • Casanovas, Francesc
  • Sanchez-Pastor, Luis
  • Valtueña, Mercedes
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Butjosa, Ana
  • Rubio-Abadal, Elena
  • Ribeiro, María
  • López-Ilundain, Jose M.
  • Saiz-Ruiz, Jeronimo
  • León-Quismondo, Luis
  • Rivero, Olga
  • Ruiz, Pedro
  • Echevarría, Rafael Segarra
  • García-Portilla, M. Paz
Little is known about genetic predisposition to relapse. Previous studies have linked cognitive and psychopathological (mainly schizophrenia and bipolar disorder) polygenic risk scores (PRS) with clinical manifestations of the disease. This study aims to explore the potential role of PRS from major mental disorders and cognition on schizophrenia relapse. 114 patients recruited in the 2EPs Project were included (56 patients who had not experienced relapse after 3 years of enrollment and 58 patients who relapsed during the 3-year follow-up). PRS for schizophrenia (PRS-SZ), bipolar disorder (PRS-BD), education attainment (PRS-EA) and cognitive performance (PRS-CP) were used to assess the genetic risk of schizophrenia relapse.Patients with higher PRS-EA, showed both a lower risk (OR=0.29, 95% CI [0.11–0.73]) and a later onset of relapse (30.96± 1.74 vs. 23.12± 1.14 months, p=0.007. Our study provides evidence that the genetic burden of neurocognitive function is a potentially predictors of relapse that could be incorporated into future risk prediction models. Moreover, appropriate treatments for cognitive symptoms appear to be important for improving the long-term clinical outcome of relapse.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: a mediation analysis

  • Clougher, Derek
  • G Segura, Àlex
  • Forte, María Florencia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Vieta, Eduard
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • M. Díaz-Caneja, Covadonga
  • Roldán, Alexandra
  • Fico, Giovanna
  • de la Serna, Elena
  • Bergé, Daniel
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Verdolini, Norma
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ribasés, Marta
  • Bernardo, Miguel
  • Mas, Sergi
Background: Polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), and clinical symptoms are associated with psychosocial functioning in first-episode psychosis (FEP). Nevertheless, the mechanisms underlying their complex interaction is yet to be explored. This study aimed to assess the mediating role of CR and clinical symptoms, both negative (NS) and positive (PS), on the interrelationship between PRSEA and functionality, one year after a FEP. Methods: A total of 162 FEP patients underwent clinical, functional, and genetic assessments. Using genome-wide association study (GWAS) summary results, PRSEA were constructed for each individual. Two mediation models were explored. The parallel mediation model explored the relationship of PRSEA with functionality through CR and clinical symptoms, NS, and PS. The serial mediation model tested a causal chain of the three mediators: CR, NS and PS. Mediation analysis was performed using the PROCESS function V.4.1 in SPSS V.22. Results: A serial mediation model revealed a causal chain for PRSEA > CR > NS > Functionality (β=-0.35, 95%CI [-0.85, -0.04], p<0.05). The model fit the data satisfactorily (CFI=1.00; RMSEA=0.00; SRMR=7.2x10-7). Conversely, in a parallel mediation, none of the three mediators significantly mediated the relationship between PRSEA and functionality and the model poorly fit the data (CFI=0.30; RMSEA=0.25; SRMR=0.11). Conclusions: Both CR and NS mediate the relationship between PRSEA and functionality at oneyear follow-up, using serial mediation analysis. This may be relevant for prevention and personalized early intervention to reduce illness impact and improve functional outcomes in FEP patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

  • Bioque, Miquel
  • Llorca-Bofí, Vicent
  • Salmerón, Sergi
  • García-Bueno, Borja
  • MacDowell, Karina S.
  • Moreno, Carmen
  • Sáiz, Pilar A.
  • González-Pinto, Ana
  • Hidalgo-Figueroa, María
  • Barcones, María Fe
  • Rodriguez-Jimenez, Roberto
  • Bernardo, Miquel
  • Leza, Juan Carlos
Neutrophil to lymphocyte ratio (NLR) has been proposed as an emerging marker of the immune system alterations in psychotic disorders. However, it is not entirely clear whether NLR elevation is a characteristic of the psychotic disorder itself, which inflammatory pathways activation is detecting, or which possible confounding variables could alter its interpretation. We aimed to analyze the relationship of NLR values with a panel of inflammatory and oxidative/nitrosative stress biomarkers and main potential confounding factors in a well-characterized cohort of 97 patients with a first episode of psychosis (FEP) and 77 matched healthy controls (HC). In the FEP group, NLR values presented a moderate, positive correlation with the pro-inflammatory mediator Prostaglandin E2 levels (r = 0.36, p < 0.001) and a small but significant, positive correlation with cannabis use (r = 0.25, p = 0.017). After controlling for cannabis use, the association between NLR and PGE2 remained significant (beta = 0.31, p = 0.012). In the HC group, NLR values negatively correlated with body mass index (BMI, r = −0.24, p = 0.035) and positively correlated with tobacco use (r = 0.25, p = 0.031). These findings support a relationship between the elevation of NLR values and an elevated expression of proinflammatory pathways related to stress response in patients with a FEP. In addition, our study highlights the importance of considering variables such as cannabis or tobacco consumption, and BMI when interpreting the results of studies aimed to establish a clinical use of NLR. These considerations may help future research to use NLR as a reliable biomarker to determine immune system status in this population.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

  • Amoretti, Silvia
  • Mezquida, Gisela
  • Verdolini, Norma
  • Bioque, Miquel
  • Sánchez-Torres, Ana M.
  • Pina-Camacho, Laura
  • Zorrilla, Iñaki
  • Trabsa, Amira
  • Rodríguez-Jiménez, Roberto
  • Corripio, Iluminada
  • Sarró, Salvador
  • Ibáñez, Ángela
  • Usall, Judith
  • Segarra, Rafael
  • Vieta, Eduard
  • Roberto, Natalia
  • Ramos-Quiroga, Josep Antoni
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miguel
  • Forte, María Florencia
  • Serra, María
  • Alonso-Solís, Anna
  • Grasa, Eva
  • Corres, Edurne García
  • Fernández Sevillano, Jessica
  • Toll, Alba
  • Martínez-Sadurní, Laura
  • Núñez-Doyle, Aggie
  • Sánchez-Pastor, Luis
  • Pomarol-Clotet, Edith
  • Guerrero-Pedraza, Amalia
  • Butjosa, Anna
  • Pardo, Marta
  • López-Ilundain, José M.
  • Ribeiro, María
  • Saiz-Ruiz, Jerónimo
  • León-Quismondo, Leticia
  • Escartí, María José
  • Contreras, Fernando
  • Cámara, Concepción de la
  • Zabala Rabadán, Arantzazu
  • Portilla, M. Paz
Introduction: Negative symptoms (NS) include asociality, avolition, anhedonia, alogia, and blunted affect and are linked to poor prognosis. It has been suggested that they reflect two different factors: diminished expression (EXP) (blunted affect and alogia) and amotivation/pleasure (MAP) (anhedonia, avolition, asociality). The aim of this article was to examine potential sex differences among first-episode schizophrenia (FES) patients and analyze sex-related predictors of two NS symptoms factors (EXP and MAP) and functional outcome. Material and methods: Two hundred and twenty-three FES (71 females and 152 males) were included and evaluated at baseline, six-months and one-year. Repeated measures ANOVA was used to examine the effects of time and sex on NS and a multiple linear regression backward elimination was performed to predict NS factors (MAP-EXP) and functioning. Results: Females showed fewer NS (p = 0.031; Cohen's d = −0.312), especially those related to EXP (p = 0.024; Cohen's d = −0.326) rather than MAP (p = 0.086), than males. In both male and female group, worse premorbid adjustment and higher depressive symptoms made a significant contribution to the presence of higher deficits in EXP at one-year follow-up, while positive and depressive symptoms predicted alterations in MAP. Finally, in females, lower deficits in MAP and better premorbid adjustment predicted better functioning at one-year follow-up (R2 = 0.494; p < 0.001), while only higher deficits in MAP predicted worse functioning in males (R2 = 0.088; p = 0.012). Conclusions: Slightly sex differences have been found in this study. Our results lead us to consider that early interventions of NS, especially those focusing on motivation and pleasure symptoms, could improve functional outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

  • Costas-Carrera, Ana
  • Verdolini, Norma
  • Garcia-Rizo, Clemente
  • Mezquida, Gisela
  • Janssen, Joost
  • Valli, Isabel
  • Corripio, Iluminada
  • Sanchez-Torres, Ana M.
  • Bioque, Miquel
  • Lobo, Antonio
  • Gonzalez-Pinto, Ana
  • Rapado-Castro, Marta
  • Vieta, Eduard
  • De la Serna, Helena
  • Mane, Anna
  • Roldan, Alexandra
  • Crossley, Nicolas
  • Penades, Rafael
  • Cuesta, Manuel J.
  • Parellada, Mara
  • Bernardo, Miquel
Patients with a first episode of psychosis (FEP) display clinical, cognitive, and structural brain abnormalities at illness onset. Ventricular enlargement has been identified in schizophrenia since the initial development of neuroimaging techniques. Obstetric abnormalities have been associated with an increased risk of developing psychosis but also with cognitive impairment and brain structure abnormalities. Difficulties during delivery are associated with a higher risk of birth asphyxia leading to brain structural abnormalities, such as ventriculomegaly, which has been related to cognitive disturbances. Methods We examined differences in ventricular size between 142 FEP patients and 123 healthy control participants using magnetic resonance imaging. Obstetric complications were evaluated using the Lewis–Murray scale. We examined the impact of obstetric difficulties during delivery on ventricle size as well as the possible relationship between ventricle size and cognitive impairment in both groups. Results FEP patients displayed significantly larger third ventricle size compared with healthy controls. Third ventricle enlargement was associated with diagnosis (higher volume in patients), with difficulties during delivery (higher volume in subjects with difficulties), and was highest in patients with difficulties during delivery. Verbal memory was significantly associated with third ventricle to brain ratio. Conclusions Our results suggest that difficulties during delivery might be significant contributors to the ventricular enlargement historically described in schizophrenia. Thus, obstetric complications may contribute to the development of psychosis through changes in brain architecture.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez-Torres, Ana M.
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Trabsa, Amira
  • Martínez-Arán, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miquel
  • Amoretti, Silvia
  • Salmerón, Sergi
  • Arbelo, Néstor
  • Ferrer-Quintero, Marta
  • Echevarría, Ana
  • Selma, Judit
  • Grasa, Eva Ma
  • Marin, Julen
  • Mar, Lorea
  • De la Cámara, Concepción
  • Ruíz-Lázaro, Pedro M
  • Nacher, Juan
  • Nicolas, Carlos Cañete
  • Mané, Anna
  • Toll, Alba
  • Solé, Brisa
  • Mallorqui, Aida
  • Castro-Fornieles, Josefina
  • Baeza, Inmaculada
  • Contreras, Fernando
  • Sáiz, Pilar A.
  • Bobes-Bascarán, Teresa
  • Segarra, Rafael
  • Zabala, Arantzazu
  • Scala, Mauro
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Ibañez, Angela
  • Moreno-Izco, Lucía
  • Balanzá-Martínez, Vicent
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Validación española de la entrevista MacArthur Competence Assessment Tool for Treatment para evaluar la capacidad de los pacientes para consentir tratamiento = Spanish validation of the MacArthur Competence Assessment Tool for Treatment interview to assess patients competence to consent treatment

  • Álvarez Marrodán, Ignacio
  • Baón Pérez, Beatriz
  • Navío Acosta, Mercedes
  • López-Antón, Raúl
  • Lobo Escolar, Elena
  • Ventura Faci, Tirso
Fundamento y objetivo: Validar al español la entrevista MacArthur Competence Assessment Tool for Treatment (MacCAT-T), que valora la capacidad de los pacientes para consentir tratamiento examinando 4 áreas (comprensión, apreciación, razonamiento y expresión de una elección). Pacientes y método: La muestra se componía de 160 sujetos (80 ingresados en Medicina Interna, 40 ingresados en Psiquiatría y 40 controles sanos). Se utilizaron los instrumentos MacCAT-T y Mini-Mental State Examination (MMSE). Se llevó a cabo un estudio de factibilidad, cálculo de fiabilidad y validez (contra gold standard del experto clínico). Resultados: La duración media de la entrevista MacCAT-T fue de 18 min. Respecto a la fiabilidad interobservador, el coeficiente de correlación intraclase fue para Comprensión = 0,98, Apreciación = 0,97, Razonamiento = 0,98 y Expresión de una elección = 0,91. La consistencia interna (alfa de Cronbach) fue: Comprensión = 0,87, Apreciación = 0,76 y Razonamiento = 0,86. Los pacientes considerados incapaces (gold standard) obtienen puntuaciones menores en todas las áreas de la MacCAT-T. Un rendimiento bajo en la MacCAT-T se relaciona con el deterioro cognitivo evaluado por MMSE. Conclusiones: La versión española de la MacCAT-T es fiable, factible y válida para la evaluación de la capacidad de los pacientes para consentir tratamiento.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia

  • Segura, Alex-González
  • Prohens, Llucia
  • Julià, Laura
  • Amoretti, Silvia
  • RIbero, Maria
  • Pino-Camacho, Laura
  • Cano-Escalera, Guillermo
  • Mane, Anna
  • Rodriguez-Jimenez, Roberto
  • Roldan, Alexandra
  • Sarró, Salvador
  • Ibañez, Angela
  • Usall, Judith
  • Lobo, Antonio
  • Garcia-Rizo, Clemente
  • Cuesta, Manuel Jesus
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Bernardo, Miquel
  • Mas, Sergi
  • Rodríguez, Natalia
  • Perez-Ramos, Anaid
  • Salmeron, Sergi
  • González-Peñas, Javier
  • Gurriarán, Xaquín
  • Farré, Adriana
  • Pousa, Esther
  • Zorrilla, Iñaki
  • Mar-Barrutia, Lorea
  • Trabsa, Amira
  • Martinez, Laura
  • Sánchez-Cabezudo, Ángeles
  • Jiménez-López, Estela
  • Pomarol-Clotet, Edith
  • Salvador, Raymond
  • Butjosa, Anna
  • Elena, Rubio-Abadal
  • Moreno-Izco, Lucía
  • Torres, Ana M. Sánchez
  • Saiz, Jeronimo
  • León-Quismondo, Leticia
  • Rivero, Olga
  • González-Blanco, Leticia
  • Cámara Izquierdo, Concepción de la
Both genetic and environmental factors have been found to play a significant role in psychosis relapse, either independently or through their synergistic interaction. Recently, DNA methylation (DNAm) has been proposed through the calculation of methylation profile scores (MPS). The aim of the present study is to evaluate the association of MPS as a surrogate marker of the biological impact of early stressful life events (including stressful intrauterine conditions and obstetric complications, childhood adversity and toxic habits), with the risk of schizophrenia (SCZ) relapse. 91 participants from a cohort of first-episode schizophrenia (FES) patients with less than five years of evolution were classified as non-relapse (patients who had not experienced a relapse after 3 years of enrollment) or relapse (patients who relapsed during the 3-year follow-up). As inclusion criteria, patients fulfilled Andreasen's criteria of symptomatic remission. Genome-wide DNA methylation (DNAm) was profiled and fourteen MPS reflecting environmental exposure were constructed including both early stressful life events (including stressful intrauterine conditions and delivery issues, childhood adversity) and toxic habits. Increased levels of MPS reflecting gestational diabetes (p = 0.009), hypertensive disorders during pregnancy (p = 0.004), pre-eclampsia (p = 0.049), early preterm birth (p = 0.030), childhood adversity abuse (p = 0.021) and all childhood adversity (p = 0.030) were significantly associated with an increased risk of relapse. Our study suggests that changes in specific methylation patterns may represent one of the biological mechanisms linking early stressful life events to an increased risk of relapse.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

  • Verdolini N.
  • Amoretti S.
  • Mezquida G.
  • Cuesta M.J.
  • Pina-Camacho L.
  • García-Rizo C.
  • Lobo A.
  • González-Pinto A.
  • Merchán-Naranjo J.
  • Corripio I.
  • Salagre E.
  • Baeza I.
  • Bergé D.
  • Garriga M.
  • Bioque M.
  • Vallespir C.
  • Serra M.
  • Vieta E.
  • Bernardo M.
The aim of the present study was to evaluate the contribution of family environment styles and psychiatric family history on functioning of patients presenting first-episode psychosis (FEP). Patients with FEP and healthy controls (HC) were assessed at baseline and after 2 years. The Functional Assessment Short Test (FAST) was used to assess functional outcome and the Family Environment Scale (FES) to evaluate family environment. Linear regressions evaluated the effect that family environment exerts on functioning at baseline and at 2-year follow-up, when FEP patients were diagnosed according to non-affective (NA-PSYCH) or affective psychoses (A-PSYCH). The influence of a positive parents’ psychiatric history on functioning was evaluated through one-way between-groups analysis of covariance (ANCOVA) models, after controlling for family environmental styles. At baseline, FEP patients presented moderate functioning impairment, significantly worse than HC (28.65±16.17 versus 3.25±7.92; p<0.001, g = 1.91). At 2-year follow-up, the functioning of NA-PSYCH patients was significantly worse than in A-PSYCH (19.92±14.83 versus 12.46±14.86; p = 0.020, g = 0.50). No specific family environment style was associated with functioning in FEP patients and HC. On the contrary, a positive psychiatric father''s history influenced functioning of FEP patients. After 2 years, worse functioning in NA-PSYCH patients was associated with lower rates of active-recreational and achievement orientated family environment and with higher rates of moral-religious emphasis and control. In A-PSYCH, worse functioning was associated with higher rates of conflict in the family. Both family environment and psychiatric history influence psychosocial functioning, with important implications for early interventions, that should involve both patients and caregivers.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Impact of relapse in BDNF receptors expression in patients with a first episode of schizophrenia

  • Bioque, Miquel
  • Llorca-Bofí, Vicent
  • MacDowell, Karina S
  • Amoretti, Sílvia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Díaz-Caneja, Covadonga M.
  • Ibáñez, Ángela
  • Segarra, Rafael
  • González-Pinto, Ana
  • Roldán, Alexandra
  • Sáiz, Pilar A.
  • Mané, Anna
  • Lobo, Antonio
  • Martínez-Pinteño, Albert
  • Cano-Escalera, Guillermo
  • Berrocoso, Esther
  • Bernardo, Miquel
  • 2EPs Group
Background and Hypothesis Relapsing after a first episode of schizophrenia (FES) is a main predictor of clinical and functional prognosis. Brain-derived neurotrophic factor (BDNF) plays a critical role in neuronal development and plasticity, and its signaling may be altered by successive relapses. Design We assessed the impact of first relapse in the expression of the 2 isoforms of the BDNF tropomyosin-related kinase B (TrkB) receptor (active full-length TrkB-F and inactive truncated TrkB-T) in peripheral blood mononuclear cells from 53 FES patients in clinical remission followed up for 3 years. Results The group of participants that relapsed (n = 24) during the follow-up presented a significant decrease in the expression of the active TrkB-F receptor compared to baseline (M = 100 ± 28.13 vs. M = 83.42 ± 33.84, t = 2.5, P = .02), with no changes in the inactive TrkB-T receptor expression nor in BDNF plasma levels. This decrease also led to a significant decline in the F/T ratio (M = 1.13 ± 0.38 vs. 0.94 ± 0.36, t = 2.17, P = .041). No significant differences were found in the receptors’ expression nor in plasma levels in the group of cases that remained in remission (n = 29). These results were not associated with baseline differences between the groups in terms of the BDNF signaling pathway biomarkers, clinical or treatment variables. Conclusions These findings highlight the biological impact that a relapse produces over the systemic BDNF-TrkB signaling pathway, potentially undermining crucial neuronal functions. Identifying the actors involved can help design specific interventions for relapse prevention and improve the functional prognosis of people in the early stages of schizophrenia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial

  • Castells, Antoni
  • Quintero, Enrique
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Cubiella, Joaquín
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Akiko, Ono
  • Serra-Burriel, Miquel
  • Frías-Arrocha, Eladio
  • Hernández, Cristina
  • Jover, Rodrigo
  • Andreu, Montserrat
  • Carballo, Fernando
  • Morillas, Juan Diego
  • Salas, Dolores
  • Almazán, Raquel
  • Alonso-Abreu, Inmaculada
  • Banales, Jesús M.
  • Hernández, Vicent
  • Portillo, Isabel
  • Vanaclocha-Espí, Mercedes
  • Vega, Mariola de la
  • COLONPREV study investigators
Background: Colonoscopy and the faecal immunochemical test are accepted strategies for colorectal cancer screening in the average-risk population (ie, people aged ≥50 years without personal or family history of colorectal cancer). In this trial, we aimed to compare whether invitation to screening with faecal immunochemical test was non-inferior to colonoscopy in a screening programme. Methods: COLONPREV was a pragmatic, randomised, controlled, non-inferiority trial done at 15 tertiary hospitals across eight regions of Spain. Eligible participants were presumptively healthy and aged between 50 years and 69 years without a personal history of colorectal cancer, adenoma or inflammatory bowel disease, family history of hereditary or familial colorectal cancer (ie, two or more first-degree relatives with colorectal cancer or one diagnosed before age 60 years), severe comorbidities, or previous colectomy. Participants were randomly assigned (1:1) to one-time colonoscopy or biennial faecal immunochemical test before invitation to screening. The primary endpoint was colorectal cancer mortality at 10 years, assessed in the intention-to-screen population. An absolute difference of less than 0·16 percentage points was required to show non-inferiority. This trial was registered with ClinicalTrials.gov, NCT00906997. Findings: Between June 1, 2009, and Dec 31, 2021, 57 404 individuals were randomly assigned to receive an invitation for colonoscopy (n=28 708) or the faecal immunochemical test (n=28 696). The intention-to-screen population consisted of 26 332 individuals in the colonoscopy group and 26 719 in the faecal immunochemical test group. In the intention-to-screen population, participation in any form of screening was 31·8% in the colonoscopy group and 39·9% in the faecal immunochemical test group (risk ratio [RR] 0·79 [95% CI 0·77 to 0·82]). Faecal immunochemical testing was non-inferior to colonoscopy with regard to the risk of colorectal cancer mortality at 10 years: the risk was 0·22% (55 deaths) in the colonoscopy group and 0·24% (60 deaths) in the faecal immunochemical test group (risk difference -0·02 [95% CI -0·10 to 0·06; RR 0·92 [95% CI 0·64 to 1·32]; pnon-inferiority=0·0005). Interpretation: Participation in screening was higher among individuals invited to faecal immunochemical test screening than colonoscopy screening. On the basis of participation observed in this study, a faecal immunochemical test-based programme was non-inferior to a colonoscopy-based programme for colorectal cancer-related mortality.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Obstetric complications, cortical gyrification, and cognition in first-episode psychosis

  • Costas-Carrera, Ana
  • Verdolini, Norma
  • Mezquida, Gisela
  • Forte, Maria Florencia
  • Janssen, Joost
  • Garcia-Rizo, Clemente
  • Martinez-Aran, Anabel
  • Andres-Camazon, Pablo
  • Sánchez-Torres, Ana Maria
  • Berge, Daniel
  • de la Serna, Elena
  • Penades, Rafael
  • Valli, Isabel
  • Amoretti, Silvia
Background: Obstetric complications (OCs) are associated with cognitive and brain abnormalities observed in patients with schizophrenia. Gyrification, a measure of cortical integrity sensitive to events occurring during the prenatal and perinatal periods, is also altered in first-episode psychosis (FEP). We examined the relationship between OCs and gyrification in FEP, as well as whether gyrification mediates the relationship between OCs and cognition. Methods: We examined differences in the Local Gyrification Index (LGI) for the frontal, parietal, temporal, occipital, and cingulate cortices between 139 FEP patients and 125 healthy controls (HCs). Regression analyses explored whether OCs and diagnosis interact to explain LGI variation. Parametric mediation analyses were conducted to assess the effect of LGI on the relationship between OCs and cognition for FEP and HC. Results: Significant LGI differences were observed between FEP patients and HC in the left parietal and bilateral cingulate and occipital cortices. There was a significant interaction between OCs and diagnosis on the left cingulate cortex (LCC) that was specific to males (p = 0.04) and was driven by gestational rather than intrauterine OCs. In HCs, OCs had a direct effect on working memory (WM) (p = 0.048) in the mediation analysis, whereas in FEP, we observed no significant effect of OCs on either verbal or WM. Conclusions: OCs interact with diagnosis to predict LCC gyrification, such that males with FEP exposed to OCs exhibit the lowest LGI. OCs influence WM, and LCC gyrification may mediate this relation only in HC, suggesting a differential neurodevelopmental process in psychosis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study

  • Castells, Antoni
  • Quintero, Enrique
  • Serra-Burriel, Miquel
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Cubiella, Joaquín
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Ono, Akiko
  • Coll-Vinent, Blanca
  • Frías-Arrocha, Eladio
  • Hernández, Cristina
  • Jover, Rodrigo
  • Andreu, Montserrat
  • Carballo, Fernando
  • Morillas, Juan Diego
  • Salas, Dolores
Background. Colorectal cancer (CRC) screening is effective and cost-effective in average-risk individuals. The COLONPREV study recently showed that individuals invited to a faecal immunochemical test (FIT) were more likely to participate in screening than those invited to colonoscopy, and that FIT-based screening was non-inferior to colonoscopy with respect to CRC-related mortality and CRC incidence. Objective. To assess whether the outcomes of colonoscopy- and FIT-based screening differ according to sex and age in the invited population. Methods. Presumptively healthy men and women aged 50–69 years were randomised to either a one-time screening colonoscopy or biennial FIT. In this analysis, we report participation and crossover rates, CRC-related mortality, CRC incidence, all-cause mortality, and diagnostic yield for both screening strategies, stratified by sex and by age group (50–59 and 60–69 years). Results. The eligible population consisted of 26,332 individuals assigned to colonoscopy and 26,719 assigned to FIT. As expected, participation and crossover rates were higher in women than in men and in older individuals compared with younger individuals. Participation was also consistently higher in those invited to FIT screening than in those assigned to colonoscopy across both sexes and age groups. The observed reductions in CRC-related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age. However, CRC-related mortality, all-cause mortality, and CRC incidence remained higher in men and older participants than in women and younger participants. Colonoscopy screening showed a higher diagnostic yield of premalignant precursor lesions across all demographic subgroups. Conclusion. Participation and reductions in CRC-related mortality and incidence were consistent across sex and age groups for both FIT- and colonoscopy-based screening strategies. The higher baseline risk observed in men could not be fully mitigated by screening. Trial Registration. ClinicalTrials.gov: NCT00906997
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Colonoscopy versus biennial FIT screening: a post hoc sustained-strategy analysis of the COLONPREV Trial

  • Castells, Antoni
  • Quintero, Enrique
  • Chen, Hongruyu
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Cubiella, Joaquín
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Ono, Akiko
  • Serra-Burriel, Miquel
Background Pragmatic colorectal cancer (CRC) screening trials compare colonoscopy with faecal immunochemical testing (FIT), but differences in adherence complicate interpretation of comparative outcomes. Objective To compare 10-year risks of CRC mortality, CRC incidence and all-cause mortality under one-time colonoscopy versus sustained FIT strategies in the COLONPREV Trial. Design We conducted a post hoc per-protocol analysis of 17 270 screening initiators aged 50–69 years in eight Spanish regions, using inverse probability weighting to adjust for observed confounding and informative protocol deviations. Results Weighted 10-year risks were similar for CRC incidence (0.80% FIT vs 0.86% colonoscopy; risk difference (RD) 0.06%, 95% CI −0.25% to 0.37%) and all-cause mortality (4.02% vs 4.09%; RD 0.07%, 95% CI −0.76% to 0.84%). CRC mortality was lower with colonoscopy (0.072% FIT vs 0.042% colonoscopy; RD −0.03%, 95% CI −0.12% to 0.06%), but estimates were imprecise. Conclusion Background Pragmatic colorectal cancer (CRC) screening trials compare colonoscopy with faecal immunochemical testing (FIT), but differences in adherence complicate interpretation of comparative outcomes. Objective To compare 10-year risks of CRC mortality, CRC incidence and all-cause mortality under one-time colonoscopy versus sustained FIT strategies in the COLONPREV Trial. Design We conducted a post hoc per-protocol analysis of 17 270 screening initiators aged 50–69 years in eight Spanish regions, using inverse probability weighting to adjust for observed confounding and informative protocol deviations. Results Weighted 10-year risks were similar for CRC incidence (0.80% FIT vs 0.86% colonoscopy; risk difference (RD) 0.06%, 95% CI −0.25% to 0.37%) and all-cause mortality (4.02% vs 4.09%; RD 0.07%, 95% CI −0.76% to 0.84%). CRC mortality was lower with colonoscopy (0.072% FIT vs 0.042% colonoscopy; RD −0.03%, 95% CI −0.12% to 0.06%), but estimates were imprecise. Conclusion Sustained colonoscopy and FIT showed similar 10-year outcomes overall, highlighting the importance of adherence pathways in pragmatic screening trials.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Long‐Term Colorectal Cancer Incidence After Adenoma and Serrated Polyp Removal: Results From the Colonprev Trial

  • Cubiella, Joaquín
  • García-Benito, Carme
  • Castells, Antoni
  • Quintero, Enrique
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Ono, Akiko
  • Frías-Arrocha, Eladio
  • Hernández, Cristina
  • Jover, Rodrigo
  • Andreu, Montserrat
  • Carballo, Fernando
  • Morillas, Juan Diego
  • Salas, Dolores
  • Regueiro-Expósito, Cristina
  • Davila-Piñón, Pedro
  • Diez-Martín, Astrid
Background: The risk of colorectal cancer (CRC) after serrated polyp resection remains unclear, and current surveillance recommendations rely on limited evidence. We evaluated CRC incidence in individuals with advanced serrated lesions (ASL) detected at baseline colonoscopy and compared risk according to the most advanced lesion identified. Methods: Participants undergoing colonoscopy within the COLONPREV trial (n = 8989) were included in this post hoc analysis. Individuals were classified according to the most advanced baseline lesion: no lesion, non-advanced adenoma, advanced adenoma, or ASL. The primary outcome was incident CRC. Cumulative incidence and hazard ratios (HR) were estimated using Cox proportional hazard models. Results: At baseline colonoscopy, serrated polyps were detected in 19.8% of participants, including ASL in 2.5%. Over a mean follow-up of 9.5 years, 44 CRC cases were diagnosed (cumulative incidence 0.49%; incidence rate 0.52 per 1000 person-years). The 10-year cumulative incidence was 0.27% in individuals without baseline lesions (n = 5496), 0.57% in those with non-advanced adenomas (n = 2091), 1.23% in advanced adenomas (n = 1218), and 1.09% in ASL (n = 184). In multivariable analysis, CRC risk was increased for non-advanced adenomas (HR 3.25, 95% CI 1.48–7.16), advanced adenomas (HR 9.77, 95% CI 4.24–22.50), and ASL (HR 6.37, 95% CI 1.42–28.54). Surveillance colonoscopy was associated with lower CRC incidence (HR 0.46, 95% CI 0.22–0.95 for one colonoscopy; HR 0.09, 95% CI 0.02–0.40 for ≥ 2 colonoscopies). Conclusion: In this screening cohort, ASL were associated with increased CRC risk in the range of advanced adenomas. These findings provide risk estimates relevant to post-polypectomy management.
Docta Complutense
Publication Artículo científico (JournalArticle)

Generation and characterization of monospecific and bispecific hexavalent trimerbodies

  • Blanco Toribio, Ana
  • Sainz Pastor, Noelia
  • Álvarez Cienfuegos, Ana
  • Merino, Nekane
  • Sánchez Martín, David
  • Bonet, Jaume
  • Santos Valle, Patricia
  • Sanz, Laura
  • Oliva, Baldo
  • Blanco, Francisco J.
  • Álvarez Vallina, Luis
  • Cuesta Martínez, Ángel
Here, we describe a new class of multivalent and multispecific antibody-based reagents for therapy. The molecules, termed “trimerbodies,” use a modified version of the N-terminal trimerization region of human collagen XVIII noncollagenous 1 domain flanked by two flexible linkers as trimerizing scaffold. By fusing single-chain variable fragments (scFv) with the same or different specificity to both N- and C-terminus of the trimerizing scaffold domain, we produced monospecific or bispecific hexavalent molecules that were efficiently secreted as soluble proteins by transfected mammalian cells. A bispecific anti-laminin x anti-CD3 N-/C-trimerbody was found to be trimeric in solution, very efficient at recognizing purified plastic-immobilized laminin and CD3 expressed at the surface of T cells, and remarkably stable in human serum. The bispecificity was further demonstrated in T cell activation studies. In the presence of laminin-rich substrate, the bispecific anti-laminin x anti-CD3 N-/C-trimerbody stimulated a high percentage of human T cells to express surface activation markers. These results suggest that the trimerbody platform offers promising opportunities for the development of the next-generation therapeutic antibodies, i.e., multivalent and bispecific molecules with a format optimized for the desired pharmacokinetics and adapted to the pathological context.
Docta Complutense
Publication Artículo científico (JournalArticle)

The Heterotrimeric Laminin Coiled-Coil Domain Exerts Anti-Adhesive Effects and Induces a Pro-Invasive Phenotype

  • Santos-Valle, Patricia
  • Guijarro-Muñoz, Irene
  • Cuesta Martínez, Ángel
  • Alonso-Camino, Vanesa
  • Villate, Maider
  • Álvarez-Cienfuegos, Ana
  • Blanco, Francisco J.
  • Sanz, Laura
  • Álvarez-Vallina, Luis
Laminins are large heterotrimeric cross-shaped extracellular matrix glycoproteins with terminal globular domains and a coiled-coil region through which the three chains are assembled and covalently linked. Laminins are key components of basement membranes, and they serve as attachment sites for cell adhesion, migration and proliferation. In this work, we produced a recombinant fragment comprising the entire laminin coiled-coil of the α1-, β1-, and γ1-chains that assemble into a stable heterotrimeric coiled-coil structure independently of the rest of the molecule. This domain was biologically active and not only failed to serve as a substrate for cell attachment, spreading and focal adhesion formation but also inhibited cell adhesion to laminin when added to cells in a soluble form at the time of seeding. Furthermore, gene array expression profiling in cells cultured in the presence of the laminin coiled-coil domain revealed up-regulation of genes involved in cell motility and invasion. These findings were confirmed by real-time quantitative PCR and zymography assays. In conclusion, this study shows for the first time that the laminin coiled-coil domain displays anti-adhesive functions and has potential implications for cell migration during matrix remodeling.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Telomere length analysis in Cushing's syndrome

  • Aulinas, Anna|||0000-0002-1205-7114
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Barahona, María-José|||0000-0003-2935-6521
  • Valassi, Elena|||0000-0002-3864-0105
  • Resmini, Eugenia|||0000-0003-1529-5465
  • Mato, Eugènia|||0000-0001-8121-9335
  • Santos, Alicia|||0000-0002-2179-6189
  • Crespo, Iris|||0000-0002-1212-4540
  • Bell, Olga|||0009-0000-2858-6187
  • Surralles, Jordi|||0000-0002-4041-7519
  • Webb, S. M.|||0000-0001-7052-6436
Introduction: Hypercortisolism in Cushing's syndrome (CS) is associated with increased morbidity and mortality. Hypercortisolism also occurs in chronic depressive disorders and stress, where telomere length (TL) is shorter than in controls. We hypothesized that shortening of telomere might occur in CS and contribute to premature aging and morbidity. - Aim: To investigate TL in CS patients compared with controls. - Methods: Seventy-seven CS patients (14 males, 59 pituitary, 17 adrenal, and one ectopic; 21 with active disease) were compared with 77 gender-, age-, and smoking-matched controls. Fifteen CS were evaluated longitudinally, during active disease and after remission of hypercortisolism. Leukocyte TL was measured by telomere restriction fragment-Southern technique. Clinical markers were included in a multiple linear regression analysis to investigate potential predictors of TL. - Results : Mean TL in CS patients and controls was similar (7667 vs 7483 bp, NS). After adjustment for age, in the longitudinal evaluation, TL was shorter in active disease than after remission (7273 vs 7870, P<0.05). Age and dyslipidemia were negative predictors (P<0.05), and total leukocyte count was a positive predictor for TL (P<0.05). As expected, a negative correlation was found between TL and age (CS, R=-0.400 and controls, R=-0.292; P<0.05). No correlation was found between circulating cortisol, duration of exposure to hypercortisolism or biochemical cure and TL. - Conclusion : Even though in the cross-sectional comparison of CS and controls no difference in TL was found, in the longitudinal evaluation, patients with active CS had shorter TL than after biochemical cure of hypercortisolism. These preliminary results suggest that hypercortisolism might negatively impact telomere maintenance. Larger studies are needed to confirm these findings.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome

  • Aulinas, Anna|||0000-0002-1205-7114
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Barahona, María-José|||0000-0003-2935-6521
  • Valassi, Elena|||0000-0002-3864-0105
  • Resmini, Eugenia|||0000-0003-1529-5465
  • Mato, Eugènia|||0000-0001-8121-9335
  • Santos, Alicia|||0000-0002-2179-6189
  • Crespo, Iris|||0000-0002-1212-4540
  • Bell, Olga|||0009-0000-2858-6187
  • Surralles, Jordi|||0000-0002-4041-7519
  • Webb, S. M.|||0000-0001-7052-6436
INTRODUCTION: Cushing's syndrome (CS) increases cardiovascular risk (CVR) and adipocytokine imbalance, associated with an increased inflammatory state. Telomere length (TL) shortening is a novel CVR marker, associated with inflammation biomarkers. We hypothesized that inflammatory state and higher CVR in CS might be related to TL shortening, as observed in premature aging. - AIM: to evaluate relationships between TL, CVR and inflammation markers in CS. - METHODS: in a cross-sectional study, 77 patients with CS (14 males, 59 pituitary-, 17 adrenal- and 1 ectopic-origin; 21 active disease) and 77 age-, gender-, smoking-matched controls were included. Total white blood cell TL was measured by TRF-Southern technique. Clinical data and blood samples were collected (lipids, adrenal function, glucose). Adiponectin, interleukin-6 (IL6) and C-reactive protein (CRP) were available in a subgroup of patients (n=32). Correlations between TL and clinical features were examined and multiple linear regression analysis was performed to investigate potential predictors of TL. - RESULTS: dyslipidemic CS had shorter TL than non-dyslipidemic subjects (7328±1274 vs 7957±1137 bp, p<0.05). After adjustment for age and body mass index, cured and active CS dyslipidemic patients had shorter TL than non-dyslipidemic CS (cured: 7187±1309 vs 7868±1104; active: 7203±1262 vs 8615±1056, respectively, p<0.05). Total cholesterol and triglycerides negatively correlated with TL (r-0.279 and -0.259, respectively, p<0.05), as well as CRP and IL6 (r-0.412 and -0.441, respectively, p<0.05). No difference in TL according the presence of other individual CVR factors (hypertension, diabetes mellitus, obesity) were observed in CS or in the control group. Additional TL shortening was observed in dyslipidemic obese patients who were also hypertensive, compared to those with two or less CVR factors (6956±1280 vs 7860±1180, respectively, p<0.001). Age and dyslipidemia were independent negative predictors of TL. -CONCLUSION :TL is shortened in dyslipidemic CS patients, further worse if hypertension and/or obesity coexist and is negatively correlated with increased inflammation markers. Increased lipids and a "low" grade inflammation may contribute to TL shortening and consequently to premature ageing and increased morbidity in CS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sperm DNA Integrity and Meiotic Behavior Assessment in an Infertile Male Carrier of a 9qh+++ Polymorphism

  • García-Peiró, Agustín|||0000-0002-8492-3165
  • Oliver Bonet, Maria|||0000-0001-5635-6741
  • Navarro i Ferreté, Joaquima|||0000-0002-9245-2260
  • Abad, Carlos|||0000-0002-2703-4062
  • Guitart, Maria|||0000-0003-2957-7404
  • Amengual Guedan, Maria Jose|||0000-0002-5385-3061
  • Benet i Català, Jordi|||0000-0001-6185-2555
Although several reports on male infertility suggest a relationship between chromosome 9 polymorphisms and infertility, the effects on the phenotype have not been extensively reported. In this study, an infertile patient was found to carry a 9qh+++ chromosome. The flow cytometric TUNEL assay and SCD test have been applied to characterize sperm DNA integrity. In order to assess its meiotic behaviour, synapsis, recombination, and aneuploidy, analyses have been also performed. Sperm DNA fragmentation (SDF) was 77.81% and 87% for the TUNEL and SCD tests, respectively. Ninety-two percent of pachytene cells analyzed showed meiotic abnormalities. The mean number of MLH1 foci per pachytene in the control group was higher (49) than the mean found in the 9qh+++ patient (38) (P <.0001). In spermatozoa, significant increases of disomy rates were observed for chromosome 18 and for the sex chromosomes (P <.0001). These disturbances could be present in other male carriers of a less marked 9qh+.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brain Perihematoma Genomic Profile Following Spontaneous Human Intracerebral Hemorrhage

  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Vilalta Saura, Anna
  • García-Berrocoso, Teresa|||0000-0001-7387-7389
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Domingues-Montanari, Sophie
  • Cuadrado Godia, Eloy
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Ribo, Marc|||0000-0001-9242-043X
  • Martinez-Saez, Elena|||0000-0001-6004-5364
  • Ortega-Aznar, Arantxa
  • Montaner, Joan|||0000-0003-4845-2279
Spontaneous intracerebral hemorrhage (ICH) represents about 15% of all strokes and is associated with high mortality rates. Our aim was to identify the gene expression changes and biological pathways altered in the brain following ICH. Twelve brain samples were obtained from four deceased patients who suffered an ICH including perihematomal tissue (PH) and the corresponding contralateral white (CW) and grey (CG) matter. Affymetrix GeneChip platform for analysis of over 47,000 transcripts was conducted. Microarray Analysis Suite 5.0 was used to process array images and the Ingenuity Pathway Analysis System was used to analyze biological mechanisms and functions of the genes. We identified 468 genes in the PH areas displaying a different expression pattern with a fold change between -3.74 and +5.16 when compared to the contralateral areas (291 overexpressed and 177 underexpressed). The top genes which appeared most significantly overexpressed in the PH areas codify for cytokines, chemokines, coagulation factors, cell growth and proliferation factors while the underexpressed codify for proteins involved in cell cycle or neurotrophins. Validation and replication studies at gene and protein level in brain samples confirmed microarray results. The genomic responses identified in this study provide valuable information about potential biomarkers and target molecules altered in the perihematomal regions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas

  • Martínez Sáez, Elena
  • Peg, Vicente|||0000-0002-5203-6166
  • Ortega-Aznar, Arantxa
  • Martínez Ricarte, Francisco
  • Camacho, Jessica|||0000-0001-8018-8274
  • Hernández Losa, Javier
  • Ferreres Piñas, Joan Carles|||0000-0001-7742-0239
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Malignant transformation in tumors is a complex process requiring accumulation of numerous oncogenic abnormalities. Brain tumors show considerable phenotypic and genetic heterogeneity. In a series comprising diffuse infiltrating astrocytomas () and reactive gliosis, we investigated the main factors associated with signaling pathways. We assessed expression levels and their association with tumor progression and survival. We studied 19 grade astrocytomas, 25 anaplastic astrocytomas (grade ), 60 glioblastomas (grade ), and 15 cases of reactive gliosis. Epidermal growth factor receptor (), , 4E-1, p4E-1, 6, 4E, and pe4E expression levels were evaluated using immunohistochemistry. Expression levels were semiquantitatively evaluated using a histoscore. Immunohistochemistry and were used for 1 mutations. Statistical analysis was based on the following tests: chi-square, Student's t, Pearson correlation, Spearman's rho, and Mann-Whitney; and Kaplan-Meier curves were constructed. A significant increase was observed between grades for expression of total and phosphorylated 4E-1 and for 4E, Ki67, , and cyclin D1. Although expression of ,4E, and Ki67 correlated with survival, only pe4E was an independent predictor of survival in the multivariate analysis. Combining the evaluation of different proteins enables us to generate helpful diagnostic nomograms. In conclusion, cell signaling pathways are activated in s; pe4E is an independent prognostic factor and a promising therapeutic target. Joint analysis of the expression of 4E-1 and pe4E could be helpful in the diagnosis of glioblastoma multiforme in small biopsy samples.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Neurofilament light chain level is a weak risk factor for the development of MS

  • Arrambide, Georgina|||0000-0002-2657-5510
  • Espejo, Carmen|||0000-0001-9949-5901
  • Eixarch, Herena|||0000-0001-7525-9533
  • Villar, Luisa M.|||0000-0002-9067-3668
  • Alvarez-Cermeño, José C.|||0000-0002-1345-2837
  • Picón, Carmen
  • Kuhle, Jens|||0000-0002-6963-8892
  • Disanto, Giulio
  • Kappos, Ludwig|||0000-0003-4175-5509
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Pareto, Deborah|||0000-0001-7356-3769
  • Simon, Eva
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Río, Jordi|||0000-0003-4546-7627
  • Nos, Carlos|||0000-0002-3830-4910
  • Tur, Carmen|||0000-0003-1849-3184
  • Castilló, Joaquín|||0000-0002-8951-6315
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Galan, Ingrid|||0000-0001-5774-4260
  • Arévalo, María Jesús|||0000-0003-0626-5555
  • Auger, Cristina|||0000-0001-9846-4767
  • Rovira, Alex|||0000-0002-2132-6750
  • Montalban, Xavier|||0000-0002-0098-9918
  • Tintoré, Mar|||0000-0001-9999-5359
To determine the prognostic value of selected biomarkers in clinically isolated syndromes (CIS) for conversion to multiple sclerosis (MS) and disability accrual. Data were acquired from 2 CIS cohorts. The screening phase evaluated patients developing clinically definite MS (CIS-CDMS) and patients who remained as CIS during a 2-year minimum follow-up (CIS-CIS). We determined levels of neurofascin, semaphorin 3A, fetuin A, glial fibrillary acidic protein, and neurofilament light (NfL) and heavy chains in CSF (estimated mean [95% confidence interval; CI]). We evaluated associations between biomarker levels, conversion, disability, and magnetic resonance parameters. In the replication phase, we determined NfL levels (n = 155) using a 900 ng/L cutoff. Primary endpoints in uni- and multivariate analyses were CDMS and 2010 McDonald MS. The only biomarker showing significant differences in the screening was NfL (CIS-CDMS 1,553.1 [1,208.7-1,897.5] ng/L and CIS-CIS 499.0 [168.8-829.2] ng/L, p < 0.0001). The strongest associations were with brain parenchymal fraction change (r = -0.892) and percentage brain volume change (r = -0.842) at 5 years. NfL did not correlate with disability. In the replication phase, more NfL-positive patients, according to the cutoff, evolved to MS. Every 100-ng/L increase in NfL predicted CDMS (hazard ratio [HR] = 1.009, 95% CI 1.005-1.014) and McDonald MS (HR = 1.009, 95% CI 1.005-1.013), remaining significant for CDMS in the multivariate analysis (adjusted HR = 1.005, 95% CI 1.000-1.011). This risk was lower than the presence of oligoclonal bands or T2 lesions. NfL is a weak independent risk factor for MS. Its role as an axonal damage biomarker may be more relevant as suggested by its association with medium-term brain volume changes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case- Control (MCC) Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Palazuelos, Camilo
  • Morros, Rosa|||0000-0001-6752-8748
  • Aragonés, Nuria
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Jiménez Monleón, Jose J.
  • Ruiz Cerdá, José Luis
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Ruiz-Dominguez, José Manuel
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Pollán, Marina|||0000-0002-4328-1565
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Llorca, Javier|||0000-0001-8569-861X
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Economic evaluation of treatments for patients with localized prostate cancer in Europe, a systematic review

  • Becerra, Virginia|||0000-0002-8811-3899
  • Ávila, Mónica|||0000-0001-9583-5104
  • Jimenez, Jorge
  • Cortes Sanabria, Laura|||0000-0002-2828-3896
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Garin, Olatz|||0000-0001-6193-0779
  • Pont, Angels|||0000-0002-0602-552X
  • Alonso, Jordi|||0000-0001-8627-9636
  • Cots Reguant, Francesc|||0000-0003-0238-8902
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
Background: Our objective was to assess the efficiency of treatments in patients with localized prostate cancer, by synthesizing available evidence from European economic evaluations through systematic review. Methods: Articles published 2000-2015 were searched in MEDLINE, EMBASE and NHS EED (Prospero protocol CRD42015022063). Two authors independently selected studies for inclusion and extracted the data. A third reviewer resolved discrepancies. We included European economic evaluations or cost comparison studies, of any modality of surgery or radiotherapy treatments, regardless the comparator/s. Drummond's Checklist was used for quality assessment. Results: After reviewing 8,789 titles, 13 European eligible studies were included: eight cost-utility, two cost-effectiveness, one cost-minimization, and two cost-comparison analyses. Of them, five compared interventions with expectant management, four contrasted robotic with non robotic-assisted surgery, three assessed new modalities of radiotherapy, and three compared radical prostatectomy with brachytherapy. All but two studies scored ≥8 in the quality checklist. Considering scenario and comparator, three interventions were qualified as dominant strategies (active surveillance, robotic-assisted surgery and IMRT), and six were cost-effective (radical prostatectomy, robotic-assisted surgery, IMRT, proton therapy, brachytherapy, and 3DCRT). However, QALY gains in most of them were small. For interventions considered as dominant strategies, QALY gain was 0.013 for active surveillance over radical prostatectomy; and 0.007 for robotic-assisted over non-robotic techniques. The highest QALY gains were 0.57-0.86 for radical prostatectomy vs watchful waiting, and 0.72 for brachytherapy vs conventional radiotherapy. Conclusions: Currently, relevant treatment alternatives for localized prostate cancer are scarcely evaluated in Europe. Very limited available evidence supports the cost-effectiveness of radical prostatectomy over watchful waiting, brachytherapy over radical prostatectomy, and new treatment modalities over traditional procedures. Relevant disparities were detected among studies, mainly based on effectiveness. These apparently contradictory results may be reflecting the difficulty of interpreting small differences between treatments regarding QALY gains.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparación de costes de tres tratamientos del cáncer de próstata localizado en España, prostatectomía radical, braquiterapia prostática y radioterapia conformacional externa 3D, Cost comparison of three treatments for localized prostate cancer in Spain

  • Becerra, Virginia|||0000-0002-8811-3899
  • Cots Reguant, Francesc|||0000-0003-0238-8902
  • Guedea, Ferran|||0000-0001-8798-8696
  • Pera, Joan
  • Boladeras, Ana
  • Aguiló Coll, Ferran
  • Suárez, José Francisco|||0000-0001-6427-4391
  • Gallo, Pedro
  • Murgui, Lluis
  • Pont, Angels|||0000-0002-0602-552X
  • Cunillera, O.|||0000-0003-2891-099X
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
Objetivo: comparar los costes de los tratamientos más establecidos para el cáncer de próstata localizado según grupos de riesgo, edad y comorbilidad, desde la perspectiva del proveedor asistencial. Métodos: comparación de costes en pacientes reclutados consecutivamente entre 2003 y 2005 en una unidad funcional de tratamiento del cáncer de próstata. La utilización de servicios hasta 6 meses después del inicio del tratamiento se obtuvo de las bases de datos hospitalarias, y los costes directos se estimaron mediante cálculo microcoste. La información sobre las características clínicas de los pacientes y los tratamientos recogió prospectivamente. Los costes se compararon mediante tests no paramétricos de comparación de medianas (Kruskall-Wallis) y un modelo semilogarítmico de regresión múltiple. Resultados: la diferencia de costes fue estadísticamente significativa: medianas de 3229.10D, 5369.00Dy 6265.60D para los pacientes tratados con radioterapia conformacional externa 3D, braquiterapia, y prostatectomía radical retro pública, respectivamente (p <0,001). En el análisis multivariado (R2 ajustada=0,8), los costes medios de la braquiterapia y de la radioterapia externa fueron significativamente menores que los de la prostatectomía (coeficiente -0,212 y -0,729, respectivamente). Conclusiones: la prostatectomía radical resultó ser la opción terapéutica de mayor coste. En general, los costes estimados en nuestro estudio son inferiores a los publicados en otros ámbitos. La opción terapéutica explica gran parte de los costes, y tanto la comorbilidad como el grupo de riesgo no mostraron efecto independiente del tratamiento sobre los costes totales., Objective: To compare the initial costs of the three most established treatments for clinically localized prostate cancer according to risk, age and comorbidity groups, from the healthcare provider's perspective. Methods: We carried out a cost comparison study in a sample of patients consecutively recruited between 2003 and 2005 from a functional unit for prostate cancer treatment in Catalonia (Spain). The use of services up to 6 months after the treatment start date was obtained from hospital databases and direct costs were estimated by micro-cost calculation. Information on the clinical characteristics of patients and treatments was collected prospectively. Costs were compared by using nonparametric tests comparing medians (Kruskall-Wallis) and a semi-logarithmic multiple regression model. Results: Among the 398 patients included, the cost difference among treatments was statistically significant: medians were €3,229.10, €5,369.00 and €6,265.60, respectively, for the groups of patients treated with external 3D conformal radiotherapy, brachytherapy and radical retropublic prostatectomy, (p<0.001). In the multivariate analysis (adjusted R=0.8), the average costs of brachytherapy and external radiotherapy were significantly lower than that of prostatectomy (coefficient -0.212 and -0.729, respectively). Conclusions: Radical prostatectomy proved to be the most expensive treatment option. Overall, the estimated costs in our study were lower than those published elsewhere. Most of the costs were explained by the therapeutic option and neither comorbidity nor risk groups showed an effect on total costs independent of treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Alkylphenolic compounds and risk of breast and prostate cancer in the MCC-Spain study

  • Peremiquel-Trillas, Paula
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Martín-Bustamante, Mayte
  • Casabonne, Delphine
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Oliete-Canela, Anna
  • Diéguez-Rodríguez, Marta
  • Tusquets, Ignasi
  • Amiano, Pilar
  • Mengual, Lourdes
  • Ardanaz, Eva
  • Capelo, Rocío
  • Molina de la Torre, Antonio José
  • Salas Trejo, Dolores
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Lope, Virginia
  • Jimenez-Moleon, José J.
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Azpiri, Mikel
  • Muñoz, Montse
  • Guevara, Marcela|||0000-0001-9242-6364
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Aragonés, Nuria
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Alguacil, Juan|||0000-0003-2703-9725
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Costas, Laura
Background: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compounds on human health. Objectives: We investigated whether occupational exposure to alkylphenolic compounds is associated with breast and prostate cancer. Methods: We carried out a population-based case-control study including 1513 incident cases of breast cancer, 1095 of prostate cancer, and 3055 controls, frequency matched by sex, age and region. Occupational exposure to alkylphenolic compounds was estimated using a recently developed job-exposure matrix, which considered different scenarios of exposure and different subtypes of alkylphenolic compounds. Results: History of occupational exposure to alkylphenolic compounds was modestly associated with breast cancer (OR = 1.23; 95% CI = 1.01-1.48). Within the different scenarios, the occupational use of domestic tensioactives was positively associated with breast cancer (OR = 1.28; 95% CI = 1.02-1.60), while occupational exposure in other scenarios showed mostly a suggestion of a similar positive associations. Exposure to nonylphenol ethoxylates was positively associated with breast cancer (OR = 1.21; 95% CI = 1.00-1.47), while exposure to other compounds was uncommon. In general, we did not observe associations between alkylphenolic compounds and prostate cancer, except for a positive association among men occupationally exposed to cosmetic, hair and personal hygiene products. Conclusions: Our findings suggest a modest association between breast cancer risk and occupational exposure to alkylphenolic compounds, and no associations between these compounds and prostate cancer risk. These findings warrant further corroboration in other studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Langohr, Klaus|||0000-0001-7075-9192
  • Pujadas, Mitona|||0000-0002-0506-3030
  • Civit, Ester
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Ramon, Jose Manuel
  • Benaiges, David|||0000-0001-5411-364X
  • Castañer, Olga|||0000-0003-3169-997X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torre, Rafael de la|||0000-0002-6765-1866
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Conway, Olivia J.
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Carrasquillo, Minerva M.
  • Kleineidam, Luca
  • van den Akker, Erik
  • Hernández, Isabel|||0000-0001-8119-393X
  • Van Eijk, Kristel R.
  • Stringa, Najada|||0000-0001-6350-452X
  • Chen, Jason A.
  • Zettergren, Anna|||0000-0002-7182-8417
  • Andlauer, Till F. M.|||0000-0002-2917-5889
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Simón Sánchez, Javier|||0000-0001-5141-5829
  • Lleó, Alberto|||0000-0002-2568-5478
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Nygaard, Marianne|||0000-0003-0703-2665
  • Blauwendraat, Cornelis|||0000-0001-9358-8111
  • Savage, Jeanne E.
  • Mengel-From, Jonas
  • Moreno-Grau, Sonia
  • Wagner, Michael
  • Fortea, Juan|||0000-0002-1340-638X
  • Keogh, Michael J.
  • Blennow, Kaj|||0000-0002-1890-4193
  • Skoog, Ingmar
  • Friese, Manuel A.
  • Pletnikova, Olga|||0000-0001-6516-4944
  • Zulaica, Miren
  • Lage, Carmen|||0000-0003-1703-121X
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Riedel-Heller, Steffi|||0000-0003-4321-6090
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Wei, Wei
  • Jeune, Bernard
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Then Bergh, Florian
  • Wang, Xue
  • Hulsman, Marc|||0000-0002-9889-3606
  • Beker, Nina
  • Tesi, Niccolo|||0000-0002-1413-5091
  • Morris, Christopher M.
  • Indakoetxea, Begoña
  • Collij, Lyduine E.
  • Scherer, Martin
  • Morenas-Rodríguez, Estrella|||0000-0002-7591-6051
  • Ironside, James W.
  • van Berckel, Bart N. M.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Wiendl, Heinz|||0000-0003-4310-3432
  • Strickland, Samantha L.
  • Pastor, Pau|||0000-0002-7493-8777
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Boeve, Bradley
  • Petersen, Ronald C.
  • Ferman, Tanis J.
  • van Gerpen, Jay A.
  • Reinders, Marcel J. T.|||0000-0002-1148-1562
  • Uitti, Ryan J.
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Maier, Wolfgang
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Kawalia, Amit
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Boada, Mercè|||0000-0003-2617-3009
  • Zettl, Uwe K.
  • van Schoor, Natasja M.
  • Beekman, Marian|||0000-0003-0585-6206
  • Allen, Mariet
  • Masliah, Eliezer
  • de Munain, Adolfo López
  • Pantelyat, Alexander
  • Wszolek, Zbigniew K.|||0000-0001-5487-1053
  • Ross, Owen A.|||0000-0003-4813-756X
  • Dickson, Dennis W.|||0000-0001-7189-7917
  • Graff-Radford, Neill R.
  • Knopman, David
  • Rademakers, Rosa
  • Lemstra, Afina W.|||0000-0002-8933-3260
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Scheltens, Philip|||0000-0002-1046-6408
  • Gasser, Thomas|||0000-0003-4882-2647
  • Chinnery, Patrick F.
  • Hemmer, Bernhard|||0000-0001-5985-6784
  • Huisman, Martijn A.
  • Troncoso, Juan
  • Moreno, Fermin|||0000-0001-5200-3164
  • Nohr, Ellen A.
  • Sørensen, Thorkild I. A.|||0000-0003-4821-430X
  • Heutink, Peter|||0000-0001-5218-1737
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Christensen, Kaare|||0000-0002-5429-5292
  • Ertekin-Taner, Nilüfer
  • Scholz, Sonja|||0000-0002-6623-0429
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Slagboom, Eline
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Holstege, Henne|||0000-0002-7688-3087
The genetic variant rs72824905-G (minor allele) in the PLCG2 gene was previously associated with a reduced Alzheimer's disease risk (AD). The role of PLCG2 in immune system signaling suggests it may also protect against other neurodegenerative diseases and possibly associates with longevity. We studied the effect of the rs72824905-G on seven neurodegenerative diseases and longevity, using 53,627 patients, 3,516 long-lived individuals and 149,290 study-matched controls. We replicated the association of rs72824905-G with reduced AD risk and we found an association with reduced risk of dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). We did not find evidence for an effect on Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) risks, despite adequate sample sizes. Conversely, the rs72824905-G allele was associated with increased likelihood of longevity. By-proxy analyses in the UK Biobank supported the associations with both dementia and longevity. Concluding, rs72824905-G has a protective effect against multiple neurodegenerative diseases indicating shared aspects of disease etiology. Our findings merit studying the PLCγ2 pathway as drug-target.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Tumour characteristics and survivorship in a cohort of breast cancer, the MCC-Spain study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos-Calderón, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Guevara, Marcela|||0000-0001-9242-6364
  • Molina de la Torre, Antonio José
  • Domingo, Laia|||0000-0003-4420-0891
  • Fernández-Ortiz, María|||0000-0003-0017-875X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Alguacil, Juan|||0000-0003-2703-9725
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Ibáñez, Josefa
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Diaz-Santos, Marian
  • Alonso, M. Henar
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Ardanaz, Eva
  • Molinuevo, Amaia
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The objective of this study is to analyse the relative survival with breast cancer in women diagnosed after new treatments were generalised and to ascertain the current effect that tumour characteristics such as grade, stage or subtype have on survival as well as the new AJCC-pathological prognostic score. The breast cancer MCC-Spain follow-up study is a prospective cohort study of 1685 incident breast cancer cases. Women between 20 and 85 years old were recruited between the years 2008 and 2013 in 18 hospitals located in 10 Spanish provinces and they have been followed until 2017/2018. Relative survival was estimated after 3, 5 and 8 years of follow-up using Ederer II method. In addition, Weibull regression adjusted by age, hospital, grade and stage was used to investigate prognosis factors. Among components of TNM staging system, tumour size greater than 50 mm (i.e. T3 or T4) more than doubled the risk of dying, while N3 nodal involvement and presence of metastasis had a huge effect on mortality. The AJCC pathological prognostic score strongly correlated with survival; thus, hazard ratios increased as the score rose, being 2.31, 4.00, 4.94, 7.92, 2.26, 14.9 and 58.9 for scores IB, IIA, IIB, IIIA, IIIB, IIIC and IV, respectively. Both TNM staging and histological/molecular biomarkers are associated with overall survival in Spanish women with breast cancer; when both are combined in the AJCC pathological prognosis score, the prognostic value improved with risk indices that increased rapidly as the pathological prognosis score increased The online version of this article (10.1007/s10549-020-05600-x) contains supplementary material, which is available to authorised users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study)

  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Espinosa, Ana|||0000-0001-7399-3267
  • Castelló, Adela|||0000-0002-1308-9927
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Guevara, Marcela|||0000-0001-9242-6364
  • Martín, Vicente|||0000-0003-0552-2804
  • Amiano, Pilar
  • Alguacil, Juan|||0000-0003-2703-9725
  • Peiro, Rosana
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Costas, Laura
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Jimenez, Jose Juan
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Llorca, Javier|||0000-0001-8569-861X
  • Moreno-Iribas, Conchi|||0000-0001-6537-0131
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Oribe, Madalen
  • Aragonés, Nuria
  • Papantoniou, Kyriaki|||0000-0002-0340-9659
  • Pollán, Marina|||0000-0002-4328-1565
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Romaguera, Dora|||0000-0002-5762-8558
Modern life involves mistimed sleeping and eating patterns that in experimental studies are associated with adverse health effects. We assessed whether timing of meals is associated with breast and prostate cancer risk taking into account lifestyle and chronotype, a characteristic correlating with preference for morning or evening activity. We conducted a population-based case-control study in Spain, 2008-2013. In this analysis we included 621 cases of prostate and 1,205 of breast cancer and 872 male and 1,321 female population controls who had never worked night shift. Subjects were interviewed on timing of meals, sleep and chronotype and completed a Food Frequency Questionaire. Adherence to the World Cancer Research Fund/American Institute of Cancer Research recommendations for cancer prevention was examined. Compared with subjects sleeping immediately after supper, those sleeping two or more hours after supper had a 20% reduction in cancer risk for breast and prostate cancer combined (adjusted Odds Ratio [OR] = 0.80, 95%CI 0.67-0.96) and in each cancer individually (prostate cancer OR = 0.74, 0.55-0.99; breast cancer OR = 0.84, 0.67-1.06). A similar protection was observed in subjects having supper before 9 pm compared with supper after 10 pm. The effect of longer supper-sleep interval was more pronounced among subjects adhering to cancer prevention recommendations (OR both cancers= 0.65, 0.44-0.97) and in morning types (OR both cancers = 0.66, 0.49-0.90). Adherence to diurnal eating patterns and specifically a long interval between last meal and sleep are associated with a lower cancer risk, stressing the importance of evaluating timing in studies on diet and cancer. What's new? Evidence shows that long-term disruption of endogenous circadian rhythms may be associated with cancer. The effects of mistimed sleeping and eating patterns that come with modern life are however less clear. This large Spanish population-based study examined whether meal timing and sleep patterns are associated with the two most common nightshift-related cancers. Adherence to a more diurnal eating pattern, and specifically an early supper and a long interval between last meal and sleep were associated with a lower breast and prostate cancer risk, stressing the importance of evaluating circadian rhythms in diet and cancer studies and revisiting recommendations for prevention.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis

  • Salagre, Estela|||0000-0001-6352-5179
  • Grande, Iria|||0000-0002-0137-0666
  • Solé, Brisa|||0000-0003-1673-8248
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Moreno, Carmen|||0000-0003-0541-4846
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Verdolini, Norma|||0000-0001-9488-2881
  • Carvalho, André F.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bernardo, Miquel|||0000-0001-8748-6717
Being able to predict functional outcomes after First-Episode Psychosis (FEP) is a major goal in psychiatry. Thus, we aimed to identify trajectories of psychosocial functioning in a FEP cohort followed-up for 2 years in order to find premorbid/baseline predictors for each trajectory. Additionally, we explored diagnosis distribution within the different trajectories. A total of 261 adults with FEP were included. Latent class growth analysis identified four distinct trajectories: Mild impairment-Improving trajectory (Mi-I) (38.31% of the sample), Moderate impairment-Stable trajectory (Mo-S) (18.39%), Severe impairment-Improving trajectory (Se-I) (12.26%), and Severe impairment-Stable trajectory (Se-S) (31.03%). Participants in the Mi-I trajectory were more likely to have higher parental socioeconomic status, less severe baseline depressive and negative symptoms, and better premorbid adjustment than individuals in the Se-S trajectory. Participants in the Se-I trajectory were more likely to have better baseline verbal learning and memory and better premorbid adjustment than those in the Se-S trajectory. Lower baseline positive symptoms predicted a Mo-S trajectory vs. Se-S trajectory. Diagnoses of Bipolar disorder and Other psychoses were more prevalent among individuals falling into Mi-I trajectory. Our findings suggest four distinct trajectories of psychosocial functioning after FEP. We also identified social, clinical, and cognitive factors associated with more resilient trajectories, thus providing insights for early interventions targeting psychosocial functioning.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dietary Constituents, Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Gutiérrez-Ruiz, Nuria
  • Aragonés, Nuria
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Guevara, Marcela|||0000-0001-9242-6364
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Fernández-Tardon, Guillermo|||0000-0002-7680-158X
  • Molina-Barceló, Ana|||0000-0001-5113-6475
  • Alguacil, Juan|||0000-0003-2703-9725
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Rodríguez-Cundín, Paz
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Canseco Fernandez, Rosario
  • Castilla, Jesus|||0000-0002-6396-7265
  • Molinuevo, Amaia
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed up. Information about their dietary habits before diagnosis was collected using a semi-quantitative Food Frequency Questionnaire. Participants without FFQ or with implausible energy intake were excluded. The total amount consumed of each nutrient (Kcal/day) was divided into tertiles, considering as "high intakes" those above third tertile. The main effect studied was overall survival. Cox regression was used to assess the association between death and nutrient intake. During a median follow-up of 6.5 years, 171 deaths were observed. None of the nutrients analysed was associated with mortality in the whole sample. However, in normal-weight women (BMI 18.5-25 kg/m 2) a high intake of carbohydrates (≥809 Kcal/day), specifically monosaccharides (≥468 Kcal/day), worsened prognostic compared to lowest (≤352 Kcal/day). Hazard Ratios (HRs) for increasing tertiles of intake were HR:2.22 95% CI (1.04 to 4.72) and HR:2.59 95% CI (1.04 to 6.48), respectively (p trend = 0.04)). Conversely, high intakes of polyunsaturated fats (≥135 Kcal/day) improved global survival (HR: 0.39 95% CI (0.15 to 1.02) p -trend = 0.05) compared to the lowest (≤92.8 kcal/day). In addition, a protective effect was found substituting 100 kcal of carbohydrates with 100 kcal of fats in normal-weight women (HR: 0.76 95% CI (0.59 to 0.98)). Likewise, in premenopausal women a high intake of fats (≥811 Kcal/day) showed a protective effect (HR:0.20 95% CI (0.04 to 0.98) p trend = 0.06). Finally, in Estrogen Receptors (ER) negative tumors, we found a protective effect of high intake of animal proteins (≥238 Kcal/day, HR: 0.24 95% CI (0.06 to 0.98). According to our results, menopausal status, BMI and ER status could play a role in the relationship between diet and BC survival and must be taken into account when studying the influence of different nutrients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validating a breast cancer score in Spanish women. The MCC-Spain study

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Palazuelos, Camilo
  • Fernández-Navarro, Pablo|||0000-0001-9427-2581
  • Altzibar, Jone M.
  • González-Donquiles, Carmen
  • Ardanaz, Eva
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Alonso Molero, Jessica|||0000-0002-1939-8798
  • Vidal, Carmen|||0000-0003-2768-2710
  • Bayo-Calero, Juan
  • Tardón, Adonina|||0000-0001-5150-1209
  • Salas, Dolores|||0000-0003-0064-1222
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Morros, Rosa|||0000-0001-6752-8748
  • Rodriguez-Cundin, Paz
  • Vinyals, Gemma Castaño
  • Ederra, María
  • Vilorio-Marqués, Laura
  • Amiano, Pilar
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, 1,732 breast cancer cases and 1,910 controls were studied. The GRS92, modifiable and non-modifiable risk factor scores were estimated via logistic regression. SNPs without available genotyping were simulated as in the aforementioned 2016 study. The full model score was obtained by combining GRS92, modifiable and non-modifiable risk factor scores. Score performances were tested via the area under the ROC curve (AUROC), net reclassification index (NRI) and integrated discrimination improvement (IDI). Compared with non-modifiable and modifiable factor scores, GRS92 had higher discrimination power (AUROC: 0.6195, 0.5885 and 0.5214, respectively). Adding the non-modifiable factor score to GRS92 improved patient classification by 23.6% (NRI = 0.236), while the modifiable factor score only improved it by 7.2%. The full model AUROC reached 0.6244. A simulation study showed the ability of the full model for identifying women at high risk for breast cancer. In conclusion, a model combining genetic and risk factors can be used for stratifying women by their breast cancer risk, which can be applied to individualizing genetic counseling and screening recommendations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride

  • Sánchez, Elisabet|||0000-0002-3280-9301
  • Nieto Sáchica, Juan Camilo|||0000-0002-3400-1488
  • Vidal, Silvia|||0000-0002-3909-6682
  • Santiago, Alba|||0000-0002-3773-8020
  • Martínez, Xavier
  • Sancho, Francesc J.
  • Sancho-Bru, Pau|||0000-0001-5569-9259
  • Mirelis, Beatriz
  • Corominola, Helena
  • Juárez Rubio, Cándido|||0000-0003-2235-9893
  • Manichanh, Chaysavanh|||0000-0002-2287-4003
  • Guarner, Carlos|||0000-0001-5957-9481
  • Soriano, German|||0000-0002-9267-6811
Probiotics can prevent pathological bacterial translocation by modulating intestinal microbiota and improving the gut barrier. The aim was to evaluate the effect of a fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 on bacterial translocation in rats with carbon tetrachloride (CCl)-induced cirrhosis. Sprague-Dawley rats treated with CCl were randomized into a probiotic group that received fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 in drinking water or a water group that received water only. Laparotomy was performed one week after ascites development. We evaluated bacterial translocation, intestinal microbiota, the intestinal barrier and cytokines in mesenteric lymph nodes and serum. Bacterial translocation decreased and gut dysbiosis improved in the probiotic group compared to the water group. The ileal β-defensin-1 concentration was higher and ileal malondialdehyde levels were lower in the probiotic group than in water group. There were no differences between groups in serum cytokines but TNF-α levels in mesenteric lymph nodes were lower in the probiotic group than in the water group. Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 decreases bacterial translocation, gut dysbiosis and ileal oxidative damage and increases ileal β-defensin-1 expression in rats treated with CCl, suggesting an improvement in the intestinal barrier integrity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer, results from the EPIC Cohort

  • Roura, Esther
  • Travier, Noémie
  • Waterboer, Tim
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Bosch José, Francesc Xavier|||0000-0002-7172-3412
  • Pawlita, Michael
  • Pala, Valeria
  • Weiderpass, Elisabete
  • Margall, Núria|||0000-0001-9370-6931
  • Dillner, Joakim
  • Gram, Inger T.
  • Tjønneland, Anne
  • Munk, Christian
  • Palli, Domenico
  • Khaw, Kay-Tee
  • Overvad, Kim
  • Clavel-Chapelon, Françoise
  • Mesrine, Sylvie
  • Fournier, Agnès
  • Fortner, Renée T.
  • Ose, Jennifer
  • Steffen, Annika
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Orfanos, Philippos
  • Masala, Giovanna
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Polidoro, Silvia
  • Mattiello, Amalia
  • Lund, Eiliv
  • Peeters, Petra H.
  • Bueno-de-Mesquita, H. Bas
  • Quirós García, José Ramón
  • Sánchez Pérez, María José|||0000-0003-4817-0757
  • Navarro Sánchez, Carmen|||0000-0001-8896-7483
  • Barricarte, Aurelio
  • Larrañaga, Nerea
  • Ekström, Johanna
  • Lindquist, David
  • Idahl, Annika
  • Travis, Ruth C.
  • Merritt, Melissa A.
  • Gunter, Marc J.
  • Rinaldi, Sabina
  • Tommasino, Massimo
  • Franceschi, Silvia
  • Riboli, Elio
  • Castellsagué, Xavier|||0000-0002-0802-3595
In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). We followed a cohort of 308,036 women recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. At enrollment, participants completed a questionnaire and provided serum. After a 9-year median follow-up, 261 ICC and 804 CIN3/CIS cases were reported. In a nested case-control study, the sera from 609 cases and 1,218 matched controls were tested for L1 antibodies against HPV types 11,16,18,31,33,35,45,52,58, and antibodies against Chlamydia trachomatis and Human herpesvirus 2. Multivariate analyses were performed to estimate hazard ratios (HR), odds ratios (OR) and corresponding 95% confidence intervals (CI). The cohort analysis showed that number of full-term pregnancies was positively associated with CIN3/CIS risk (p-trend = 0.03). Duration of oral contraceptives use was associated with a significantly increased risk of both CIN3/CIS and ICC (HR = 1.6 and HR = 1.8 respectively for ≥15 years versus never use). Ever use of menopausal hormone therapy was associated with a reduced risk of ICC (HR = 0.5, 95%CI: 0.4-0.8). A non-significant reduced risk of ICC with ever use of intrauterine devices (IUD) was found in the nested case-control analysis (OR = 0.6). Analyses restricted to all cases and HPV seropositive controls yielded similar results, revealing a significant inverse association with IUD for combined CIN3/CIS and ICC (OR = 0.7). Even though HPV is the necessary cause of CC, our results suggest that several hormonal factors are risk factors for cervical carcinogenesis. Adherence to current cervical cancer screening guidelines should minimize the increased risk of CC associated with these hormonal risk factors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population, The MCC-Spain Study

  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Palazuelos, Camilo
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Lope, Virginia
  • Tusquets, Ignasi
  • Alonso, María Henar
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Amiano, Pilar
  • Molina de la Torre, Antonio José
  • Barricarte, Aurelio
  • Tardón, Adonina|||0000-0001-5150-1209
  • Camacho, Antonio
  • Peiro-Perez, Rosana
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Muñoz, Montse
  • Michelena-Echeveste, Maria Jesus
  • Ortega Valin, Luis
  • Guevara, Marcela|||0000-0001-9242-6364
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers. In this case-control study, we report the antihypertensive drugs-breast cancer relationship in 1,736 breast cancer cases and 1,895 healthy controls; results are reported stratifying by the women's characteristics (i.e., menopausal status or body mass index category) tumor characteristics and length of use of antihypertensive drugs. The relationship among breast cancer and use of calcium channel blockers (CCB) for 5 or more years had odds ratio (OR) = 1.77 (95% CI, 0.99 to 3.17). Stratifying by BMI, the OR increased significantly in the group with BMI ≥ 25 (OR 2.54, 95% CI, 1.24 to 5.22). CCBs were even more strongly associated with more aggressive tumors, (OR for invasive tumors = 1.96, 95% CI = 1.09 to 3.53; OR for non ductal cancers = 3.97, 95% CI = 1.73 to 9.05; OR for Erbb2+ cancer = 2.97, 95% CI: 1.20 to 7.32). On the other hand, premenopausal women were the only group in which angiotensin II receptor blockers may be associated with breast cancer (OR = 4.27, 95% CI = 1.32 to 13.84) but this could not be identified with any type or stage. Use of angiotensin-converting-enzyme inhibitors, beta blockers and diuretics were not associated with risk. In this large population-based study we found that long term use of calcium channel blockers is associated with some subtypes of breast cancer (and with breast cancer in overweight women).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer, The Spanish Multi-Case-control (MCC) study

  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Gomez-Acebo, Ines|||0000-0001-8793-8314
  • de Pedro, María
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Servitja, Sonia|||0000-0001-6988-4519
  • Morros, Rosa|||0000-0001-6752-8748
  • Amiano, Pilar
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Barricarte, Aurelio
  • Tardón, Adonina|||0000-0001-5150-1209
  • Diaz-Santos, Marian
  • Peiro-Perez, Rosana
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Lope, Virginia
  • Gracia-Lavedan, Esther
  • Alonso, M. Henar
  • Michelena-Echeveste, Maria Jesus
  • García Palomo, Andrés|||0000-0002-9159-9025
  • Guevara, Marcela|||0000-0001-9242-6364
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Aragonés, Nuria
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Pollán, Marina|||0000-0002-4328-1565
  • Llorca, Javier|||0000-0001-8569-861X
The relationship between non-steroidal anti-inflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this effect. Most studies have dealt with NSAIDs as a whole group or with specific drugs, such aspirin, ibuprofen, or others, but not with NSAID subgroups according to the Anatomical Therapeutic Chemical Classification System; moreover, scarce attention has been paid to their effect on different tumor categories (i.e.: ductal/non-ductal, stage at diagnosis or presence of hormonal receptors). In this case-control study, we report the NSAID - breast cancer relationship in 1736 breast cancer cases and 1895 healthy controls; results are reported stratifying by the women's characteristics (i.e.: menopausal status or body mass index category) and by tumor characteristics. In our study, NSAID use was associated with a 24 % reduction in breast cancer risk (Odds ratio [OR] = 0.76; 95 % Confidence Interval [CI]: 0.64-0.89), and similar results were found for acetic acid derivatives, propionic acid derivatives and COXIBs, but not for aspirin. Similar results were found in postmenopausal and premenopausal women. NSAID consumption also protected against hormone + or HER2+ cancers, but not against triple negative breast cancers. The COX-2 selectivity showed an inverse association with breast cancer (i.e. OR < 1), except in advanced clinical stage and triple negative cancers. Most NSAIDs, but not aspirin, showed an inverse association against breast cancer; this effect seems to be restricted to hormone + or HER2+ cancers. The online version of this article (doi:10.1186/s12885-016-2692-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Abnormal Social Reward Responses in Anorexia Nervosa, An fMRI Study

  • Via, Esther|||0000-0002-2331-3232
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Sánchez Díaz, Isabel María|||0000-0001-5874-8204
  • Forcano, Laura|||0000-0002-8478-1451
  • Harrison, Ben J.
  • Davey, Christopher|||0000-0003-1431-3852
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Cardoner, Narcís|||0000-0001-9633-0888
Patients with anorexia nervosa (AN) display impaired social interactions, implicated in the development and prognosis of the disorder. Importantly, social behavior is modulated by reward-based processes, and dysfunctional at-brain-level reward responses have been involved in AN neurobiological models. However, no prior evidence exists of whether these neural alterations would be equally present in social contexts. In this study, we conducted a cross-sectional social-judgment functional magnetic resonance imaging (fMRI) study of 20 restrictive-subtype AN patients and 20 matched healthy controls. Brain activity during acceptance and rejection was investigated and correlated with severity measures (Eating Disorder Inventory -EDI-2) and with personality traits of interest known to modulate social behavior (The Sensitivity to Punishment and Sensitivity to Reward Questionnaire). Patients showed hypoactivation of the dorsomedial prefrontal cortex (DMPFC) during social acceptance and hyperactivation of visual areas during social rejection. Ventral striatum activation during rejection was positively correlated in patients with clinical severity scores. During acceptance, activation of the frontal opercula-anterior insula and dorsomedial/dorsolateral prefrontal cortices was differentially associated with reward sensitivity between groups. These results suggest an abnormal motivational drive for social stimuli, and involve overlapping social cognition and reward systems leading to a disruption of adaptive responses in the processing of social reward. The specific association of reward-related regions with clinical and psychometric measures suggests the putative involvement of reward structures in the maintenance of pathological behaviors in AN.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Attitudes and Perceptions about Clinical Guidelines, A Qualitative Study with Spanish Physicians

  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Carrasco, José Miguel
  • Díaz del Campo, Petra
  • Gracia, Javier
  • Orrego, Carola|||0000-0002-2978-6268
  • Martínez, Flora
  • Kotzeva, Anna
  • Guillamón, Imma
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • De Gaminde, Idoia|||0000-0002-0275-8849
  • Louro González, Arturo|||0000-0002-8334-9210
  • Rotaeche, Rafael
  • Salcedo, Flavia
  • Velázquez, Paola
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Clinical guidelines (CGs) are popular for healthcare decision making but their acceptability and use by healthcare providers is influenced by numerous factors. Some of these factors are professional-related, such as knowledge and perceptions of and attitudes toward CGs in general. The aim of our study was to evaluate attitudes and perceptions of Spanish physicians towards CGs. We coordinated six discussion groups with a total of 46 physicians. The participants were drawn from 12 medical specialties from both specialized and primary care. We recorded the sessions and transcribed the content verbatim. We analyzed the data using an approach based on the grounded theory. We identified two main constructs that defined the physicians' perceptions towards guidelines: knowledge and usefulness. "Knowledge" defined the theoretical meanings of guidelines, while "Usefulness" referred to the pragmatic approach to guidelines. These constructs were interrelated through a series of categories such as confidence, usability, accessibility, dissemination and formats. In our study, the constructs that impacted most on physician's attitudes to clinical guidelines were knowledge and usefulness. The tension between the theoretical and the pragmatic constructs determined the attitudes and how physicians use guidelines. Groups developing guidelines should ask relevant clinical questions and develop implementable and context specific recommendations. Developers should be explicit and consistent in the development and presentation of recommendations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Oligonucleotide Arrays vs. Metaphase-Comparative Genomic Hybridisation and BAC Arrays for Single-Cell Analysis, First Applications to Preimplantation Genetic Diagnosis for Robertsonian Translocation Carriers

  • Ramos Masdeu, Laia|||0000-0003-0869-8063
  • Rey Azpiri, Javier del|||0000-0001-7887-7871
  • Daina Noves, Gemma
  • García Aragonés, Manel
  • Armengol, Lluís
  • Fernandez Encinas, Alba|||0000-0003-2701-4739
  • Parriego, Mònica|||0000-0002-6459-3947
  • Boada i Palà, Montserrat|||0000-0003-0389-0638
  • Martinez-Pasarell, Olga|||0000-0002-9760-2854
  • Martorell, Maria Rosa
  • Casagran, Oriol
  • Benet i Català, Jordi|||0000-0001-6185-2555
  • Navarro i Ferreté, Joaquima|||0000-0002-9245-2260
Comprehensive chromosome analysis techniques such as metaphase-Comparative Genomic Hybridisation (CGH) and array-CGH are available for single-cell analysis. However, while metaphase-CGH and BAC array-CGH have been widely used for Preimplantation Genetic Diagnosis, oligonucleotide array-CGH has not been used in an extensive way. A comparison between oligonucleotide array-CGH and metaphase-CGH has been performed analysing 15 single fibroblasts from aneuploid cell-lines and 18 single blastomeres from human cleavage-stage embryos. Afterwards, oligonucleotide array-CGH and BAC array-CGH were also compared analysing 16 single blastomeres from human cleavage-stage embryos. All three comprehensive analysis techniques provided broadly similar cytogenetic profiles; however, non-identical profiles appeared when extensive aneuploidies were present in a cell. Both array techniques provided an optimised analysis procedure and a higher resolution than metaphase-CGH. Moreover, oligonucleotide array-CGH was able to define extra segmental imbalances in 14.7% of the blastomeres and it better determined the specific unbalanced chromosome regions due to a higher resolution of the technique (≈20 kb). Applicability of oligonucleotide array-CGH for Preimplantation Genetic Diagnosis has been demonstrated in two cases of Robertsonian translocation carriers 45,XY,der(13;14)(q10;q10). Transfer of euploid embryos was performed in both cases and pregnancy was achieved by one of the couples. This is the first time that an oligonucleotide array-CGH approach has been successfully applied to Preimplantation Genetic Diagnosis for balanced chromosome rearrangement carriers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Serum Biomarker gMS-Classifier2, Predicting Conversion to Clinically Definite Multiple Sclerosis

  • Arrambide, Georgina|||0000-0002-2657-5510
  • Espejo, Carmen|||0000-0001-9949-5901
  • Yarden, Jennifer
  • Fire, Ella
  • Spector, Larissa
  • Dotan, Nir
  • Dukler, Avinoam
  • Rovira, Alex|||0000-0002-2132-6750
  • Montalban, Xavier|||0000-0002-0098-9918
  • Tintoré, Mar|||0000-0001-9999-5359
Anti-glycan antibodies can be found in autoimmune diseases. IgM against glycan P63 was identified in clinically isolated syndromes (CIS) and included in gMS-Classifier2, an algorithm designed with the aim of identifying patients at risk of a second demyelinating attack. To determine the value of gMS-Classifier2 as an early and independent predictor of conversion to clinically definite multiple sclerosis (CDMS). Data were prospectively acquired from a CIS cohort. gMS-Classifier2 was determined in patients first seen between 1995 and 2007 with ≥ two 200 µL serum aliquots (N = 249). The primary endpoint was time to conversion to CDMS at two years, the factor tested was gMS-Classifier2 status (positive/negative) or units; other exploratory time points were 5 years and total time of follow-up. Seventy-five patients (30.1%) were gMS-Classifier2 positive. Conversion to CDMS occurred in 31/75 (41.3%) of positive and 45/174 (25.9%) of negative patients (p = 0.017) at two years. Median time to CDMS was 37.8 months (95% CI 10.4-65.3) for positive and 83.9 months (95% CI 57.5-110.5) for negative patients. gMS-Classifier2 status predicted conversion to CDMS within two years of follow-up (HR = 1.8, 95% CI 1.1-2.8; p = 0.014). gMS-Classifier2 units were also independent predictors when tested with either Barkhof criteria and OCB (HR = 1.2, CI 1.0-1.5, p = 0.020) or with T2 lesions and OCB (HR = 1.3, CI 1.1-1.5, p = 0.008). Similar results were obtained at 5 years of follow-up. Discrimination measures showed a significant change in the area under the curve (ΔAUC) when adding gMS-Classifier2 to a model with either Barkhof criteria (ΔAUC 0.0415, p = 0.012) or number of T2 lesions (ΔAUC 0.0467, p = 0.009), but not when OCB were added to these models. gMS-Classifier2 is an independent predictor of early conversion to CDMS and could be of clinical relevance, particularly in cases in which OCB are not available
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients

  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Mateo, Maria Gracia
  • Pruvost, Alain
  • Torres, Ferran|||0000-0002-7355-7913
  • Salazar, Juliana|||0000-0002-3581-4499
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Domingo, Joan Carles|||0000-0002-6356-0836
  • Fernandez, Irene
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Vidal, Francesc|||0000-0002-6692-6186
  • Baiget Bastús, Montserrat
  • Calle Martín, Óscar de la|||0000-0001-9717-053X
To assess in a cohort of Caucasian patients exposed to stavudine (d4T) the association of polymorphisms in pyrimidine pathway enzymes and HLA-B*40∶01 carriage with HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS). Three-hundred and thirty-six patients, 187 with HALS and 149 without HALS, and 72 uninfected subjects were recruited. The diagnosis of HALS was performed following the criteria of the Lipodystrophy Severity Grading Scale. Polymorphisms in the thymidylate synthase (TS) and methylene-tetrahydrofolate reductase (MTHFR) genes were determined by direct sequencing, HLA-B genotyping by PCR-SSOr Luminex Technology, and intracellular levels of stavudine triphosphate (d4T-TP) by a LC-MS/MS assay method. HALS was associated with the presence of a low expression TS genotype polymorphism (64.7% vs. 42.9%, OR = 2.43; 95%CI: 1.53-3.88, P<0.0001). MTHFR gene polymorphisms and HLA-B*40∶01 carriage were not associated with HALS or d4T-TP intracellular levels. Low and high expression TS polymorphisms had different d4T-TP intracellular levels (25.60 vs. 13.60 fmol/10 6 cells, P<0.0001). Independent factors associated with HALS were(OR [95%CI]: (a) Combined TS and MTHFR genotypes (p = 0.006, reference category (ref.): 'A+A'; OR for 'A+B' vs. ref.: 1.39 [0.69-2.80]; OR for 'B+A' vs. ref.: 2.16 [1.22-3.83]; OR for 'B+B' vs. ref.: 3.13, 95%CI: 1.54-6.35), (b) maximum viral load ≥5 log10 (OR: 2.55, 95%CI: 1.56-4.14, P = 0.001), (c) use of EFV (1.10 [1.00-1.21], P = 0.008, per year of use). HALS is associated with combined low-expression TS and MTHFR associated with high activity polymorphisms but not with HLA-B*40∶01 carriage in Caucasian patients with long-term exposure to stavudine.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus, Relationship with Cardiovascular Risk Factors. A Case-Control Study

  • Llauradó, Gemma|||0000-0002-3237-6366
  • González Clemente, José Miguel|||0000-0002-7409-8720
  • Maymó-Masip, Elsa
  • Subías, David
  • Vendrell, Joan|||0000-0002-6994-6115
  • Chacón, Matilde R.
To test the usefulness of serum concentrations of tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and soluble scavenger receptor CD163 (sCD163) as markers of subtle inflammation in patients with type 1 diabetes mellitus (T1DM) without clinical cardiovascular (CV) disease and to evaluate their relationship with arterial stiffness (AS). Sixty-eight patients with T1DM and 68 age and sex-matched, healthy subjects were evaluated. Anthropometrical variables and CV risk factors were recorded. Serum concentrations of sTWEAK and sCD163 were measured. AS was assessed by aortic pulse wave velocity (aPWV). All statistical analyses were stratified by gender. T1DM patients showed lower serum concentrations of sTWEAK (Men: 1636.5 (1146.3-3754.8) pg/mL vs. 765.9 (650.4-1097.1) pg/mL; p<0.001. Women: 1401.0 (788.0-2422.2) pg/mL vs. 830.1 (562.6-1175.9) pg/mL; p = 0.011) compared with their respective controls. Additionally, T1DM men had higher serum concentrations of sCD163 (285.0 (247.7-357.1) ng/mL vs. 224.8 (193.3-296.5) ng/mL; p = 0.012) compared with their respective controls. sTWEAK correlated negatively with aPWV in men (r = -0.443; p<0.001). However, this association disappeared after adjusting for potential confounders. In men, the best multiple linear regression model showed that the independent predictors of sTWEAK were T1DM and WHR (R 2 = 0.640; p<0.001). In women, T1DM and SBP were the independent predictors for sTWEAK (R 2 = 0.231; p = 0.001). sTWEAK is decreased in T1DM patients compared with age and sex-matched healthy subjects after adjusting for classic CV risk factors, although sTWEAK levels may be partially influenced by some of them. Additionally, T1DM men have higher serum concentrations of sCD163. These results point out an association between the inflammatory system and CV risk in T1DM.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia

  • Lage, Carmen|||0000-0003-1703-121X
  • López-García, Sara
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Kazimierczak, Martha
  • Aracil-Bolaños, Ignacio|||0000-0002-8246-5025
  • Calvo-Córdoba, Alberto
  • Pozueta, Ana
  • García-Martínez, María
  • Fernández-Rodríguez, Andrea
  • Bravo-González, María
  • Jiménez-Bonilla, Julio
  • Banzo, Ignacio
  • Irure-Ventura, Juan
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Fortea, Juan|||0000-0002-1340-638X
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Lleó, Alberto|||0000-0002-2568-5478
  • García-Cena, Cecilia E.
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
Oculomotor behavior can provide insight into the integrity of widespread cortical networks, which may contribute to the differential diagnosis between Alzheimer's disease and frontotemporal dementia. Three groups of patients with Alzheimer's disease, behavioral variant of frontotemporal dementia (bvFTD) and semantic variant of primary progressive aphasia (svPPA) and a sample of cognitively unimpaired elders underwent an eye-tracking evaluation. All participants in the discovery sample, including controls, had a biomarker-supported diagnosis. Oculomotor correlates of neuropsychology and brain metabolism evaluated with 18F-FDG PET were explored. Machine-learning classification algorithms were trained for the differentiation between Alzheimer's disease, bvFTD and controls. A total of 93 subjects (33 Alzheimer's disease, 24 bvFTD, seven svPPA, and 29 controls) were included in the study. Alzheimer's disease was the most impaired group in all tests and displayed specific abnormalities in some visually-guided saccade parameters, as pursuit error and horizontal prosaccade latency, which are theoretically closely linked to posterior brain regions. BvFTD patients showed deficits especially in the most cognitively demanding tasks, the antisaccade and memory saccade tests, which require a fine control from frontal lobe regions. SvPPA patients performed similarly to controls in most parameters except for a lower number of correct memory saccades. Pursuit error was significantly correlated with cognitive measures of constructional praxis and executive function and metabolism in right posterior middle temporal gyrus. The classification algorithms yielded an area under the curve of 97.5% for the differentiation of Alzheimer's disease vs. controls, 96.7% for bvFTD vs. controls, and 92.5% for Alzheimer's disease vs. bvFTD. In conclusion, patients with Alzheimer's disease, bvFTD and svPPA exhibit differentiating oculomotor patterns which reflect the characteristic neuroanatomical distribution of pathology of each disease, and therefore its assessment can be useful in their diagnostic work-up. Machine learning approaches can facilitate the applicability of eye-tracking in clinical practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A longitudinal study of gene expression in first-episode schizophrenia, exploring relapse mechanisms by co-expression analysis in peripheral blood

  • Gassó, Patricia|||0000-0001-6930-3454
  • Rodríguez, Natalia|||0000-0002-9618-9383
  • Martínez Piñeiro, Alberto|||0000-0003-2035-5979
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Ribeiro-Fernández, María
  • González-Peñas, Javier|||0000-0002-3850-3012
  • Zorrilla, Iñaki|||0000-0001-6444-8208
  • Martínez Sadurní, Laura|||0000-0001-8693-8902
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ibáñez, Ángela
  • Usall, Judith|||0000-0002-1746-7737
  • Lobo, Antonio|||0000-0002-9098-655X
  • Moren, C.
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Parellada, Mara|||0000-0001-7977-3601
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Berrocoso, E.
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Mas, Sergi|||0000-0003-3336-6298
  • Alonso-Solís, Anna|||0000-0002-5393-9391
  • Grasa, Eva|||0000-0003-1100-7489
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Trabsa, Amira|||0000-0002-8669-0676
Little is known about the pathophysiological mechanisms of relapse in first-episode schizophrenia, which limits the study of potential biomarkers. To explore relapse mechanisms and identify potential biomarkers for relapse prediction, we analyzed gene expression in peripheral blood in a cohort of first-episode schizophrenia patients with less than 5 years of evolution who had been evaluated over a 3-year follow-up period. A total of 91 participants of the 2EPs project formed the sample for baseline gene expression analysis. Of these, 67 provided biological samples at follow-up (36 after 3 years and 31 at relapse). Gene expression was assessed using the Clariom S Human Array. Weighted gene co-expression network analysis was applied to identify modules of co-expressed genes and to analyze their preservation after 3 years of follow-up or at relapse. Among the 25 modules identified, one module was semi-conserved at relapse (DarkTurquoise) and was enriched with risk genes for schizophrenia, showing a dysregulation of the TCF4 gene network in the module. Two modules were semi-conserved both at relapse and after 3 years of follow-up (DarkRed and DarkGrey) and were found to be biologically associated with protein modification and protein location processes. Higher expression of DarkRed genes was associated with higher risk of suffering a relapse and early appearance of relapse (p = 0.045). Our findings suggest that a dysregulation of the TCF4 network could be an important step in the biological process that leads to relapse and suggest that genes related to the ubiquitin proteosome system could be potential biomarkers of relapse.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Perceptions and attitudes of clinicians in Spain toward clinical practice guidelines and grading systems, A protocol for a qualitative study and a national survey

  • Kotzeva, Anna
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Carrasco, José Miguel
  • Díaz del Campo, Petra
  • Gracia, Francisco Javier
  • Calderón, Enrique J.|||0000-0002-3166-5086
  • De Gaminde, Idoia|||0000-0002-0275-8849
  • Estrada Sabadell, M. Dolors
  • Martínez, Flora
  • Orrego, Carola|||0000-0002-2978-6268
  • Rotaeche, Rafael
  • Salcedo, Flavia
  • Velzquez, Paola
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Background: Clinical practice guidelines (CPGs) have become a very popular tool for decision making in healthcare. While there is some evidence that CPGs improve outcomes, there are numerous factors that influence their acceptability and use by healthcare providers. While evidence of clinicians' knowledge, perceptions and attitudes toward CPGs is extensive, results are still disperse and not conclusive. Our study will evaluate these issues in a large and representative sample of clinicians in Spain. Methods/Design. A mixed-method design combining qualitative and quantitative research techniques will evaluate general practitioners (GPs) and hospital-based specialists in Spain with the objective of exploring attitudes and perceptions about CPGs and evidence grading systems. The project will consist of two phases: during the first phase, group discussions will be carried out to gain insight into perceptions and attitudes of the participants, and during the second phase, this information will be completed by means of a survey, reaching a greater number of clinicians. We will explore these issues in GPs and hospital-based practitioners, with or without previous experience in guideline development. Discussion. Our study will identify and gain insight into the perceived problems and barriers of Spanish practitioners in relation to guideline knowledge and use. The study will also explore beliefs and attitudes of clinicians towards CPGs and evidence grading systems used to rate the quality of the evidence and the strength of recommendations. Our results will provide guidance to healthcare researchers and healthcare decision makers to improve the use of guidelines in Spain and elsewhere. © 2010 Kotzeva et al; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

  • Solanes, Aleix|||0000-0002-2491-200X
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Janssen, Joost|||0000-0001-7613-2067
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Arango, Celso|||0000-0003-3382-4754
  • Vieta, Eduard|||0000-0002-0548-0053
  • Castro-Fornieles, Josefina|||0000-0003-0632-2687
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Albacete, Auria|||0000-0003-4156-4972
  • Giné Serven, Eloi|||0000-0002-3130-5566
  • Parellada, Mara|||0000-0001-7977-3601
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Radua, Joaquim|||0000-0003-1240-5438
Detecting patients at high relapse risk after the first episode of psychosis (HRR-FEP) could help the clinician adjust the preventive treatment. To develop a tool to detect patients at HRR using their baseline clinical and structural MRI, we followed 227 patients with FEP for 18-24 months and applied MRIPredict. We previously optimized the MRI-based machine-learning parameters (combining unmodulated and modulated gray and white matter and using voxel-based ensemble) in two independent datasets. Patients estimated to be at HRR-FEP showed a substantially increased risk of relapse (hazard ratio = 4.58, P < 0.05). Accuracy was poorer when we only used clinical or MRI data. We thus show the potential of combining clinical and MRI data to detect which individuals are more likely to relapse, who may benefit from increased frequency of visits, and which are unlikely, who may be currently receiving unnecessary prophylactic treatments. We also provide an updated version of the MRIPredict software.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

  • Verdolini, Norma|||0000-0001-9488-2881
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Merchán-Naranjo, Jessica
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Salagre, Estela|||0000-0001-6352-5179
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Garriga, Marina|||0000-0001-7312-4969
  • Bioque, Miquel|||0000-0001-6887-7149
  • Vallespir, Catalina
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Vieta, Eduard|||0000-0002-0548-0053
  • Bernardo, Miquel|||0000-0001-8748-6717
The aim of the present study was to evaluate the contribution of family environment styles and psychiatric family history on functioning of patients presenting first-episode psychosis (FEP). Patients with FEP and healthy controls (HC) were assessed at baseline and after 2 years. The Functional Assessment Short Test (FAST) was used to assess functional outcome and the Family Environment Scale (FES) to evaluate family environment. Linear regressions evaluated the effect that family environment exerts on functioning at baseline and at 2-year follow-up, when FEP patients were diagnosed according to non-affective (NA-PSYCH) or affective psychoses (A-PSYCH). The influence of a positive parents' psychiatric history on functioning was evaluated through one-way between-groups analysis of covariance (ANCOVA) models, after controlling for family environmental styles. At baseline, FEP patients presented moderate functioning impairment, significantly worse than HC (28.65±16.17 versus 3.25±7.92; p<0.001, g = 1.91). At 2-year follow-up, the functioning of NA-PSYCH patients was significantly worse than in A-PSYCH (19.92±14.83 versus 12.46±14.86; p = 0.020, g = 0.50). No specific family environment style was associated with functioning in FEP patients and HC. On the contrary, a positive psychiatric father's history influenced functioning of FEP patients. After 2 years, worse functioning in NA-PSYCH patients was associated with lower rates of active-recreational and achievement orientated family environment and with higher rates of moral-religious emphasis and control. In A-PSYCH, worse functioning was associated with higher rates of conflict in the family. Both family environment and psychiatric history influence psychosocial functioning, with important implications for early interventions, that should involve both patients and caregivers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparative Effectiveness Research in Localized Prostate Cancer, A 10-Year Follow-up Cohort Study

  • Garin, Olatz|||0000-0001-6193-0779
  • Suárez, J.F.
  • Guedea, Ferran|||0000-0001-8798-8696
  • Pont, À.
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Goñi, Alai|||0000-0002-6365-9617
  • Mariño, Alfonso|||0000-0002-6720-3916
  • Hervás Morón, Asunción|||0000-0002-7439-1820
  • Herruzo, I.
  • Cabrera, Patricia|||0000-0001-6050-7354
  • Sancho-Pardo, Gemma|||0000-0003-2266-6172
  • Ponce de León Roca, Javier|||0000-0003-0250-2533
  • Macías Hernández, Víctor|||0000-0003-2904-5715
  • Gutierrez, Cristina
  • Castells-Esteve, Manel|||0000-0003-2370-2008
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
Purpose: Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and evidence is lacking especially for brachytherapy. The aim of this study was to assess the long-term impact of the side effects of radical prostatectomy, brachytherapy, and external radiation therapy on patients with localized prostate cancer at 10 years, using propensity score analyses. Methods and Materials: This was a prospective observational study of a cohort of men who received a diagnosis of clinically localized prostate cancer (clinical stage T1 or T2, low and intermediate risk group) and were treated with radical prostatectomy (n = 139), brachytherapy (n = 317), or external radiation therapy (n = 194). Treatment decisions were jointly made by patients and physicians. Patient-reported outcome (PRO) evaluation included the Expanded Prostate Cancer Index Composite and Short Form-36, administered centrally by telephone interviews before and annually after treatment. The Expanded Prostate Cancer Index Composite covers urinary, bowel, sexual, and hormonal domains. To assess PRO changes over time, while accounting for correlation among repeated measures, generalized estimating equation models adjusted by propensity scores were constructed. Results: The PRO completion rate at 10 years was 85.8%. Generalized estimating equation models showed that the pattern of radical prostatectomy side effects, with substantial urinary incontinence and sexual dysfunction, remained until 10 years after treatment (standard deviation [SD], -1.1 and -1.3, respectively). Brachytherapy produced late deterioration in urinary continence (SD, -0.4) and sexual function (SD, -0.9) that appeared midterm, but the differences from radical prostatectomy remained statistically significant at 10 years (P <.001 after adjusting by propensity score). External radiation therapy showed similar results to brachytherapy, but with bowel bother (SD, -0.3). Conclusions: Although late deterioration in radiation therapy groups attenuated differences from radical prostatectomy, relevant PRO differences still remained after 10 years. Our findings support that brachytherapy is the treatment option that causes the least impact on PROs; it is therefore an alternative to be considered when making evidence-based decisions on localized prostate cancer treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

  • Amoretti, Silvia|||0000-0001-6017-2734
  • Verdolini, Norma|||0000-0001-9488-2881
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Rabelo-da-Ponte, Francisco Diego|||0000-0001-9016-2414
  • Cuesta, Manuel J.|||0000-0003-0250-5718
  • Pina-Camacho, Laura|||0000-0003-1960-6443
  • Gomez-Ramiro, Marta|||0000-0002-3463-0866
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Solé, Brisa|||0000-0003-1673-8248
  • Carvalho, André F.
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Bernardo, Miquel|||0000-0001-8748-6717
The extreme variability in symptom presentation reveals that individuals diagnosed with a first-episode psychosis (FEP) may encompass different sub-populations with potentially different illness courses and, hence, different treatment needs. Previous studies have shown that sociodemographic and family environment factors are associated with more unfavorable symptom trajectories. The aim of this study was to examine the dimensional structure of symptoms and to identify individuals' trajectories at early stage of illness and potential risk factors associated with poor outcomes at follow-up in non-affective FEP. One hundred and forty-four non-affective FEP patients were assessed at baseline and at 2-year follow-up. A Principal component analysis has been conducted to identify dimensions, then an unsupervised machine learning technique (fuzzy clustering) was performed to identify clinical subgroups of patients. Six symptom factors were extracted (positive, negative, depressive, anxiety, disorganization and somatic/cognitive). Three distinct clinical clusters were determined at baseline: mild; negative and moderate; and positive and severe symptoms, and five at follow-up: minimal; mild; moderate; negative and depressive; and severe symptoms. Receiving a low-dose antipsychotic, having a more severe depressive symptomatology and a positive family history for psychiatric disorders were risk factors for poor recovery, whilst having a high cognitive reserve and better premorbid adjustment may confer a better prognosis. The current study provided a better understanding of the heterogeneous profile of FEP. Early identification of patients who could likely present poor outcomes may be an initial step for the development of targeted interventions to improve illness trajectories and preserve psychosocial functioning.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The effect of early life events on glucose levels in first-episode psychosis

  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Cabrera, Bibiana|||0000-0002-7749-5449
  • Bioque, Miquel|||0000-0001-6887-7149
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Díaz-Caneja, Covadonga M.|||0000-0001-8538-3175
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Vieta, Eduard|||0000-0002-0548-0053
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • García-Portilla, María Paz|||0000-0003-3643-1622
  • Gutiérrez Fraile, Miguel
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Garriga, Marina|||0000-0001-7312-4969
  • Fernández Egea, Emilio|||0000-0003-4128-8955
  • Bernardo, Miquel|||0000-0001-8748-6717
First episode of psychosis (FEP) patients display a wide variety of metabolic disturbances at onset, which might underlie these patients' increased morbidity and early mortality. Glycemic abnormalities have been previously related to pharmacological agents; however, recent research highlights the impact of early life events. Birth weight (BW), an indirect marker of the fetal environment, has been related to glucose abnormalities in the general population over time. We aim to evaluate if BW correlates with glucose values in a sample of FEP patients treated with different antipsychotics. Two hundred and thirty-six patients were included and evaluated for clinical and metabolic variables at baseline and at 2, 6, 12, and 24 months of follow-up. Pearson correlations and linear mixed model analysis were conducted to analyze the data. Antipsychotic treatment was grouped due to its metabolic risk profile. In our sample of FEP patients, BW was negatively correlated with glucose values at 24 months of follow-up [r=-0.167, p=0.037]. BW showed a trend towards significance in the association with glucose values over the 24-month period (F=3.22; p=0.073) despite other confounders such as age, time, sex, body mass index, antipsychotic type, and chlorpromazine dosage. This finding suggests that BW is involved in the evolution of glucose values over time in a cohort of patients with an FEP, independently of the type of pharmacological agent used in treatment. Our results highlight the importance of early life events in the later metabolic outcome of patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

  • Jansen, Iris E.|||0000-0003-1901-8131
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Gomez-Fonseca, Duber
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Grenier-Boley, Benjamin
  • Zettergren, Anna|||0000-0002-7182-8417
  • Mishra, Aniket|||0000-0002-8141-1543
  • Ali, Muhammad|||0000-0002-1399-6631
  • Andrade, Victor|||0000-0003-0682-269X
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Kleineidam, Luca
  • Küçükali, Fahri
  • Sung, Ju Sung
  • Tesí, Niccolo
  • Vromen, Ellen|||0000-0001-7774-5500
  • Wightman, Douglas P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Athanasiu, Lavinia
  • Bahrami, Shahram
  • Bailly, Henri
  • Belbin, Olivia|||0000-0002-6109-6371
  • Bergh, Sverre|||0000-0001-9593-2967
  • Bertram, Lars|||0000-0002-0108-124X
  • Biessels, Geert Jan|||0000-0001-6862-2496
  • Blennow, Kaj|||0000-0002-1890-4193
  • Blesa, Rafael|||0000-0003-4026-2884
  • Boada, Mercè|||0000-0003-2617-3009
  • Boland, Anne|||0000-0001-8789-5676
  • Buerger, K.
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Chene, Geneviève|||0000-0002-8368-6460
  • Claassen, Jurgen|||0000-0002-1778-8151
  • Debette, Stéphanie|||0000-0001-8675-7968
  • Deleuze, Jean-Francois
  • De Deyn, Peter Paul|||0000-0002-2228-2964
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Dufouil, Carole|||0000-0003-2442-4476
  • Duron, Emmanuelle
  • Düzel, Emrah
  • Fladby, Tormod|||0000-0002-9984-9797
  • Fortea, Juan|||0000-0002-1340-638X
  • Froelich, Lutz|||0000-0003-1494-0813
  • García-González, Pablo|||0000-0003-0125-5403
  • Garcia-Martinez, María
  • Giegling, Ina
  • Goldhardt, Oliver
  • Gobom, Johan|||0000-0001-6193-6193
  • Grimmer, Timo
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Hampel, Harald
  • Hanon, Olivier|||0000-0002-4697-122X
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Helisalmi, Seppo
  • Heneka, Michael|||0000-0003-4996-1630
  • Hernández, Isabel|||0000-0001-8119-393X
  • Herukka, Sanna-Kaisa|||0000-0003-3308-8662
  • Holstege, Henne|||0000-0002-7688-3087
  • Jarholm, Jonas
  • Kern, Silke
  • Knapskog, Anne-Brita
  • Koivisto, A.M.
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • Lage, Carmen|||0000-0003-1703-121X
  • Laske, Christoph
  • Leinonen, Ville|||0000-0002-4282-4687
  • Lewczuk, Piotr|||0000-0002-8101-6535
  • Lleó, Alberto|||0000-0002-2568-5478
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • López-Garcia, Sara
  • Maier, Wolfgang
  • Marquié, Marta|||0000-0002-0660-0950
  • Mol, Merel O.|||0000-0003-2533-2530
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Moreno, Fermin|||0000-0001-5200-3164
  • Moreno-Grau, Sonia
  • Nicolas, Gael|||0000-0001-9391-7800
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Pålhaugen, Lene
  • Papma, Janne M.
  • Pasquier, Florence|||0000-0001-9880-9788
  • Perneczky, Robert|||0000-0003-1981-7435
  • Peters, Oliver|||0000-0003-0568-2998
  • Pijnenburg, Yolande A.L.
  • Popp, Julius|||0000-0002-0068-0312
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Pozueta, Ana
  • Priller, Josef|||0000-0001-7596-0979
  • Puerta, Raquel|||0000-0002-1191-5893
  • Quintela, Inés|||0000-0002-0239-7975
  • Ramakers, Inez
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Scheltens, Philip|||0000-0002-1046-6408
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Schmid, Matthias
  • Schneider, Anja|||0000-0001-9540-8700
  • Selbæk, Geir|||0000-0001-6511-8219
  • Selnes, Per
  • Shadrin, Alexey
  • Skoog, Ingmar
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Teipel, Stefan
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • van Swieten, John C.
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Visser, Pieter Jelle|||0000-0001-8008-9727
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Waern, Margda|||0000-0002-8330-6915
  • Wagner, Michael
  • Wiltfang, Jens W.
  • Wittens, Mandy M.J.
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Zulaica, Miren
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Bjerke, Maria
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Jessen, Frank
  • Teunissen, Charlotte E.|||0000-0002-4061-0837
  • Pastor, Pau|||0000-0002-7493-8777
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for Aβ42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple Aβ42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer, a 10-year follow-up cohort study

  • Suárez, José Francisco|||0000-0001-6427-4391
  • Zamora, Víctor|||0000-0003-2061-0052
  • Garin, Olatz|||0000-0001-6193-0779
  • Gutiérrez, Cristina|||0000-0003-2626-1957
  • Pont, Angels|||0000-0002-0602-552X
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Goñi, Alai|||0000-0002-6365-9617
  • Mariño, Alfonso|||0000-0002-6720-3916
  • Hervás, Asunción
  • Herruzo, Ismael
  • Cabrera, Patricia|||0000-0001-6050-7354
  • Sancho-Pardo, Gemma|||0000-0003-2266-6172
  • Ponce de León Roca, Javier|||0000-0003-0250-2533
  • Macías Hernández, Víctor|||0000-0003-2904-5715
  • Guedea, Ferran|||0000-0001-8798-8696
  • Vigués, Francesc|||0000-0003-3717-6301
  • Castells-Esteve, Manel|||0000-0003-2370-2008
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
To compare the effectiveness at ten years of follow-up of radical prostatectomy, brachytherapy and external radiotherapy, in terms of overall survival, prostate cancer-specific mortality and biochemical recurrence. Cohort of men diagnosed with localized prostate cancer (T1/T2 and low/intermediate risk) from ten Spanish hospitals, followed for 10 years. The treatment selection was decided jointly by patients and physicians. Of 704 participants, 192 were treated with open radical retropubic prostatectomy, 317 with 125 I brachytherapy alone, and 195 with 3D external beam radiation. We evaluated overall survival, prostate cancer-specific mortality, and biochemical recurrence. Kaplan-Meier estimators were plotted, and Cox proportional-hazards regression models were constructed to estimate hazard ratios (HR), adjusted by propensity scores. Of the 704 participants, 542 patients were alive ten years after treatment, and a total of 13 patients have been lost during follow-up. After adjusting by propensity score and Gleason score, brachytherapy and external radiotherapy were not associated with decreased 10-year overall survival (aHR = 1.36, p = 0.292 and aHR = 1.44, p = 0.222), but presented higher biochemical recurrence (aHR = 1.93, p = 0.004 and aHR = 2.56, p < 0.001) than radical prostatectomy at ten years of follow-up. Higher prostate cancer-specific mortality was also observed in external radiotherapy (aHR = 9.37, p = 0.015). Novel long-term results are provided on the effectiveness of brachytherapy to control localized prostate cancer ten years after treatment, compared to radical prostatectomy and external radiotherapy, presenting high overall survival, similarly to radical prostatectomy, but higher risk of biochemical progression. These findings provide valuable information to facilitate shared clinical decision-making. Study identifier at ClinicalTrials.gov : NCT01492751.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona (Catalonia, Spain) by whole genome sequencing

  • Andrés, Cristina|||0000-0002-3200-0895
  • del Cuerpo Casas, Margarita|||0000-0001-7973-5496
  • Rabella, Núria|||0000-0002-3409-0468
  • Piñana, Maria|||0000-0002-4766-2613
  • Iglesias Cabezas, Manuel Jesús
  • González Sánchez, Alejandra|||0000-0002-1809-3415
  • Esperalba, Juliana|||0000-0003-1326-1341
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Martín, Maria Carmen
  • Fuentes, Francisco
  • Rubio, Susana
  • Saubi, Narcis|||0000-0001-5493-1044
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
Influenza B viruses (FLUBV) have segmented genomes which enables the virus to evolve by segment reassortment. Since the divergence of both FLUBV lineages, B/Victoria / 2/87 (FLUBV/VIC) and B/Yamagata/16/88 (FLUBV/YAM), PB2, PB1 and HA have kept the same ancestor, while some reassortment events in the other segments have been reported worldwide. The aim of the present study was to find out reassortment episodes in FLUBV strains detected in cases attended at Hospital Universitari Vall d'Hebron and Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) from 2004 to 2015 seasons. From October 2004 to May 2015, respiratory specimens were received from patients with respiratory tract infection suspicion. Influenza detection was carried out by either cell culture isolation, immunofluorescence or PCR-based assays. A RT-PCR was performed to distinguish both lineages by agarose gel electrophoresis. Whole genome amplification was performed using the universal primer set by Zhou et al. in 2012, and subsequently sequenced using Roche 454 GS Junior platform. Bioinformatic analysis was performed to characterise the sequences with B/Malaysia/2506/2007 and B/Florida/4/2006 corresponding sequences as reference of (B/VIC) and (B/YAM), respectively. A total of 118 FLUBV (75 FLUBV/VIC and 43 FLUBV/YAM), from 2004 to 2006, 2008-2011 and 2012-2015 seasons, were studied. The whole genome of 58 FLUBV/VIC and 42 FLUBV/YAM viruses was successfully amplified. Based on HA sequences, most FLUBV/VIC viruses (37; 64%) belonged to clade 1A (B/Brisbane/60/2008) except to 11 (19%), which fell within clade 1B (B/HongKong/514/2009) and 10 (17%) to B/Malaysia/2506/2004. Nine (20%) FLUBV/YAM viruses belonged to clade 2 (B/Massachusetts/02/2012), 18 (42%) to clade 3 (B/Phuket/3073/2013) and 15 (38%) fell within Florida/4/2006. Numerous intra-lineage reassortments in PB2, PB1, NA and NS were found in 2 2010-2011 viruses. An important inter-lineage reassortment event from 2008 to 2009 (11), 2010-2011 (26) and 2012-2013 (3) FLUBV/VIC (clade 1) strains to FLUBV/YAM (clade 3) was found, in addition to 1 reassortant NS in 2010-2011 B/VIC virus. Intra- and inter-lineage reassortment episodes were revealed by WGS. While PB2-PB1-HA remained in complex, NP and NS reassortant viruses were found in both lineages. Despite reassorment events are not often, the characterisation only by HA and NA sequences might be underestimating their detection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels, a longitudinal study and meta-analysis

  • Yeung, Edwina H.
  • Guan, Weihua
  • Zeng, Xuehuo
  • Salas, Lucas A.
  • Mumford, Sunni L.
  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Van Meel, Evelien R.
  • Malmberg, Anni
  • Sunyer, Jordi
  • Duijts, Liesbeth
  • Felix, Janine F.|||0000-0002-9801-5774
  • Czamara, Darina
  • Hämäläinen, Esa
  • Binder, Elisabeth B.
  • Raïkkönen, Katri|||0000-0003-3124-3470
  • Lahti, Jari|||0000-0002-4310-5297
  • London, Stephanie J.|||0000-0003-4911-5290
  • Silver, Robert M.
  • Schisterman, Enrique F.
Background: Prenatal inflammation has been proposed as an important mediating factor in several adverse pregnancy outcomes. C-reactive protein (CRP) is an inflammatory cytokine easily measured in blood. It has clinical value due to its reliability as a biomarker for systemic inflammation and can indicate cellular injury and disease severity. Elevated levels of CRP in adulthood are associated with alterations in DNA methylation. However, no studies have prospectively investigated the relationship between maternal CRP levels and newborn DNA methylation measured by microarray in cord blood with reasonable epigenome-wide coverage. Importantly, the timing of inflammation exposure during pregnancy may also result in different effects. Thus, our objective was to evaluate this prospective association of CRP levels measured during multiple periods of pregnancy and in cord blood at delivery which was available in one cohort (i.e., Effects of Aspirin in Gestation and Reproduction trial), and also to conduct a meta-analysis with available data at one point in pregnancy from three other cohorts from the Pregnancy And Childhood Epigenetics consortium (PACE). Secondarily, the impact of maternal randomization to low dose aspirin prior to pregnancy on methylation was assessed. Results: Maternal CRP levels were not associated with newborn DNA methylation regardless of gestational age of measurement (i.e., CRP at approximately 8, 20, and 36 weeks among 358 newborns in EAGeR). There also was no association in the meta-analyses (all p.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

From premorbid adjustment dimensions to clinical outcomes: exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes

  • Perez-Ramos, Anaid
  • Gonzalez-Segura, Àlex
  • Julià, Laura
  • García-Rizo, Clemente
  • Sánchez Torres, Ana María
  • Cavone, Vito
  • Zorrilla, Iñaki
  • Mané, Anna
  • Rodríguez-Jiménez, Roberto
  • Roldán, Alexandra
  • Pomarol-Clotet, Edith
  • Ibáñez, Ángela
  • Usall, Judith
  • Lobo, Antonio
  • Bioque, Miquel
  • Bernardo, Miguel
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Amoretti, Silvia
  • Mezquida, Gisela
  • 2EPs Working Group
Introduction Schizophrenia is a complex and multifaceted mental disorder characterized by cognitive, emotional, and behavioral dysfunctions that significantly impact the patients' daily lives. Premorbid adjustment (PA) is a multidimensional framework, the severity of which has been associated with more severe phenotypic traits and unfavorable outcomes, offering insights into the development of this disorder. This study aims to characterize a group of first-episode schizophrenia (FES) patients based on academic (PAA) and social (PSA) PA, explore the overlap across these dimensions, and examine their associations with early clinical, environmental, and epigenetic factors, through methylation profile scores (MPS). Material and methods A total of 218 FES subjects were included. K-means clustering identified "poor" and "good" groups for PAA and PSA. Clusters overlaps were explored using multiple correspondence analysis and were characterized by sociodemographic, clinical, functional, and cognitive features. Associations with clinical, environmental factors and MPS were examined using multivariable models adjusted for key covariates. Results Poor-PAA individuals showed worse cognitive performance (working memory, attention, and executive function), lower educational level, and higher cannabis use. Poor-PSA individuals had more severe negative symptoms. MPS for early-life adversity and cannabis use were associated with PSA clusters, while MPS for birth weight and tobacco use were linked to PAA clusters. Conclusions PAA and PSA dimensions show distinct clinical, cognitive, functional, and epigenetic profiles. These findings support the use of premorbid functioning subtypes for identifying early markers and tailoring interventions., This study is part of a coordinated multicenter project funded by the Ministerio de Economía y Competitividad (PI08/0208, PI11/00325, PI14/00612) (M.B.); the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF), A way to build Europe; the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); the CERCA Programme/Generalitat de Catalunya; and the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2021 SGR 01120). Furthermore, this study is part of the projects PI24/00196 (C.G.-R. and G.M.) funded by Instituto de Salud Carlos II (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, ERCA Program/Generalitat de Catalunya and Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). G.M. is a Serra Hunter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212-024, Generalitat de Catalunya). Supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD-7216 (AGES 3-CM), and CIBERSAM-ISCIII.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

From genetics to psychosocial functioning: unraveling the mediating roles of cognitive reserve, cognition, and negative symptoms in first-episode psychosis

  • Forte, María Florencia
  • Clougher, Derek
  • Segura, Àlex G.
  • Sánchez Torres, Ana María
  • Vieta, Eduard
  • Garriga, Marina
  • Lobo, Antonio
  • González Pinto, Ana
  • Díaz-Caneja, Covadonga M.
  • Roldán, Alexandra
  • Martínez-Aran, Anabel
  • Serna, Elena de la
  • Mané, Anna
  • Mas, Sergi
  • Torrent, Carla
  • Allot, Kelly
  • Bernardo, Miguel
  • Amoretti, Silvia
  • PEPs Group
  • Iris Rodríguez, Corina
Background: Studies have shown associations between polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), cognition, negative symptoms (NS), and psychosocial functioning in first-episode psychosis (FEP). However, theirspecific interactions remain unclear. This study aimed to investigate the mediating roles of CR, cognition, and NS in the relationship between PRSEA and psychosocial functioning one year after a FEP. Additionally, we sought to explore the impact of two NSsubtypes on this relationship: diminished Expression (EXP-NS) and Motivation and Pleasure (MAP-NS). Methods: A total of 138 FEP participants, predominantly male (70%), with a mean age of 24.77 years (SD = 5.29), underwent genetic, clinical, and cognitive assessments two months after study enrollment. Functioning evaluation followed at one-year follow-up. To investigate the mediating role of CR, cognition, and NS in the relationship between PRSEA and functioning, a serial mediation model was employed. Two further mediation models were tested to explore the differential impact of EXP-NS and MAP-NS. Mediation analysis was performed using the PROCESS macro version 4.1 within SPSS version 26. Results: The serial mediation model revealed a causal chain for PRSEA > CR > cognition > NS > Functioning (β = −3.08, 95%CI[−5.73, −0.43], p = 0.023). When differentiating by type of NS, only EXP-NS were significantly associated in the casual chain (β = −0.17, 95% CI [−0.39, −0.01], p < 0.05). Conclusions: CR, cognition and NS -specifically EXP-NS- mediate the association between PRSEA and psychosocial functioning at one-year follow-up in FEP patients. These results highlight the potential for personalized interventions based on genetic predisposition., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females

  • Serra-Navarro, María
  • Amoretti, Silvia
  • Verdolini, Norma
  • Forte, María Florencia
  • Sánchez Torres, Ana María
  • Vieta, Eduard
  • Clougher, Derek
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero-Gómez, Rocío
  • Roldán, Alexandra
  • Carvalho, André F.
  • Serna, Elena de la
  • Toll, Alba
  • Ramos-Quiroga, Josep Antoni
  • Torrent, Carla
  • Cuesta, Manuel J.
  • Bernardo, Miguel
  • PEPs Group
Background: Deficits in psychosocial functioning are present in the early stages of psychosis. Several factors, such as premorbid adjustment, neurocognitive performance, and cognitive reserve (CR), potentially influence functionality. Sex differences are observed in individuals with psychosis in multiple domains. Nonetheless, few studies have explored the predictive. factors of poor functioning according to sex in first-episode psychosis (FEP). This study aimed to explore sex differences, examine changes, and identify predictors of functioning according to sex after onset. Materials and methods: The initial sample comprised 588 individuals. However, only adults with non-affective FEP (n = 247, 161 males and 86 females) and healthy controls (n = 224, 142 males and 82 females) were included. A comprehensive assessment including functional, neuropsychological, and clinical scales was performed at baseline and at 2-year follow-up. A linear regression model was used to determine the predictors of functioning at 2-year follow-up. Results: FEP improved their functionality at follow-up (67.4% of both males and females). In males, longer duration of untreated psychosis (β = 0.328, p = 0.003) and worse premorbid adjustment (β = 0.256, p = 0.023) were associated with impaired functioning at 2-year follow-up, while in females processing speed (β = 0.403, p = 0.003), executive function (β = 0.299, p = 0.020) and CR (β = −0.307, p = 0.012) were significantly associated with functioning. Conclusion: Our data indicate that predictors of functioning at 2-year followup in the FEP group differ according to sex. Therefore, treatment and preventative efforts may be adjusted taking sex into account. Males may benefit from functional remediation at early stages. Conversely, in females, early interventions centered on CR enhancement and cognitive rehabilitation may be recommended., This study was funded with the projects PI17/01066 and PI20/00344 by the Instituto de Salud Carlos III and co-funded by the Unión Europea (FEDER) "Una manera de hacer Europa".
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: a two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez Torres, Ana María
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero-Gómez, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • Serna, Elena de la
  • Trabsa, Amira
  • Martínez-Aran, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miguel
  • Amoretti, Silvia
  • PEPs Group
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021 SGR 01120). Departament de Salut de la Generalitat de Catalunya, en la convocatòria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Diagnostic thresholds of cardiorespiratory fitness for identifying cardiometabolic risk in youth

  • García Hermoso, Antonio
  • Yáñez-Sepúlveda, Rodrigo
  • Hormazábal Aguayo, Ignacio
  • Muñoz Pardeza, Jacinto
  • Hurtado-Almonácid, Juan
  • Ezzatvar, Yasmin
  • Sánchez López, Mairena
  • Martínez Vizcaíno, Vicente
Background and aim: Cardiorespiratory fitness, measured as peak oxygen uptake (VO2peak), is a key marker of metabolic health in youth, but age- and sex-specific diagnostic thresholds for identifying elevated cardiometabolic risk (CMR) remain undefined. This study aimed to establish age- and sex-specific VO2peak cutpoints for elevated CMR by (i) conducting a cross-sectional diagnostic analysis that compared the diagnostic accuracy of commonly used VO2peak estimation equations (Barnett, L´eger, Matsuzaka) to select the bestperforming index, and (ii) performing a systematic review and meta-analysis to synthesize and validate findings. Methods and results: To establish diagnostic thresholds of VO2peak for identifying CMR in youth, we conducted a two-part study. First, a cross-sectional analysis was performed using data from 1059 children aged 8–11 years. Second, a systematic review and meta-analysis were conducted to synthesize evidence from existing observational studies. The literature search included four databases. Eligible studies included cross-sectional or cohort designs with participants aged 3–18 years, and reported cardiorespiratory fitness as VO2peak along with composite measures of CMR. We included 14 studies comprising a total of 20,780 children and adolescents. Optimal VO2peak thresholds for identifying elevated CMR were 43.2 mL/kg/min for boys and 41.9 mL/kg/min for girls aged <13 years, and 40.0 mL/kg/min for boys and 38.5 mL/kg/min for girls aged ≥13. These thresholds demonstrated moderate-to-strong diagnostic performance, and corresponded to the 20th-40th percentiles of international normative data. Conclusion: We report novel age- and sex-specific VO2peak thresholds for elevated CMR in youth, with good diagnostic performance, to aid early identification and prevention., This research was funded by the Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha (grant numbers PII1I09-0259-9898, POII10-0208-5325 ); Ministry of Health (grant number FIS PI081297); and the Research Network on Preventative Activities and Health Promotion (grant number RD06/0018/0038). This research was funded by FEDER funds.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

  • González-Ortega, Itxaso
  • González Pinto, Ana
  • Alberich, Susana
  • Echeburúa, Enrique
  • Bernardo, Miguel
  • Cabrera, Bibiana
  • Amoretti, Silvia
  • Lobo, Antonio
  • Arango, Celso
  • Corripio, Iluminada
  • Vieta, Eduard
  • Serna, Elena de la
  • Rodríguez-Jiménez, Roberto
  • Segarra-Echevarría, Rafael
  • López-Ilundain, José M.
  • Sánchez Torres, Ana María
  • Cuesta, Manuel J.
  • PEPs Group
Background. Social cognition has been associated with functional outcome in patients with first episode psychosis (FEP). Social cognition has also been associated with neurocognition and cognitive reserve. Although cognitive reserve, neurocognitive functioning, social cognition, and functional outcome are related, the direction of their associations is not clear. Therefore, the main aim of this study was to analyze the influence of social cognition as a mediator between cognitive reserve and cognitive domains on functioning in FEP both at baseline and at 2 years. Methods The sample of the study was composed of 282 FEP patients followed up for 2 years. To analyze whether social cognition mediates the influence of cognitive reserve and cognitive domains on functioning, a path analysis was performed. The statistical significance of any mediation effects was evaluated by bootstrap analysis. Results. At baseline, as neither cognitive reserve nor the cognitive domains studied were related to functioning, the conditions for mediation were not satisfied. Nevertheless, at 2 years of follow-up, social cognition acted as a mediator between cognitive reserve and functioning. Likewise, social cognition was a mediator between verbal memory and functional outcome. The results of the bootstrap analysis confirmed these significant mediations (95% bootstrapped CI (—10.215 to —0.337) and (—4.731 to —0.605) respectively). Conclusions. Cognitive reserve and neurocognition are related to functioning, and social cognition mediates in this relationship., This work was supported by the Carlos III Institute of Health and European Fund for Regional Development (PI08/1213, PI11/ 01977, PI14/01900, PI08/01026, PI11/02831, PI14/01621, PI08/1161, PI16/ 00359, PI16/01164, PI18/00805), the Basque Foundation for Health Innovation and Research (BIOEF), the Secretaria d´Universitats I Recerca del Departament d´Economia I Coneixement (2017 SGR 1365), and R&D activities in Biomedicine, Madrid Regional Government and Structural Funds of the European Union (S2017/BMD-3740 (AGES-CM 2-CM)).